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Editorial on the Research Topic
Exploration of the Physiological Effects of Exercise in Cardiovascular Diseases
With the cost of treatment for cardiovascular (CV) diseases increasing exponentially every year
(Vandenberghe and Albrecht, 2019) it is important to find adjunct therapies to compliment
established treatments. These should be sufficiently effective to either reverse or slow-down the
progression of these diseases and conditions, not only enhancing treatment, but also improving
patients’ quality of life. Exercise has been earmarked as one of the main lifestyle components that
could be introduced in therapeutic interventions, as it is usually easy to implement by facilitators
and be followed by clinical populations (i.e., Klonizakis et al., 2018; Mitropoulos et al., 2020),
offering also societal and quality of life benefits (Kesterton et al., 2019).
Nevertheless, exploring the physiological effects of exercise-based interventions is commonly
neglected, with the main focus of studies being given to the interventions’ therapeutic contribution.
In addition, there is limited knowledge on the methods to either diagnose patients with some
borderline diseases (or atypical symptoms) or to trace the efficiency of therapeutic approaches (in
patients); to this end, new methods are emerging, helping to detect patients at risk or the response
to exercise.
This Research Topic brings together contributions from researchers to advance our
understanding as of how exercise affects the vascular physiology of clinical populations, allowing
us to take valuable lessons and transfer the gained knowledge further.
Fanget et al. showed that establishing the force-velocity-power (FVP) relationship can support
the assessment of the dynamic force production capacities in coronary artery disease (CAD)
patients. In their study, mechanical parameters (e.g., theoretical maximum force, velocity, and the
maximal power output) were determined during cycloergometer sprint sessions to estimate the
FVP relationship slope. They suggest that the observed differences between patients and healthy
individuals reflect loss of muscle mass, remodeling of motor units or a neuromuscular activation
deficit, and potentially be of value for training adjustment and optimization.
A more invasive approach was applied by Chen et al. in a cohort of heart failure patients with
preserved ejection fraction (HFpEF). This clinical group can be difficult to diagnose, as many
patients remain asymptomatic at rest, but develop symptoms during exercise. Thus, it would be
desirable to predict the response during exercise by using non-invasive measures. The authors
showed that the stress echocardiography-derived E/e’ ratio (e.g., the ratio of early mitral inflow
velocity to early diastolic tissue velocity), which is a measure of diastolic function, can be a reliable
predictor of abnormal exercise hemodynamics in HFpEF patients.
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Chronic obstructive disease (COPD) patients are another
high-risk group, for whom the assessment of respiratory
muscles function (at rest and during exercise) can yield
useful information. Electromyography (EMG) of the
diaphragm, coupled to simultaneous cardiac activity tracing
by electrocardiogram (ECG) might represent an indirect
measure of neural respiratory drive. As ECG tracings are
prone to artifacts Dacha et al. developed a semi-automated
protocol for ECG artifacts removal during transesophageal
diaphragm EMG. Their findings suggest that the proposed
semi-automated method can reliably be used to evaluate changes
in EMG amplitudes over a wide range of minute ventilation
recorded at rest and during exercise testing in COPD patients. In
addition, compared to manual methods, the presented method
is more time-efficient, and exhibits less inter-rater variability,
and as such could be regarded as a reliable new standard
for objective EMG amplitude analyses in future clinical and
research settings.
Henni et al. have shown that transcutaneous oxymetry
(TcPO2) is a feasible and reliable, non-invasive clinical
test to assess microvascular responsiveness in patients
with thoracic outlet syndrome (TOS), regardless
of the underlying etiology. Using the standardized
Roos test, applied to challenge microcirculation,
they showed that the TcPO2 drop was correlated
either with the clinical symptoms or with the
ultrasonographic results allowing the detection of TOS
in patients. In addition, TcPO2 can be applied to
track potential benefits of surgical or conservative (e.g.,
kinesotherapy) therapies.
Stupin et al. elucidated the benefits of n-3 polyunsaturated
fatty acids (PUFAs) which have been confirmed in several
studies as an effective dietary supplement to induce pleiotropic
physiological effects, on CV, muscular and immune system, in
healthy and in CV patients. Potential mechanisms of PUFAs
action on CV system are presented, from their antithrombotic
and anti-inflammatory effects, to their potential to improve
endothelial (dys)function, respectively reducing the risk of CV
events’. Moreover, PUFA’s have also been suggested to modulate
oxygen consumption during intense exercise which may be
beneficial in increasing metabolic capacity, shifting the anaerobic
threshold, and accordingly diminish the delayed-onset muscle
soreness. Yet, the results of various studies are inconclusive
with respect of the effects of PUFAs in men and women,
in healthy and patients, and regarding their interaction with
exercise. To this end, the paper might encourage researchers
to perform additional mechanistic, epidemiologic and clinical
studies on PUFAs.
The study by Vasić et al. represents a starting point for
further research into optimal exercise modalities in CAD with
a recent myocardial infarction or revascularization procedure,
with water-based training likely emerging as a suitable exercise
option. Endurance plus calisthenics exercise training in thermo-
neutral water has been shown as safe, improving aerobic
exercise capacity and vascular function in patients undergoing
short-term residential cardiac rehabilitation after a recent
CAD event.
A review paper by Guo et al. discusses the cardioprotective
factors of exercise after myocardial infarction (MI). These
factors are secreted by or enriched in the heart and
execute their action in an autocrine or paracrine manner.
The paper focuses on Growth Differentiation Factor 15
(GDF15), Exercise-induced Follistatin-Like1 (FSTL1),
Non-coding RNAs (ncRNAs), Cardiac-derived miRNAs,
longcRNAs and Cardiomyocytes secrete extracellular
vesicles. All of these may be novel targets to study the
mechanism of exercise-induced benefits, besides traditional
signaling pathways.
Physical activity is an efficient strategy to delay development
of obesity and insulin resistance, and thus the progression
of obesity/diabetes-related cardiomyopathy. The study
by Boardman et al. explored the effect of exercise on
ischemic-tolerance when exercise was initiated after the
development of obesity-mediated cardiomiopathy in high-fat
fed mice.
The authors present the beneficial effects of exercise
training with regard to improving the ischemic-tolerance in
hearts with cardiomyopathy following obesity and insulin
resistance. This study also emphasizes the exercise-induced
improvement of cardiac energetics and mitochondrial function
in obesity/diabetes.
Finally, Kambič et al. presented the results of assessment of
the safety and efficacy of blood-flow restricted (BFR) resistance
training in patients with stable CAD compared to usual care.
Eight weeks of BFR resistance training did not show any
unfavorable cardiovascular responses (such as hemodynamic
alterations, anginal symptoms, or ventricular arrhythmias) but
was associated with significant improvements in muscle strength
and decrease in systolic blood pressure. Thus, it may be
therefore provided as an additional exercise option to aerobic
exercise to improve skeletal muscle functioning in patients
with CAD.
In conclusion, the topic encompasses a heterogenous range of
papers, that are relevant from the clinical point of view as they
can broaden therapeutic strategies and challenge researchers to
further study and elucidate unsolved questions. We look forward
that this knowledge will be used in further, larger trials and
translated to sustained clinical practice.
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Suspected Thoracic Outlet
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Background: Exercise oximetry allows operator-independent recordings of
microvascular blood flow impairments during exercise and can be used during
upper arm provocative maneuvers.
Objective: To study the test-retest reliability of upper-limb oximetry during the Roos test
in patients with suspected thoracic outlet syndrome (TOS).
Materials and Methods: Forty-two patients (28 men, 14 women; mean age:
40.8 years) were examined via transcutaneous oxygen pressure (TcpO2) recordings
during two consecutive Roos tests in the standing position. The minimal decrease
from rest of oxygen pressure (DROPmin) value was recorded after each maneuver was
performed on both arms. The area under the receiver operating characteristic (ROC)
curve defined the DROPmin diagnostic performance in the presence of symptoms
during the tests. The Mann–Whitney U-test was used to compare the DROPmin in the
symptomatic vs. asymptomatic arms. The test-retest reliability was analyzed with Bland-
Altman representations. The results are presented as means ± standard deviations (SD)
or medians [25–75 percentiles].
Results: The symptoms by history were different from the symptoms expressed during
the Roos maneuvers in one-third of the patients. The DROPmin measurements were
−19 [−36; −7] mmHg and −8 [−16; −5] mmHg in the symptomatic (n = 108) and
asymptomatic (n = 60) arms, respectively. When TOS observed on ultrasound imaging
was the endpoint, the area under the ROC curve (AUC) was 0.725 ± 0.058, with
an optimal cutoff point of −15 mmHg. This value provided 67% sensitivity and 78%
specificity for the presence TOS via ultrasound. When symptoms occurring during
the test represented the endpoint, the AUC was 0.698 ± 0.04, with a cutoff point of
−10 mmHg. This provided 62% sensitivity and 66% specificity for the presence of pain
in the ipsilateral arm during the test. The test-retest reliability of DROPmin proved to be
good but not perfect, partly because of unreliability of the provocation maneuvers.
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Conclusion: To the best of our knowledge, this study is the first to investigate
microvascular responses during the Roos maneuver in patients with suspected TOS.
The presence of symptoms was significantly associated with ischemia. TcpO2 facilitated
the recording of both macrovascular and microvascular responses to the Roos
test. The Roos maneuver should probably be performed at least twice in patients
with suspected TOS.
Keywords: peripheral artery disease, exercise, provocative maneuvers, ischemia, microcirculation, oximetry
INTRODUCTION
Thoracic outlet syndrome (TOS) is one of the most
controversial disorders in medicine, with multiple recent
editorials having been published on the subject (Ahmad
and Murthy, 2018; Burt, 2018; Illig, 2018). TOS comprises
a variety of symptoms and physical findings resulting from
the external compression of vessels and/or nerves as they
pass through multiple narrow spaces between the thorax
and the upper limb (Jubbal et al., 2018; Kaplan et al., 2018).
As described by Demondion et al. (2006), the diagnosis is
based on clinical findings, but making this diagnosis is often
difficult. The use of imaging (radiography, ultrasonography,
computed tomographic angiography, or magnetic resonance
imagery) is required to determine the nature and location
of the underlying structures causing the compression
(Ammi et al., 2017).
Many provocative maneuvers have been proposed to induce
dynamic compression of the neural or vascular structures.
A provocative test was proposed by Roos in 1966, which is
referred to as the “Roos test” or the “elevated arm stress test”
(EAST). Beyond the reproduction of symptoms induced by the
Roos test, an evaluation of perfusion via Doppler, pulse palpation,
and/or observation of hand pallor are generally performed
to detect arterial compression. However, coldness and color
changes could also result from sympathetic vasoconstriction
during neurogenic TOS (Sanders et al., 2007). In evaluating
vasoconstrictive responses to adrenergic stimulation, the study of
skin micro-circulation during provocative maneuvers could be of
major interest in the study of TOS, at least for research purposes.
To the best of our knowledge, such microvascular investigations
have never been reported.
We aimed to evaluate the effects of the Roos (EAST) test
on upper arm microcirculation using transcutaneous oxygen
pressure (TcpO2) measurements. We hypothesized that this
technique would be feasible and could account for both
macrovascular and microvascular impairments. We also aimed
at estimating the reliability of the responses observed in both
unaffected patients and patients referred for suspected TOS. Last,
we aimed to identify the preliminary results of preoperative
versus postoperative evaluations.
MATERIALS AND METHODS
From March 2018 to September 2018, 42 patients were recruited
into this prospective single-center study.
Ethical Standards
The patients were fully informed about the study and its
procedures; all patients signed a written consent document. This
research and all its procedures were performed in compliance
with the principles outlined in the Declaration of Helsinki.
The study was promoted by the University Hospital in Angers,
approved by our institutional Ethics Committee, and was
registered in ClinicalTrials.gov under Ref: NCT03355274.
Experimental Design
The study population comprised patients referred to the
Department of Vascular Medicine for suspected TOS. All subjects
were over 18 years of age and there was no maximum age
limit set. Exclusion criteria were: pregnancy, any legal constraint,
or current participation in another clinical trial. To date, one
female patient was referred to us for a new evaluation after
a prior surgery. Results from this observation are provided to
illustrate the presence or absence of persistent ischemia in the
surgically treated arm.
Initial Assessment
At the point of study inclusion, we recorded patient
demographics and conditions including: age, sex, presence
of one or more cardiovascular risk factors (hypertension,
diabetes mellitus, dyslipidemia, active smoking), history of
chest or shoulder surgery, and any ongoing treatments. We also
measured weight, height, systolic and diastolic blood pressures,
and evaluated positional microvascular responses to the Roos
test using transcutaneous oximetry (TcpO2) as described
below. Results from ultrasound investigations performed prior
to referral were encoded as “presence of absence of positive
TO” on each side, according to the patient’s medical record.
The technicians or physicians doing the TcpO2 test were
blinded to these data.
Transcutaneous Oxygen Pressure
Recordings
In brief, TcpO2 is a useful technique that measures the local skin
oxygen partial pressure using electrochemical probes heated to
44.5◦C to improve local perfusion and oxygen transcutaneous
diffusion. TcpO2 changes, by calculating reductions in the rest of
oxygen pressure (DROP) index, provide evidence of stimulation-
induced regional blood flow impairments (Abraham et al., 2003,
2005; Bouye et al., 2004; Abraham, 2006; Henni et al., 2018).
DROP is calculated as the limb level changes minus the changes
at a reference chest electrode. DROP allows for removal of error
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due to unpredictable transcutaneous gradients (Abraham et al.,
2003; Grouiller et al., 2006; Blake et al., 2018; Henni et al., 2018).
In the present study, we positioned one probe 5–7 cm distal to the
elbow joint at the proximal and internal portion of each forearm
and one probe on the chest (parasternal) for reference. After a
minimum of 15 min of heating, we started a 1-Hz recording
with a 30-s reference period, after which patients performed two
consecutive Roos tests. The second test was started after the
DROP values returned to zero and after a minimum recovery
period of 1 min following the end of the first test. Provocative
maneuvers were conducted in the standing position with the
patient’s back against a wall. The patients were required to
raise their arms to 90 degrees of abduction, with the arms fully
externally rotated and the elbows at 90 degrees of flexion. Further,
we asked the patients to try to touch the wall behind them with
their elbows and wrists, but not their back, to ensure that the
arms were flexed slightly behind the frontal plane, as shown in
Figure 1. This “surrender” or “candlestick” position with opening
and closing of both hands was sustained in all patients to the
point of maximum pain, or for a minimum of 2 min in the
absence of pain. Patients were repeatedly asked to report any
symptoms (pain, fatigue, numbness, or tingling) experienced
during the Roos test on each arm. The minimum value of DROP
(DROPmin) during or in the minute following the end of each
Roos maneuver was recorded for each arm. Inherently, DROP is
a negative value that decreases with the increase in the severity of
ischemia (Abraham et al., 2005) and is expressed in millimeters
of mercury (mmHg).
Statistical Analysis
The data are presented as numbers (percentages), medians
[25, 75 percentiles], or means ± standard deviations (SD).
A comparison of the DROPmin results between the symptomatic
and asymptomatic arms was performed using the Wilcoxon rank
test. A receiver operating characteristic (ROC) curve analysis
comparing the DROPmin value to the presence/absence of
FIGURE 1 | Example of the Roos maneuver with TcpO2 recordings. The
DROP calculation at time (t) is based on subtraction of the chest
measurement from the arm measurements. Chest and arm changes are
accounted for in the mean values measured over the 30 first seconds of
recording “0.” TcpO2, transcutaneous oxygen pressure; DROP, decrease from
the rest of oxygen pressure.
symptoms was used to define the optimal cutoff point for the
DROPmin values in the prediction of symptom occurrence.
All statistical analyses were performed using SPSS (IBM SPSS
statistics V15.0, Chicago, IL, United States). P < 0.05 was
considered to be statistically significant. The area under the ROC
curve (AUC) was used to determine whether DROP significantly
predicted positive results on ultrasound imaging and/or the
presence of symptoms during the Roos test. The optimal cutoff
point was defined as the DROP value that resulted in the
minimum distance to the 100% sensitivity / 100% specificity
angle. The test-retest reliability of the DROP results observed for
two consecutive Roos tests was analyzed using a Bland-Altman
representation with logarithmic (10-log) transform in cases of
heteroscedasticity, according to recommendations (Euser et al.,
2008; Ludbrook, 2010). To create the 10-log transformation,
DROPmin values were converted into absolute values (positive
values). The absence of a decrease in DROP was encoded
by −1 mmHg and not zero. Last, the test-retest reliability of
TcpO2 was evaluated according to the similarity of symptoms
between test 1 and test 2. Indeed, if discomfort or pain was
present during one of the maneuvers, but absent during the
other one, the TcpO2 difference was expected to have resulted
from unsatisfactory maneuver reproduction, with the presence
of compression during one test and the absence of compression
during the other.
RESULTS
The recruited patients included 28 men and 14 women, aged
40.8 ± 12.2 years old. The mean weight was 70.3 ± 16 kg
and mean height was 164 ± 7 cm. Fifteen patients had one
or more cardiovascular risk factors and 12 had a prior history
of chest or shoulder surgery. Ongoing treatments included
the use of lipid-lowering drugs (n = 2) and sartans (n = 2).
Systolic and diastolic arm blood pressures were 126 ± 14 and
79 ± 11 mmHg, respectively. Among these patients, 15 reported
unilateral symptoms on the right (n = 7) or left (n = 8) side and
27 reported bilateral symptoms. Among the patients reporting
unilateral symptoms, 5 had previously undergone surgery for
contralateral TOS. Among patients with unilateral symptoms,
Roos maneuvers induced unilateral (n = 8) or bilateral (n = 5)
pain. In two patients, the Roos maneuver did not reproduce the
usual symptoms. Interestingly, among patients with unilateral
symptoms, when the results were analyzed arm by arm, the
symptoms were present in two consecutive tests in 8 patients,
in neither of the tests in 5, and in one test only in 17 (in
solely the first test in 8, and in solely the second test in
9). Of the 27 patients referred for bilateral symptoms, 2 had
undergone previous unilateral (n = 1) or bilateral (n = 1)
surgery for TOS. Among these patients, the Roos maneuvers
induced unilateral (n = 6) or bilateral (n = 20) pain. In
one patient, the Roos maneuvers did not reproduce the usual
symptoms. Notably, when the 54 arms of the patients with
bilateral symptoms were analyzed arm by arm, the symptoms
were present during two consecutive tests in 31 patients, during
neither test in 10, during solely the first test in 8, and during
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solely the second test in 5. Of 42 patients, ultrasounds were
positive for TOS on one or both sides in only 25 of them, as
shown in Table 1.
TcpO2 showed excellent feasibility, with no technical failures
or missing values. The chest TcpO2 value at rest was
69 ± 10 mmHg. TcpO2 at rest in the symptomatic (69 values) and
asymptomatic (15 values) arms were 76 ± 12 and 74 ± 10 mmHg,
respectively (p > 0.05). A typical example of a recording in a
patient with TOS is presented in Figure 2. As shown, the Roos
maneuvers were responsible for a sharp decrease in the right and
left DROP values, although they were slightly decreased during
the second maneuver on the left arm.
The lowest DROPmin values of the two tests were as follows:
−12 [−21, −7] mmHg in the arm with an absence of TOS
findings on ultrasound imaging and −27 [−50, −14] mmHg in
the arms with ultrasound evidence of TOS (p< 0.01). When TOS
identified on ultrasound imaging was the endpoint, the AUC was
0.725 ± 0.058 (p < 0.001 from random choice), with an optimal
cutoff point of −15 mmHg providing 67% sensitivity and 78%
specificity for the presence of TOS on ultrasound.
On average, the DROPmin values were as follows: −14 [−26,
−6] mmHg for test 1 and −13 [−27, −7] mmHg for test 2
(p > 0.05) on the right side; −13 [−27, −7] mmHg for test and
−11 [−29, −6] mmHg for test 2 on the left side. On an arm-by-
arm basis, among the 168 available values (42 patients, 2 arms, 2
tests), the DROPmin values measured in the symptomatic (108
values) and asymptomatic (60 values) arms were −19 [−36, −7]
mmHg and −8 [−16, −5] mmHg, respectively (p< 0.001). When
the presence of symptoms during the test was the endpoint,
the AUC was 0.698 ± 0.04 (p < 0.001 from random choice),
with a cutoff point of −10 mmHg providing 62% sensitivity and
66% specificity for the presence of pain in the ipsilateral arm
during the test.
For the entire test series, the average difference between
the DROPmin results of test 2 vs. test 1 on a Bland-Altman
representation showed a clear heteroscedastic distribution with
a mean difference of 1.2 mmHg. Figure 3 shows the 10-log
transformed data, confirming good agreement between the two
tests (despite outlier values), with a mean difference close to zero
and reasonable limits of agreements (LA).
Finally, the patient presented in Figure 2 had a second
test prior to surgery (Figure 4, upper panel), confirming the
results of the first test, and then had surgery on the right
(dominant) side by an axillary approach. She was referred
3 months after surgery with complete relief of symptoms in the
right arm and normalization of the DROPmin on the right side
TABLE 1 | Distribution of symptoms by history and results of ultrasound
investigations in the studied population.
Positive ultrasound results
None Right Left Bilateral
Symptoms by history Right 2 3 0 2
Left 3 2 3 0
Bilateral 12 2 4 9
FIGURE 2 | Transcutaneous oxygen pressure recordings are expressed as
DROP values (mmHg) during two consecutive Roos maneuvers (gray
squares). The x-axis represents the time in minutes. As shown, a dramatic
decrease in the DROP values occurs during the Roos maneuvers on both
sides, below –15 mmHg (dotted line). The corresponding arteriography shows
the right (left panel) and left (right panel) sides, confirming occlusion of the
subclavian artery during abduction of the arms (white arrows). This
arteriography is from a 31-year-old woman who suffered for more than 4 years
from upper limb pain, mostly on the right (dominant) side. She previously
worked as a hairdresser, but had to stop this activity because of the pain. The
pain originated at the shoulder and extended to the hands, with some
paresthesias in the fourth and fifth digits. During the clinical examination, the
Wright and Adson positions quickly led to a loss of the radial pulses. The Tinel
test was negative. Bilateral TOS was suspected. A routine chest X-ray
showed no abnormality of the cervico-thoracic junction. A duplex-scan
demonstrated dynamic arterial and venous obstructions. Objective signs of
lower plexus nerve lesions on electromyogram favored a neurogenic-type
outlet syndrome. We also performed a dynamic bilateral angiography via a
4-Fr femoral puncture. This confirmed arterial outlet syndrome with an
occlusive costoclavicular grip and a significant dynamic stenosis in the
pectoralis minor muscle tunnel. She was prescribed an extended period of
kinesiotherapy. DROP, decrease from the rest of oxygen pressure; TOS,
thoracic outlet syndrome.
(Figure 4, lower panel). Because her left arm was only moderately
symptomatic after surgery, she was unwilling to undergo a
second operation.
DISCUSSION
To the best of our knowledge, this study is the first to investigate
microvascular responses during the Roos test, one of the most
largely used provocative maneuvers in the diagnosis of TOS. This
study provides evidence that the technique is both feasible and
reliable. Further, preliminary results suggest that it is sensitive to
the changes observed after surgery.
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FIGURE 3 | Bland-Altman representation of test-retest reliability on
logarithmic scales. “LA” are 95% limits of agreement.
Positive tests suggesting the presence of arterial, and/or
venous, and /or nerve compressions are frequently observed in
the general population. Using photo-plethysmography (PPG) in
130 apparently unaffected individuals, arterial obstructions were
identified in 78 of them (60%) (Gergoudis and Barnes, 1980).
Abnormal ultrasound or arterial PPG findings on the EAST and
Upper Limb Tension Test (ULTT) were observed in 69% of 64
high-performance string instrument musicians, in contrast to
15% of 22 control subjects (Adam et al., 2018). Arterial flow
anomalies on Doppler ultrasound and PPG were identified in
13% of 100 limbs from 50 normal volunteers (Chen et al.,
2014). In 98 dissections of the thoracic outlet from 50 unselected
cadavers, Juvonen et al. (1995) observed 63% with abnormal
anatomy and 10% (5/50) had bilaterally normal anatomy. Thus,
most neurovascular compressions remain asymptomatic and the
specificity of tests will never reach 100% if symptoms are used as
gold-standard endpoints.
There are conflicting results about the respective prevalences
of arterial (ATOS), venous (VTOS), and neurogenic (NTOS)
types of TOS and “combined” / “disputed” types (Ferrante
and Ferrante, 2017; Peek et al., 2018). Relative ATOS, VTOS,
and NTOS prevalences seem to partially rely on how each
form is defined. Restricting arterial TOS to embolic events and
venous TOS to Paget-Schroetter thromboembolic complications,
as proposed by Sanders et al. (2007), leads to the consideration
that over 95% of all TOS are neurogenic and less than 1%
are arterial. Other series have reported more balanced results,
using less restrictive definitions for ATOS and VTOS with results
ranging from 48.7 to 74% of NTOS, 22 to 44% VTOS, and 4
to 25% ATOS (Ann Freischlag, 2018; Henry et al., 2018; Likes
et al., 2014). Finally, whatever the definitions used and the exact
proportions of each TOS type, the diagnosis of compression
has generally been based on non-invasive clinical signs and
vascular investigations.
Clinical provocative tests are considered to be of limited
sensitivity and specificity (Warrens and Heaton, 1987; Gillard
et al., 2001), probably partially resulting from a high rate
of positive results in apparently asymptomatic patients, as
previously discussed (Nord et al., 2008); however, it may also
possibly result from a low test-retest reliability of the provocative
FIGURE 4 | Transcutaneous oxygen pressure recordings expressed as DROP
values (mmHg) during two consecutive Roos maneuvers (gray squares). The
x-axis represents time in minutes before and after surgery. The –15 mmHg
limit is shown as a dotted line. These recordings were performed on the same
patient described in Figure 2 above. While she previously underwent an
extended period of kinesiotherapy for several months without additional
benefit, we proposed surgical treatment for her outlet syndrome. As shown,
during the new pre-surgical visit (upper panel), the tests are positive on both
sides. The surgery included complete resection of the right first rib (image 2)
and pectoralis minor muscle resection through a Roos axillary approach. The
patient rapidly recovered from surgery and expressed rapid pain relief. After
surgery (lower panel), a moderate decrease in DROP is observed with test 2
on the left side, while test 1 was normal on both sides. The patient had no
complaints of pain on the right side, but expressed moderate discomfort on
the left side with test 2. DROP, decrease from the rest of oxygen pressure.
maneuvers (Warrens and Heaton, 1987; Nord et al., 2008).
No single non-invasive technique seems to be optimal for
diagnosing TOS. One of the most widely used and useful
tests for diagnosing TOS is ultrasonography. Unfortunately,
preoperative duplex ultrasounds are only 41% sensitive for the
diagnosis of NTO (Orlando et al., 2016). Ultrasonography only
has a sensitivity of 87% and specificity of 88%, with risks of
false-positive and false-negative results (Gillard et al., 2001).
False-positive tests are assumed to result from signal losses
or, when compared to the presence of symptoms by history,
from the possibility of compression in asymptomatic – assumed
healthy – individuals. False-negative tests could result either from
non-adapted maneuvers, insufficient practitioner experience, or
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inadequate technical recording. Magnetic resonance imaging
(MRI) sensitivity, specificity, and positive and negative predictive
values have been reported to be 41, 33, 89, and 4%, respectively
(Singh et al., 2014). Whatever the technique, assuming that
coldness and color changes would not be caused by ischemia
resulting from subclavian artery obstruction, but from an
overactive sympathetic nervous system (Sanders et al., 2007),
Doppler ultrasonography would not adequately detect neurally
induced cutaneous vasoconstriction. Whether or not pallor and
coldness are always of neural origin, the specific benefit of
TcpO2 is that it can monitor both macro- and microvascular
responses according to TcpO2 decreases at arm level. These
responses reflect cutaneous flow changes from the eventual
occlusion of proximal vessels and the eventual reduction in skin
blood flow secondary to sympathetic nervous system-induced
vasoconstriction. The specific interest in TcpO2 is that it is
expected to decrease in cases of arterial compression (Babilas
et al., 2008), secondary to neurally induced vasoconstriction
(Provenzano et al., 2008) and isolated venous occlusion
(Ostergren et al., 1983; Geis et al., 2008).
To the best of our knowledge, no other research has
investigated upper limb TcpO2 during provocative tests to
evaluate TOS. Transcutaneous oxygen pressure changes have
been well-described at rest and during exercise (Abraham et al.,
2003). During exercise, this measurement was shown to be
both accurate and reliable in the evaluation of exercise-induced
ischemia (Abraham et al., 2003, 2005; Bouye et al., 2004;
Abraham, 2006; Henni et al., 2018). Although absolute TcpO2
has shown fair reliability (Rooke and Osmundson, 1989; Daviet
et al., 2004), the calculation of the DROP index improved
reliability in test–retest recordings (Bouye et al., 2004). In the
present study, TcpO2 facilitated the measurement of regional
blood flow impairments, regardless of the underlying mechanism,
and showed satisfactory reliability. Importantly, the −15 mmHg
cutoff point, using ultrasound results as a reference, is similar to
the one identified from exercise TcpO2 measurements (Abraham
et al., 2003; Grouiller et al., 2006; Audonnet et al., 2017; Henni
et al., 2018). Determining the cutoff point is important because
limb elevation physiologically decreases TcpO2 as hydrostatic
pressure decreases (Dooley et al., 1997; Shah et al., 2008).
The present study had some limitations. First, we did not
monitor the positions of the patients using three-dimensional
cameras or accelerometers. This would be useful for excluding the
∼15% inconsistent test-retest results that relied on an imperfect
reproducibility of carefully performed provocative maneuvers.
Our opinion is that although provocative maneuvers were very
carefully supervised, even non-measurable minor changes in
position and intensity of shoulder muscle contractions could
result in variable compressive effects. Similarly, we believe that
the inconsistent test-retest results were not due to the technique
itself, because TcpO2 changes during exercise-induced ischemia
are highly reliable and operator-independent (Henni et al., 2018).
Second, we could not confirm the presence or absence
of arterial compression using contrast-enhanced imaging in
many of the patients. One reason for this was that most
patients with positive tests were referred to physical therapy
or declined surgery. Radiological imaging in such patients
is not indicated. Further, admitting that pallor and coldness
did not systematically result from arterial compression, but
rather resulted from neurovascular vasoconstriction during
nerve compression, indicated that contrast-enhanced imaging
techniques should no longer be considered gold-standard
techniques. This would be a limitation if our main goal was
to evaluate the diagnostic performance of the TcpO2 technique
compared to a gold standard. However, this was not our goal.
We only intended to test the feasibility and reliability of the
technique. Nevertheless, the postoperative results in one of our
patients confirmed that DROPmin values improve after surgery.
Third, we only tested the Roos maneuver, although other tests
have been proposed to facilitate the diagnosis of TOS. Our choice
was deliberate here, and relates to the fact that the Roos maneuver
is generally reported as the one that provides a greater number
of positive results (Rayan and Jensen, 1995; Nord et al., 2008).
Future studies should evaluate the Tcpo2 response to other tests.
Finally, TcpO2 is not considered a routine tool because of
the cost of the device and the length of time required to reach
stable values, specifically at arm level (Gorska et al., 2015; Chiang
et al., 2018). Nevertheless, the diagnosis of TOS should be based
on a holistic approach that includes the patient’s history, clinical
examination, and minimally invasive investigations. TcpO2
could provide additional non-invasive evidence of abnormal
microvascular responses to provocative tests (at least for the
Roos test) before radiological imaging is chosen in cases of
inefficient physiotherapy.
CONCLUSION
In conclusion, to the best of our knowledge, this study is the first
to examine microvascular responses during the Roos maneuver
in patients with suspected TOS. However, additional studies
with a larger number of patients are needed to evaluate the
performance of TcpO2 with respect to making the diagnosis
of TOS. These studies should compare the test results to a
gold standard, analyze the test-retest reproducibility, evaluate
the responses to other provocative maneuvers, and estimate its
sensitivity to the treatment of neural and/or vascular compression
of the outlet. The Roos maneuver should probably be performed
at least twice in patients with suspected TOS because of
the moderate test-retest reliability of symptoms induced by
the Roos test, even during carefully supervised maneuvers.
TcpO2 appears to be a promising non-operator-dependent
investigative tool that allows for the simultaneous analysis of
both arms during dynamic maneuvers in the standing position
and investigations of the microvascular response to the Roos
test. This might contribute to a holistic approach toward patients
with suspected TOS.
AUTHOR CONTRIBUTIONS
SH, JH, MA, F-EM, JP, and PA participated in patient
recruitment, data acquisition, data analysis, and patient
treatment. SH and PA participated in the preparation of the
Frontiers in Physiology | www.frontiersin.org 6 February 2019 | Volume 10 | Article 13612
fphys-10-00136 February 19, 2019 Time: 17:5 # 7
Hennin et al. Microcirculation and Ross Maneuver
study and provided technical and administrative support for
the project. JH, JP, and PA supervised the project. SH, JH, JP,
and PA wrote the manuscript. MA and F-EM reviewed and
critically revised the draft. All authors approved the final version
of the manuscript.
ACKNOWLEDGMENTS
The authors thank Marine Mauboussion and Stéphanie Marechal
for their technical assistance. The authors also thank Editage R© for
grammar and style reviewing.
REFERENCES
Abraham, P. (2006). Validation of a new device for transcutaneous oxygen pressure
recordings in real and simulated exercise tests. Med. Sci. Sports Exerc. 25,
190–196.
Abraham, P., Picquet, J., Bouye, P., L’Hoste, P., Enon, B., Vielle, B., et al.
(2005). Transcutaneous oxygen pressure measurements (tcpO2) at ankle during
exercise in arterial claudication. Int. Angiol. 24, 80–88.
Abraham, P., Picquet, J., Vielle, B., Sigaudo-Roussel, D., Paisant-Thouveny, F.,
Enon, B., et al. (2003). Transcutaneous oxygen pressure measurements on the
buttocks during exercise to detect proximal arterial ischemia: comparison with
arteriography. Circulation 107, 1896–1900. doi: 10.1161/01.CIR.0000060500.
60646.E0
Adam, G., Wang, K., Demaree, C. J., Jiang, J. S., Cheung, M., Bechara, C. F.,
et al. (2018). A prospective evaluation of duplex ultrasound for thoracic outlet
syndrome in high-performance musicians playing bowed string instruments.
Diagnostics 8:E11. doi: 10.3390/diagnostics8010011
Ahmad, U., and Murthy, S. C. (2018). Who should be “let in” when managing the
thoracic outlet? J. Thorac. Cardiovasc Surg. 156, 1324–1325. doi: 10.1016/j.jtcvs.
2018.05.035
Ammi, M., Peret, M., Henni, S., Daligault, M., Abraham, P., Papon, X., et al. (2017).
Frequency of the pectoralis minor compression syndrome in patients treated
for thoracic outlet syndrome. Ann. Vasc. Surg. 47, 253–259. doi: 10.1016/j.avsg.
2017.09.002
Ann Freischlag, J. A. (2018). Decade of excellent outcomes after surgical
intervention: 538 patients with thoracic outlet syndrome. Trans. Am. Clin.
Climatol. Assoc. 129, 88–94.
Audonnet, M., Signolet, I., Colas-Ribas, C., Ammi, M., Abraham, P., and Henni, S.
(2017). Exercise transcutaneous oximetry of the buttocks- external validation
with computed tomography angiography. Circ. J. 81, 1123–1128. doi: 10.1253/
circj.CJ-16-1316
Babilas, P., Lamby, P., Prantl, L., Schreml, S., Jung, E. M., Liebsch, G., et al. (2008).
Transcutaneous pO2 imaging during tourniquet-induced forearm ischemia
using planar optical oxygen sensors. Skin Res. Technol. 14, 304–311. doi: 10.
1111/j.1600-0846.2008.00295.x
Blake, D. F., Young, D. A., and Brown, L. H. (2018). Transcutaneous oximetry:
variability in normal values for the upper and lower limb. Diving Hyperb. Med.
48, 2–9. doi: 10.28920/dhm48.1.2-9
Bouye, P., Picquet, J., Jaquinandi, V., Enon, B., Leftheriotis, G., Saumet, J. L., et al.
(2004). Reproducibility of proximal and distal transcutaneous oxygen pressure
measurements during exercise in stage 2 arterial claudication. Int. Angiol. 23,
114–121.
Burt, B. M. (2018). Thoracic outlet syndrome for thoracic surgeons. J. Thorac.
Cardiovasc. Surg. 156, 1318.e1–1323.e1. doi: 10.1016/j.jtcvs.2018.02.096
Chen, H., Doornbos, N., Williams, K., and Criado, E. (2014). Physiologic variations
in venous and arterial hemodynamics in response to postural changes at the
thoracic outlet in normal volunteers. Ann. Vasc. Surg. 28, 1583–1588. doi:
10.1016/j.avsg.2014.05.003
Chiang, N., Jain, J. K., Sleigh, J., and Vasudevan, T. (2018). Measuring
transcutaneous oxygenation to validate the duration required to achieve
electrode equilibration. Adv. Skin Wound Care 31, 263–269. doi: 10.1097/01.
ASW.0000530847.49484.4b
Daviet, J. C., Dudognon, P., Preux, P. M., Rebeyrotte, I., Lacroix, P., Munoz, M.,
et al. (2004). Reliability of transcutaneous oxygen tension measurement
on the back of the hand and complex regional pain syndrome after
stroke. Arch. Phys. Med. Rehabil. 85, 1102–1105. doi: 10.1016/j.apmr.2003.
09.034
Demondion, X., Herbinet, P., Van Sint Jan, S., Boutry, N., Chantelot, C.,
and Cotten, A. (2006). Imaging assessment of thoracic outlet syndrome.
Radiographics 26, 1735–1750. doi: 10.1148/rg.266055079
Dooley, J., King, G., and Slade, B. (1997). Establishment of reference pressure
of transcutaneous oxygen for the comparative evaluation of problem wounds.
Undersea Hyperb. Med. 24, 235–244.
Euser, A. M., Dekker, F. W., and le Cessie, S. A. (2008). A practical approach
to bland-altman plots and variation coefficients for log transformed variables.
J. Clin. Epidemiol. 61, 978–982. doi: 10.1016/j.jclinepi.2007.11.003
Ferrante, M. A., and Ferrante, N. D. (2017). The thoracic outlet syndromes: part
1. Overview of the thoracic outlet syndromes and review of true neurogenic
thoracic outlet syndrome. Muscle Nerve 55, 782–793. doi: 10.1002/mus.25536
Geis, S., Babilas, P., Schreml, S., Angele, P., Nerlich, M., Jung, E. M., et al.
(2008). Transcutaneous pO2 measurement during tourniquet-induced venous
occlusion using dynamic phosphorescence imaging. Clin. Hemorheol. Microcirc
40, 249–258.
Gergoudis, R., and Barnes, R. W. (1980). Thoracic outlet arterial compression:
prevalence in normal persons. Angiology 31, 538–541. doi: 10.1177/
000331978003100805
Gillard, J., Perez-Cousin, M., Hachulla, E., Remy, J., Hurtevent, J. F., Vinckier, L.,
et al. (2001). Diagnosing thoracic outlet syndrome: contribution of provocative
tests, ultrasonography, electrophysiology, and helical computed tomography in
48 patients. Joint Bone Spine 68, 416–424. doi: 10.1016/S1297-319X(01)00298-6
Gorska, K., Korczynski, P., Maskey-Warzechowska, M., Chazan, R., and Krenke, R.
(2015). Variability of transcutaneous oxygen and carbon dioxide pressure
measurements associated with sensor location. Adv. Exp. Med. Biol. 858, 39–46.
doi: 10.1007/5584_2015_126
Grouiller, F., Jaquinandi, V., Picquet, J., Souday, V., Saumet, J. L., and Abraham, P.
(2006). Validation of a new device for transcutaneous oxygen pressure
recordings in real and simulated exercise tests. Int. Angiol. 25, 190–196.
Henni, S., Sempore, Y. W., Le Meliner, T., Ouedraogo, N., Hamel, J. F., and
Abraham, P. (2018). Intra-test and test-retest reliability of exercise oximetry in
arterial claudication. Microvasc. Res. 117, 44–49. doi: 10.1016/j.mvr.2018.01.003
Henry, B. M., Vikse, J., Sanna, B., Taterra, D., Gomulska, M., Pekala, P. A.,
et al. (2018). Cervical rib prevalence and its association with thoracic outlet
syndrome: a meta-analysis of 141 studies with surgical considerations. World
Neurosurg. 110, e965–e978. doi: 10.1016/j.wneu.2017.11.148
Illig, K. A. (2018). Neurogenic thoracic outlet syndrome: bringing order to chaos.
J. Vasc. Surg. 68, 939–940. doi: 10.1016/j.jvs.2018.04.030
Jubbal, K. T., Zavlin, D., Harris, J. D., Liberman, S. R., and Echo, A. (2018).
Morbidity of first rib resection in the surgical repair of thoracic outlet
syndrome. Hand [Epub ahead of print] doi: 10.1177/1558944718760037,
Juvonen, T., Satta, J., Laitala, P., Luukkonen, K., and Nissinen, J. (1995). Anomalies
at the thoracic outlet are frequent in the general population. Am. J. Surg. 170,
33–37. doi: 10.1016/S0002-9610(99)80248-7
Kaplan, T., Comert, A., Esmer, A. F., Atac, G. K., Acar, H. I., Ozkurt, B., et al.
(2018). The importance of costoclavicular space on possible compression of
the subclavian artery in the thoracic outlet region: a radio-anatomical study.
Interact. Cardiovasc Thorac. Surg. 27, 561–565. doi: 10.1093/icvts/ivy129
Likes, K., Rochlin, D. H., Salditch, Q., Dapash, T., Baker, Y., DeGuzman, R., et al.
(2014). Diagnostic accuracy of physician and self-referred patients for thoracic
outlet syndrome is excellent. Ann. Vasc. Surg. 28, 1100–1105. doi: 10.1016/j.
avsg.2013.12.011
Ludbrook, J. (2010). Confidence in Altman-Bland plots: a critical review of the
method of differences. Clin. Exp. Pharmacol. Physiol 37, 143–149. doi: 10.1111/
j.1440-1681.2009.05288.x
Nord, K. M., Kapoor, P., Fisher, J., Thomas, G., Sundaram, A., Scott, K., et al.
(2008). False positive rate of thoracic outlet syndrome diagnostic maneuvers.
Electromyogr. Clin. Neurophysiol. 48, 67–74.
Orlando, M. S., Likes, K. C., Mirza, S., Cao, Y., Cohen, A., Lum, Y. W., et al.
(2016). Preoperative duplex scanning is a helpful diagnostic tool in neurogenic
thoracic outlet syndrome. Vasc. Endovascular Surg. 50, 29–32. doi: 10.1177/
1538574415623650
Frontiers in Physiology | www.frontiersin.org 7 February 2019 | Volume 10 | Article 13613
fphys-10-00136 February 19, 2019 Time: 17:5 # 8
Hennin et al. Microcirculation and Ross Maneuver
Ostergren, J., Svedman, P., and Fagrell, B. (1983). The influence of venous and
arterial occlusion on capillary blood flow and transcutaneous oxygen tension
in fingers. Int. J. Microcirc. Clin. Exp. 2, 315–324.
Peek, J., Vos, C. G., Unlu, C., Schreve, M. A., van de Mortel, R. H. W., and de Vries,
J. P. M. (2018). Long-term functional outcome of surgical treatment for thoracic
outlet syndrome. Diagnostics 8:E7. doi: 10.3390/diagnostics8010007
Provenzano, D. A., Jarzabek, G., and Georgevich, P. (2008). The utilization of
transcutaneous oxygen pressures to guide decision-making for spinal cord
stimulation implantation for inoperable peripheral vascular disease: a report of
two cases. Pain Physician 11, 909–916.
Rayan, G. M., and Jensen, C. (1995). Thoracic outlet syndrome: provocative
examination maneuvers in a typical population. J. Shoulder Elbow Surg. 4,
113–117. doi: 10.1016/S1058-2746(05)80064-3
Rooke, T. W., and Osmundson, P. J. (1989). Variability and reproducibility of
transcutaneous oxygen tension measurements in the assessment of peripheral
vascular disease. Angiology 40, 695–700. doi: 10.1177/000331978904000802
Sanders, R. J., Hammond, S. L., and Rao, N. M. (2007). Diagnosis of thoracic outlet
syndrome. J. Vasc. Surg. 46, 601–604. doi: 10.1016/j.jvs.2007.04.050
Shah, J. B., Ram, D. M., Fredrick, E., Otto, G. H., and Sheffield,
P. J. (2008). Determination of ideal PtcO2 measurement time in
evaluation of hypoxic wound patients. Undersea Hyperb. Med.
35, 41–51.
Singh, V. K., Jeyaseelan, L., Kyriacou, S., Ghosh, S., Sinisi, M., and Fox, M. (2014).
Diagnostic value of magnetic resonance imaging in thoracic outlet syndrome.
J. Orthop. Sur. 22, 228–231. doi: 10.1177/230949901402200224
Warrens, A. N., and Heaton, J. M. (1987). Thoracic outlet compression syndrome:
the lack of reliability of its clinical assessment. Ann. R. Coll. Surg. Engl. 69,
203–204.
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Henni, Hersant, Ammi, Mortaki, Picquet, Feuilloy and Abraham.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Physiology | www.frontiersin.org 8 February 2019 | Volume 10 | Article 13614
fphys-10-00656 June 10, 2019 Time: 15:41 # 1
CLINICAL TRIAL








University of Calabria, Italy
Sushil Kumar Mahata,
University of California, San Diego,
United States
Marko Stupin,





This article was submitted to
Vascular Physiology,
a section of the journal
Frontiers in Physiology
Received: 24 October 2018
Accepted: 09 May 2019
Published: 12 June 2019
Citation:
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Tomažin K, Strojnik V and Jug B
(2019) Blood Flow Restriction
Resistance Exercise Improves Muscle
Strength and Hemodynamics, but Not
Vascular Function in Coronary Artery




Blood Flow Restriction Resistance
Exercise Improves Muscle Strength
and Hemodynamics, but Not
Vascular Function in Coronary Artery
Disease Patients: A Pilot
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Tim Kambič1,2* , Marko Novaković2,3, Katja Tomažin1, Vojko Strojnik1 and Borut Jug2,3
1 Laboratory of Kinesiology, Faculty of Sport, University of Ljubljana, Ljubljana, Slovenia, 2 Department of Vascular Diseases,
Division of Internal Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia, 3 Faculty of Medicine, University
of Ljubljana, Ljubljana, Slovenia
Resistance training may be associated with unfavorable cardiovascular responses (such
as hemodynamic alterations, anginal symptoms or ventricular arrhythmias). In healthy
adults, blood flow-restricted (BFR) resistance training improves muscle strength and
hypertrophy improvements at lower loads with minimal systemic cardiovascular adverse
responses. The aim of this study was to assess the safety and efficacy of BFR resistance
training in patients with coronary artery disease (CAD) compared to usual care.
Patients with stable CAD were randomized to either 8 weeks of supervised biweekly
BFR resistance training (30–40% 1RM unilateral knee extension) or usual exercise
routine. At baseline and after 8 weeks, patients underwent 1-RM knee extension tests,
ultrasonographic appraisal of vastus lateralis (VL) muscle diameter and of systemic
(brachial artery) flow-mediated dilation, and determination of markers of inflammation
(CD40 ligand and tumor necrosis factor alfa), and fasting glucose and insulin levels for
homeostatic model assessment (HOMA). A total of 24 patients [12 per group, mean
age 60 ± 2 years, 6 (25%) women] were included. No training-related adverse events
were recorded. At baseline groups significantly differ in age (mean difference: 8.7 years,
p < 0.001), systolic blood pressure (mean difference: 12.17 mmHg, p = 0.024) and in
metabolic control [insulin (p = 0.014) and HOMA IR (p = 0.014)]. BFR-resistance training
significantly increased muscle strength (1-RM, +8.96 kg, p < 0.001), and decreased
systolic blood pressure (−6.77 mmHg; p = 0.030), whereas VL diameter (+0.09 cm,
p = 0.096), brachial artery flow-mediated vasodilation (+1.55%; p = 0.079) and insulin
sensitivity (HOMA IR change of 1.15, p = 0.079) did not improve significantly. Blood
flow restricted resistance training is safe and associated with significant improvements
in muscle strength, and may be therefore provided as an additional exercise option to
aerobic exercise to improve skeletal muscle functioning in patients with CAD.
Clinical Trial Registration: www.ClinicalTrials.gov, identifier: NCT03087292.
Keywords: blood flow restriction, resistance training, low-loads, coronary artery disease, cardiac rehabilitation
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INTRODUCTION
Exercise training is a core component of the cardiac rehabilitation
(Leon et al., 2005; Balady et al., 2007), with aerobic training
recommended as the preferred modality (Bjarnason-Wehrens
et al., 2004). Recommendations for resistance training have
only recently and cautiously been put forward (Bjarnason-
Wehrens et al., 2004). On the one hand, resistance training
improves muscle strength, endurance and mass, bone
density, and quality of life (Bjarnason-Wehrens et al., 2004;
Williams et al., 2007; Wise and Patrick, 2011); while on
the other hand, concerns have been raised over potentially
unfavorable cardiovascular responses, such as blood pressure
elevation, myocardial ischemia, and ventricular dysrhythmias
(Haslam et al., 1988).
Current American Heart Association recommendations on
resistance training in cardiovascular patients suggest lower
loads [30% of one-repetition maximum (1-RM) for the upper
limbs and 50–60% 1-RM for the lower limbs], as this would
still improve muscle strength and endurance without excessive
blood pressure elevation or other adverse cardiovascular events
(Williams et al., 2007; Wise and Patrick, 2011). However,
recent studies have shown some conflicting evidence against
current resistance training guidelines in cardiovascular disease
patients. One study has shown that moderate exercise loads
(15 RM) induced greater hemodynamic response compared to
higher exercise loads (4 RM) (Gjovaag et al., 2016), whereas
others suggested longer sets may evoke higher hemodynamic
drifts compared to shorter sets (Lamotte et al., 2010). Also,
evidence suggests that higher training loads (>75% of 1-RM) are
needed for optimal improvements in muscle hypertrophy and
strength in healthy adults (American College of Sports Medicine
[ACSM], 2009), whereas recommended loads for patients with
coronary artery disease (CAD) are much lower (<30% 1-RM)
(Bjarnason-Wehrens et al., 2004; Piepoli et al., 2011) and thus
possibly insufficient to elicit increases in isometric strength
and hypertrophy.
Blood flow restriction (BFR) exercise is a novel exercise
modality in clinical settings, which induces muscle hypertrophy
and strength with low to moderate training intensity through
increased anabolic processes mediated by BFR (usually with
cuff inflation) (Manini and Clark, 2009). BFR improves
training adaptations (Loenneke and Pujol, 2009), such as
muscle hypertrophy, muscle strength (Takarada et al., 2000;
Madarame et al., 2008; Yasuda et al., 2014b), endurance (Kacin
and Stražar, 2011) and acute hormonal responses (Pearson
and Hussain, 2015), with minimal adverse cardiovascular
or muscular effects (Manini and Clark, 2009). In healthy
adults, BFR resistance exercise yields muscle hypertrophy
and strength comparable to heavy-load resistance training
(Hughes et al., 2017), using loads as low as 30% of 1-RM
(Takarada et al., 2000). In addition to the improvement in
muscle strength and hypertrophy, BFR resistance exercise was
proven to be safe, with no significant differences following
training in resting creatine kinase, interleukin-6, insulin-
like growth factor 1 (IGF-1) or hemostatic markers (Fujita
et al., 2007; Nakajima et al., 2007; Madarame et al., 2010;
Karabulut et al., 2013; Patterson et al., 2013). Although most
BFR research focused on muscular effects, it is important
to note that resistance and aerobic BFR exercises may cause
increases in heart rate and blood pressure that are greater
than those observed with exercise performed at a similar
intensity without BFR (Hackney et al., 2012). Since most BFR
studies were conducted in healthy older adults (Karabulut
et al., 2010, 2011; Yasuda et al., 2014b; Vechin et al.,
2015) and musculoskeletal settings (ACL reconstruction, knee
osteoarthritis) (Hughes et al., 2017), it is important to evaluate
the cardiovascular response in individuals presenting with
cardiovascular disease risk factors in a controlled settings
(Hackney et al., 2012).
To date, only one study examined the acute effect of BFR
resistance exercise in cardiovascular patients (Madarame et al.,
2013). Apart from steadily increased heart rate, no adverse
effects were reported during and after acute bouts of exercise,
as the increase in haemostatic and inflammatory markers was
independent of the exercise (Madarame et al., 2013). Chronic
effects were observed in a recent trial in which decrease in
brain natriuretic peptide and C-reactive protein were shown
after 6 months of low intensity BFR aerobic cycling exercise in
patients with chronic heart failure (Yasushi and Yudai, 2018),
as the chronic impact of BFR resistance exercise in CAD
patients still remains elusive. Therefore, we wanted to assess
the impact of low-load BFR resistance training in patients with
CAD on muscle strength and hypertrophy, vascular function,




Patients with stable CAD were recruited from the Center
for Preventive Cardiology, Department of Vascular Diseases,
Division of Internal Medicine, University Medical Centre
Ljubljana, or Coronary Club Ljubljana, both located in Slovenia.
Patients with documented CAD (>3 months after a
myocardial infarction, percutaneous coronary intervention
or/and coronary artery bypass grafting), aged between 18 to
75 years and physically active more than three times a week
were included into the study. All participants were clinically
stable and engaged in regular unsupervised physical activity (e.g.,
walking, cycling) after completion of cardiac rehabilitation, as
assessed with short interview. Exclusion criteria were unstable
or uncontrolled cardiovascular disease/event (unstable angina,
recent myocardial infarction <3 months prior to inclusion,
class III or IV heart failure, uncontrolled dysrhythmias,
severe pulmonary hypertension, severe and/or symptomatic
valve disease, acute myocarditis, endocarditis, or pericarditis,
aortic syndrome or venous thromboembolism), acute systemic
illness, uncontrolled hypertension (>180/110 mmHg), postural
hypotension (≥20 mmHg drop in systolic blood pressure with
symptoms of dizziness or light-headedness) (Williams et al., 2007;
Wise and Patrick, 2011).
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Study Design
Study was designed as randomized, open-label clinical trial
aligned with the CONSORT guidelines (Schulz et al., 2010),
adapted for two parallel groups (Figure 1). Participants were
randomized into 2 groups (1 interventional and 1 control
group) with ratio of 1:1 using adaptive (urn) randomization
with sealed envelopes and randomization concealment from
the recruiting investigator. Measurements were performed two
times: at baseline and after the intervention period (8 weeks).
Patients in both groups underwent clinical examination
prior to inclusion and ultrasonographic assessment [systemic
brachial vascular function and muscle thickness of m. vastus
lateralis (VL)], muscle strength assessment and blood sample
withdrawal at baseline and post-training intervention. The
primary outcome of the study was change in muscle strength and
hypertrophy from baseline to 8-week follow-up. The secondary
outcome was change in vascular function. Other exploratory
outcomes included cardiovascular markers, insulin resistance
and inflammatory markers.
Measurements and exercise intervention were conducted
at the Center for Preventive Cardiology, University Medical
Centre Ljubljana, Slovenia. One week ahead of baseline
measurement participants were familiarized with testing and
training procedures. The intervention period lasted for 8 weeks
of BFR resistance training period with baseline and post-
training testing.
During the week ahead of study, all subject underwent full
medical examination and a familiarization session. Each testing
session was split to 2 days, with at least a day of rest between
testing. On the first day, ultrasonographic images were taken to
assess flow mediated dilatation (FMD) and muscle thickness, and
unilateral 1-RM strength was assessed as well. During the second
day, blood samples were collected before subjects performed 3
sets of 10 repetitions of BFR resistance exercise at an intensity
of 30% of their previously achieved 1-RM leg extension. All
subjects performed a standardized warm-up before each testing
or training session as noted in previous section.
Prior to inclusion, all patients underwent a run-in phase
aerobic exercise training for 4 weeks (3 times a week, 45 min
of cycling, walking or combination thereof at 70–80% maximum
heart rate). After the baseline measurements, the control group
continued with usual care (aerobic exercise training), while in the
intervention group BFR training was added on usual care.
Both groups were informed of the risk associated with the
methods and procedures, and signed written consent prior to
their inclusion. The protocol was approved by the Republic of
Slovenia National Medical Ethics Committee and was registered
on ClinicalTrials.gov (identifier: NCT03087292). The study was
conducted in accordance with the Declaration of Helsinki and
the American College of Sports Medicine guidelines for Use of
Human Participants.
Exercise Intervention
Subjects in BFR resistance training group trained for 8 weeks,
performing a total of 16 unilateral leg extension exercise sessions.
During each week two exercise sessions were performed with
48 h of rest period in between. Each training sessions consisted
of three sets of 8, 10, and 12 repetitions in first, second, and
third set, respectively, with 45 s inter-set rest interval. Training
intensity was initially set to 30% of 1-RM. At every next training
session the number of repetitions was increased for at least two
repetitions per set. Additionally, training load was increased
every 2 weeks, from initial 30% 1-RM to 32.5% 1-RM in the third
week, to 37.5% 1-RM in the fifth week and finally to 40% 1-
RM in the seventh week. Furthermore, as the training intensity
increased, the number of repetitions was lowered to those in
first training session. A lifting cadence of 1 s:2 s (concentric:
eccentric part) was used for both groups throughout the full
range of motion. For exercise purposes, BFR was applied by
compressing the medium part of each thigh separately using
a pneumatic cuff (Riester, Jungingen, Germany). The cuff was
23 cm width and 42–50 cm in length. Before each session or
test, the cuff was inflated between 15 and 20 mmHg greater
than resting brachial systolic pressure (Manini and Clark, 2009),
taking into consideration the width of the cuff (Hackney et al.,
2012) and thigh circumference (Loenneke et al., 2012a). Pressure
was maintained throughout the entire training session and
was released at the end of last set. To assure safety of the
patients, brachial blood pressure and heart rate were measured
at the rest, after sets and 5 min after the end of each training
session. Brachial systolic and diastolic pressures were monitored
using automatic blood pressure monitor (Omron M6, Omron
Healthcare, Inc., Vernon Hills, IL, United States) and heart
rate was obtained using telemetry (Polar, Kempele, Finland).
All measurement and training sessions were monitored by
cardiologist and kinesiologist.
Maximal Muscle Strength Measurement
BFR resistance training and unilateral isotonic leg extension
strength measurements were performed on leg extension
machine (Technogym, Cesena, Italy) following previous
recommendations (Brown and Weir, 2001; Karabulut et al.,
2011). Maximal strength was assessed by performing 1-RM
testing at baseline (pre-training) and after (post-training) the
completion of exercise intervention. The participants were
familiarized with exercise testing protocol and were advised
with proper lifting technique at least 3 days prior to testing.
Patients were advised to perform the exercise while seated in an
upright position with their back in permanent contact with the
machine during the test, and with hands holding the handles
of the machine. Before the measurement, participants were
instructed to complete a warm up that included a 5–8 min
of brisk walking (>4 km/h) on treadmill followed by two
sets of static stretching for quadriceps muscles. During the
test, participants were instructed to complete a warm-up set
comprised of 8–10 repetitions for each leg at approximately 50%
of their perceived maximal effort (1-RM). The weight was then
increased progressively each set with simultaneously lowering
number of repetitions until reaching the maximum weight that
could be lifted for one repetition. Between each maximal effort
there was a 2–3 min rest interval. Maximal muscle strength was
determined within five attempts. Before and after measurement
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FIGURE 1 | Flow diagram of parallel randomization.
brachial blood pressure was obtained, while heart rate was
monitored throughout the procedure.
Muscle Thickness and Vascular Function
Measurement
Muscle thickness and vascular function was assessed with
Aloka Prosound α7 ultrasound machine (Hitachi Healthcare
Americas, Twinsburg, OH, United States) at baseline and after
the completion of the study. Both measurements were performed
at the same exact time of the day, mostly in the mornings.
Muscle thickness was assessed at rest, with subjects
performing no physical activity at least a day before the
testing. After applying hypoallergenic, watersoluble transmission
gel, ultrasound transducer was placed on the surface of the skin.
Muscle thicknesses of right VL were assessed. The measurement
sites were determined at upper, midway and lower thirds between
the greater trochanter and the lateral epicondyle of the knee.
Those distances were measured with the subjects standing still
with their knees fully extended. Three longitudinal images of the
VL were recorded for each measurement, and the mean of the
three values was used for further analysis (Martín-Hernández
et al., 2013). Images were then independently analyzed by
two experienced researchers and the mean of both was used
as a final result.
Flow-mediated dilation was measured on the right brachial
artery, approximately 5 cm above the antecubital fossa, according
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to previously described guidelines (Corretti et al., 2002). The
participants were instructed to lie in supine position. The artery
was firstly visualized in the horizontal position on the screen,
after which three measurements of the arterial diameter were
obtained (d1). A cuff was then inflated below the antecubital fossa
with the pressure of 50 mmHg above the systolic blood pressure.
Ischemia was maintained for 4.5 min. Sixty seconds after the
cuff deflation, three measurements of the arterial diameter were
obtained again (d2). FMD was calculated with the following
formula: [mean(d2)−mean(d1)]/mean(d1) and expressed in %.
Blood Markers Measurement
Blood samples were drawn from the antecubital vein using a
21-gauge needle; firstly, into a 4.5 mL vacuum tube containing
0.11 mol/L sodium citrate (9:1 v/v) (Becton Dickinson,
Vacutainer System Europe, Heidelberg, Germany), followed
by serum and K3-EDTA vacuum tubes (Laboratory Technic
Burnik, Ljubljana, Slovenia). Plasma was prepared with 20-
min centrifugation at 2000 × g and 15◦C. Serum was
prepared with 20-min centrifugation at 2000 × g and 20◦C.
Half milliliter aliquots of serum were snap frozen in liquid
nitrogen and stored at ≤−70◦C until analysis. Concentration
of glucose was measured in fresh serum on the Fusion 5.1
biochemistry analyzer (Ortho Clinical Diagnostics, Rochester,
NY, United States). Levels of CD40 ligand, insulin, TNF-
α were measured in a thawed serum aliquote with the
Luminex’s xMAP R© Technology utilizing magnetic beads coupled
with specific antibodies, which allowed multiplexing. Analysis
was performed according to manufacturer’s instructions (R&D
Systems, Abingdon, United Kingdom). Homeostatic model
assessment (HOMA) was calculated using values plasma glucose
levels and insulin levels via the HOMA Calculator1.
Sample Size Calculation and Statistical
Analysis
Sample size was calculated based on muscle strength as our
primary outcome, as the loss of muscle strength in CAD
patients is attributed to long term bed confinement, physical
inactivity and in some cases also significant impairment in the
cardiovascular disease itself (Bjarnason-Wehrens et al., 2004).
The calculations suggested that 28 patients with CAD should
be included in order to detect effect size value for muscle
strength after BFR training larger 0.58 as described previously
(Loenneke et al., 2012b), with an actual power of 0.95 at a level
of statistical significance <0.05. Statistical power and sample size
was calculated using G∗Power statistical software (University of
Düsseldorf, Germany).
Numeric variables were described as mean values and
standard errors of mean, and categorical variables were described
as numbers. Data were firstly screened for normality of
distribution and homogeneity of variances and/or regression
through Shapiro–Wilk’s test, Levene’s test and interaction
between independent variables× covariate, respectively. Baseline
and post-training differences between groups were determined
with the Independent-Samples t-test for normally distributed
1https://www.dtu.ox.ac.uk/homacalculator/index.php
variables and equal variances between groups, and Mann–
Whitney U test was used for asymmetrically distributed variables
and/or unequal variances between groups. Two-way analysis
of variance (ANOVA) for repeated measurements was used
to calculate main effects of group, time and group × time
interaction. Within group effect of training intervention (baseline
vs. post-training) was assessed with Paired-Samples t-test for
normally distributed variables and with Wilcoxon’s test for
asymmetrically distributed variables. All data are displayed in the
text, tables and figures. The data were analyzed using IBM SPSS
Statistics v.21 statistical software package for Windows (SPSS
Inc., Chicago, IL, United States). The level of significance was set
a priori to an alpha of <0.05.
RESULTS
During the recruitment process, 51 volunteers agreed to
participate in the study. After initial medical examination and
measurements, 24 were included into the study (6 women, 18
men; age 60.5± 2.4 years). Among excluded participants, 15 were
excluded due to medical exclusion criteria and 12 left the study
prior to start due to personal reasons/preferences (Figure 1).
Patients were randomly assigned to either BFR resistance training
group (3 women, 9 men; age 64.9 ± 1.6 years) or the control
(CON) group (3 women, 9 men; age 56.2± 2.5 years) (Figure 2).
Among 24 included patients, all have completed the study
(Figure 1). The adherence rate remained complete (100%)
throughout the exercise intervention in both groups. Despite
some occasional reports of muscle pain at the end of
training, no deaths, adverse effect of exercise, such as muscle
damage, skeletal injuries, chest pain, shortness of breath,
dizziness, palpitations, venous thrombosis, pulmonary embolism
or rhabdomyolysis, were reported.
Baseline physical and clinical characteristics of the sample
and both groups are displayed in Table 1. Overall, there were
significant differences in mean age (BFR resistance training
group 64.9 ± 1.6 years vs. CON group 56.2 ± 2.5 years)
and systolic blood pressure (BFR resistance training group
129.67 ± 3.71 mmHg vs. CON group 117.50 ± 3.36 mmHg),
otherwise there were no significant differences between groups
in other physical and clinical variables.
Hemodynamic Response
Post-training responses of heart rate (RR), systolic and diastolic
blood pressure following exercise intervention are shown in
Table 2. At baseline there was a significantly lower systolic
blood pressure in CON group (p = 0.024), with no significant
differences in resting heart rate or diastolic blood pressure. After
the training intervention, there was a significant main effect for
group × time interaction (p = 0.001; η2 = 0.627) and trend for
group effect (p = 0.074) on systolic blood pressure. Contrary,
no significant main effects of time, group or group × time
interaction for resting heart rate and diastolic blood pressure
were observed. Furthermore, there was a significant decrease in
systolic blood pressure in BFR group after training intervention
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FIGURE 2 | Baseline and post-training values of one repetition maximum (1-RM) for both groups. BFR-RT group, blood flow restriction-resistance training group;
CON group, control group. Values are presented as mean ± SE.
(p = 0.030), whereas similar decrease was not observed in diastolic
blood pressure and resting heart rate.
Acute hemodynamic responses to exercise are presented in
Table 3. In both groups BFR exercise evoked significant increase
in heart rate (p < 0.001) and systolic blood pressure at baseline
and post-training exercise test, while diastolic blood pressure did
not increase significantly. There was no significant difference
between groups in hemodynamic change (at rest vs. post-last set).
Maximal Muscle Strength
At baseline and post-training there were no significant differences
between groups in maximal muscle strength (Figure 2). After
the training period, there was a significant main effect for
time (p < 0.001, η2 = 0.769) and group × time interaction
(p < 0.001; η2 = 0.724), but no for group (p = 0.233). Both
groups significantly improved muscle strength post-training,
with greater increase in the BFR resistance training group
(16.37%, p < 0.001) than control group (5.29%, p < 0.01). Post-
training leg strength increased for 8.96 and 2.88 kg in the BFR
resistance training group and the control group, respectively.
Muscle Thickness
VL muscle thickness was assessed pre- and post-training period
(Table 4). There was no between-group difference in muscle
thickness observed at baseline nor after the completion of the
study. After the training intervention, there was a significant
main effect for time in lower third of VL (p < 0.05; η2 = 0.360)
alongside borderline significant time effect in midway third of
VL (p = 0.072; η2 = 0.265), whereas no significant group × time
interaction was obtained in neither of all three thirds of VL.
Additionally, a significant post-training decrease in muscle
thickness of lower VT was observed in CON group (p = 0.031).
On the contrary, improvements of muscle thickness on upper and
midway thirds of VL in the BFR resistance training group showed
a trend toward statistical significance (1.58–1.67 cm, p = 0.096
and 1.60–1.68 cm, p = 0.082, respectively).
Vascular Function
Two-way ANOVA showed no significant main effect for group
(p = 0.134) or group × time interaction (p = 0.28), whereas a
borderline significance was observed for time effect (p = 0.092;
η2 = 0.236). There were no significant differences between
groups or pre- vs. post-training within group, although a trend
toward improvement of FMD was obtained in the BFR resistance
training group (6.48 ± 0.80% to 8.04 ± 0.98%, p = 0.079,
respectively) (Figure 3).
Blood Markers
Baseline between group differences were observed in insulin
levels and insulin resistance (HOMA IR; both biomarkers
p = 0.014; Table 4). After the training intervention, there were
significant main effects for time (p = 0.036; η2 = 0.340) for CD40
ligand, significant main effect for group (p = 0.005; η2 = 0.306)
and group × time interaction (p = 0.036; η2 = 0.342) for insulin
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Age (years) 60.5 (2.4) 64.9 (1.6) 56.2 (2.5) <0.001


























































NSTEMI, N (%) 13 (54.2) 6 (50.0) 7 (58.3)
0.682
STEMI, N (%) 11 (45.8) 6 (50.0) 5 (41.7)
Surgical intervention
CABG, N (%) 5 (20.8) 2 (16.7) 3 (25.0)
1.000
PCI, N (%) 19 (79.2) 10 (83.3) 9 (75.0)
Medications
Aspirin, N (%) 24 (100.0) 12 (50.0) 12 (50.0) /
Statin, N (%) 24 (100.0) 12 (50.0) 12 (50.0) /
Beta blocker, N (%) 16 (66.7) 8 (50.0) 8 (50.0) 1.000
ACE/ARB, N (%) 17 (70.8) 8 (47.1) 9 (52.9) 1.000
Cardiovascular risk factors
Arterial hypertension, N (%) 17 (70.8) 8 (47.1) 9 (52.9) 1.000
Hyperlipidemia, N (%) 23 (95.8) 11 (47.8) 12 (52.2) 1.000
Diabetes Mellitus, N (%) 5 (20.8) 3 (60.0) 2 (40.0) 1.000
Smoking
Non-smoker, N (%) 7 (29.2) 3 (42.9) 4 (57.1)
0.822Smoker, N (%) 4 (16.6) 2 (50.0) 2 (50.0)
Ex-smoker, N (%) 13 (54.2) 7 (53.8) 6 (46.2)
Data for continuous values are expressed as mean (±SE). BFR-RT, blood flow
restriction-resistance training; CON, control group; BMI, body mass index; BP,
blood pressure; LVEF, left ventricular ejection fraction; STEMI, ST, elevated
myocardial infarction; NSTEMI, non ST-elevated myocardial infarction; CABG,
coronary artery bypass graft; PCI, percutaneous coronary intervention.
levels. In BFR group, training intervention led to a borderline
significant decrease in insulin (p = 0.077), HOMA IR (p = 0.079)
and CD40 ligand levels (p = 0.052), while a similar trend was
additionally observed in the control group for CD40 ligand
levels (p = 0.060).
DISCUSSION
To our knowledge, this is the first study to investigate the
beyond-acute effects of BFR resistance training with low-loads
(30–40% 1-RM) in CAD patients. Exercise training proved to
TABLE 2 | Resting hemodynamics at baseline and after the intervention period.
Variable (unit) Group Baseline Post-training p
RR (bpm) BFR-RT group 63.58 (2.68) 62.25 (1.88) 0.537
CON group 64.75 (3.67) 63.67 (3.18) 0.729
Systolic BP (mmHg) BFR-RT group 129.67 (3.71) 122.9 (2.74) 0.030
CON group 117.50∗ (3.36) 120.08 (3.54) 0.306
Diastolic BP (mmHg) BFR-RT group 81.92 (1.75) 79.67 (1.99) 0.133
CON group 78.17 (1.50) 76.83 (3.15) 0.632
∗Significantly different (p < 0.05) from BFR-RT group. Data are presented as mean
(±SE). BFR-RT, blood flow restriction-resistance training; CON, control; RR, resting
heart rate; BP, blood pressure.
be safe in patients, and was associated with increased muscle
strength and a trend toward increased muscle thickness and
altered inflammatory response.
Our findings confirmed that 8 weeks of BFR resistance
training may improve muscle strength as appraised by unilateral
leg extension 1-RM. Previous studies have shown similar
increases in leg extension 1-RM strength in comparable age
groups of healthy individuals (Karabulut et al., 2010, 2011;
Yasuda et al., 2014a,b), with the exception of one study (Vechin
et al., 2015). Also, the magnitude of strength gains in our study
is consistent with previous reports (in the range between 15
and 30%). However, longer training intervention (Yasuda et al.,
2014b) or higher frequency and repetitions (Karabulut et al.,
2011) seem to provide additional strength gains. In addition to
muscle strength, our study also showed a trend in increased
muscle thickness (as observed in upper and midway section of
muscle VL). Conversely, previous studies in healthy students
(Abe et al., 2005; Fujita et al., 2008; Madarame et al., 2008)
and older adults (Yasuda et al., 2014a,b; Vechin et al., 2015)
reported a definite increase in muscle hypertrophy of VL after
BFR resistance training, which may be due to higher intensity,
volume or duration of exercise trainings, as well as (younger) age
of participants in these studies.
Resistance training under BFR reduced resting systolic blood
pressure after 8 weeks in intervention group. This may be a
result of lowered hemodynamic stress for a given muscle force
after resistance training and less evoked rate of heart rate-
pressure product (HR times SBP, an indirect index of myocardial
oxygen demand) (Williams et al., 2007). Conversely, 12 weeks
of whole body resistance training at 60–80% of 1-RM without
occlusion did not evoke any hemodynamic response at rest in
CAD patients (Grafe et al., 2018). Thus it may be postulated that
BFR using lower loads could promote better training adaptations
compared to higher loads resistance training without occlusion
(Hackney et al., 2012). Our acute hemodynamic response to
exercise is in line with previous reports in healthy older men
(Staunton et al., 2015) and women (Scott et al., 2018) using
BFR-RT, despite lower increase in heart rate. This can be
explained with the discrepancies between exercise modes. In both
studies participants performed leg press exercise training under
BFR, which involve much more muscle mass than unilateral
knee extension and thus may lead to higher hemodynamic
response. Also, longer time under occlusion may evoke higher
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TABLE 3 | Acute hemodynamic exercise response at baseline and after the intervention period.
Variable (unit) Group Baseline Post-training Baseline 1 (p) Post-training 1 (p)
Pre exercise Post-last set Pre exercise Post-last set
RR (bpm) BFR-RT group 63.58 (2.68) 81.75 (2.65) 62.09 (2.06) 83.46 (3.74) 18.17 (0.000) 21.36 (0.000)
CON group 64.40 (4.39) 76.30 (3.97) 63.67 (3.19) 78.42 (4.07) 11.90 (0.000) 14.75 (0.000)
Systolic BP (mmHg) BFR-RT group 131.46 (3.56) 143.14 (3.86) 122.37 (2.95) 142.82 (4.30) 11.68 (0.001) 20.45 (0.000)
CON group 116.70 (3.98) 129.25 (2.11) 120.73 (3.82) 129.50 (5.80) 12.55 (0.014) 8.77 (0.035)
Diastolic BP (mmHg) BFR-RT group 82.73 (1.70) 85.59 (2.16) 79.18 (2.12) 82.09 (2.31) 2.86 (0.112) 2.90 (0.217)
CON group 77.50 (1.60) 80.25 (2.61) 77.09 (3.44) 78.64 (3.02) 2.75 (0.314) 1.55 (0.722)
Data are presented as mean (±SE). RR, resting heart rate; BP, blood pressure.
hemodynamic response, as both previous studies performed
longer sets with at least 15 repetitions per set (Staunton et al.,
2015; Scott et al., 2018).
The majority of previous studies in CAD have shown
improvements in FMD after aerobic (Edwards et al., 2004;
Blumenthal et al., 2005) or combined aerobic-and-resistance
training (Vona et al., 2009; Anagnostakou et al., 2014). The
vascular response, however, was higher with high intensity
interval training (Ramos et al., 2015) or combined exercise
training (Vona et al., 2009; Anagnostakou et al., 2014). Most
clinical trials have shown improvements in FMD (Vona et al.,
2009; Anagnostakou et al., 2014) after moderate resistance
training, which is in line with our results. Apart from exercise
type, the magnitude of effect is predominately associated
with training duration, frequency and intensity, as longer
interventions (>12 weeks), higher frequencies (3–4 times a
week), higher intensities (>55% 1 RM) structured in whole body
resistance regimens have the potential to provoke higher FMD
response (Vona et al., 2009; Anagnostakou et al., 2014). Hence,
discrepancies in training parameters may explain the modest
FMD improvements in our study.
Inflammatory mediators appear to play a fundamental
role in the initiation, progression, and eventual rupture of
atherosclerotic plaques (Szmitko et al., 2003) and pathogenesis
of cardiovascular diseases (Pedersen, 2017). Evidence suggests
that increased TNF-α (Szmitko et al., 2003; Pedersen, 2017)
and CD-40 ligand are linked to endothelial dysfunction and
subsequent atherogenesis with late thrombotic complications
(Szmitko et al., 2003). In contrast, physical activity can counteract
with provoking anti-inflammatory effects by an inhibition of
TNF-α (Pedersen, 2017) and CD-40 ligand levels (Bjornstad
et al., 2008), although the latter mechanism was not proven
following our BFR resistance training. The difference may occur
as a result of short exercise duration (<15 min) and relatively
limited muscle mass involved during the exercise (unilateral
knee extension), as more pronounced systemic response between
TNF-α and IL-6 were observed after longer strenuous exercise
involving several large muscle groups (Pedersen, 2017). On
the other hand, a 20-week combined endurance and resistance
training decreased values of soluble CD-40 ligand in patients with
chronic heart failure (Bjornstad et al., 2008).
BFR resistance training improved insulin sensitivity.
Resistance training without BFR promotes a decrease in
resting insulin levels and increase in insulin sensitivity
(Williams et al., 2007), which is in line with our results.
Similar favorable effects of resistance exercise with higher loads
were also reported in patients with type 2 diabetes mellitus
(Jorge et al., 2011; Kadoglou et al., 2013). Data from two
previous study suggest that the decrease in HOMA IR can
be time dependent, as there were no significant changes in
HOMA IR after 12 weeks of resistance training in patients
with type 2 diabetes mellitus of comparable age (Jorge et al.,
2011). Contrary, a significant decrease in HOMA IR was
obtained after 6 months of resistance training at the exercise
intensity of 60–80% of 1-RM in patients with type 2 diabetes
(Kadoglou et al., 2013). Furthermore, it is plausible that
younger control group was more physically active prior to the
documented coronary event, as this could explain their the
significant lower baseline values of insulin and lower HOMA IR
(Gayoso-Diz et al., 2011).
Our study has some limitations. Firstly, a relatively small
sample size. This was reflected in a significant age-difference
between intervention groups suggesting randomization failure,
TABLE 4 | Muscle thickness and blood markers at baseline and after the
intervention period.
Variable (unit) Baseline Post-training p
Upper third of VL
diameter (cm)
BFR-RT group 1.58 (0.07) 1.67 (0.06) 0.096
CON group 1.56 (0.05) 1.51 (0.07) 0.367
Midway third of VL
diameter (cm)
BFR-RT group 1.60 (0.08) 1.68 (0.08) 0.082
CON group 1.58 (0.05) 1.64 (0.06) 0.331
Lower third of VL
diameter (cm)
BFR-RT group 1.64 (0.07) 1.57 (0.09) 0.429
CON group 1.53 (0.07) 1.43 (0.08) <0.05
Insulin (pg/mL) BFR-RT group 1247 (132) 864 (180) 0.077
CON group 655 (119)∗ 810 (253) 0.791
HOMA IR BFR-RT group 4.01 (0.43) 2.86 (0.57) 0.079
CON group 2.17 (0.40)∗ 2.38 (0.59) 0.733
CD40 ligand
(pg/mL)
BFR-RT group 9116 (1100) 5735 (1221) 0.052
CON group 7869 (1142) 5142 (784) 0.060
TNF-α (pg/mL) BFR-RT group 5.8 (1.85) 4.9 (1.41) 0.581
CON group 14.9 (6.41) 14.5 (4.99) 0.967
∗Significantly different (p < 0.05) from BFR-RT group. Data are presented as mean
(±SE). VL-m, vastus lateralis; HOMA, homeostatic model assessment; IR, insulin
resistance; TNF-α, tumor necrosis factor alpha.
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FIGURE 3 | Baseline and post-training values of flow-mediated vasodilation (FMD). BFR-RT group, blood flow restriction-resistance training group; CON group,
control group. Values are presented as mean ± SE.
which possibly yielded pronounced between-group differences
because of faster recovery in younger participants. Thus, our
study was underpowered and should be regarded as pilot
and hypothesis generating. Secondly, the allocation was not
blind. The majority of subjects were physically active, which
may have diminished the between-group differences and
effects of our intervention itself. Moreover, as all patients
(including control group) were made aware of positive
effects of exercise on their strength and health in general,
an additional increase in physical activity level during the
study period cannot be ruled out. Thirdly, duration of the
trial may have been too short to express sufficient responses.
Since safety of BFR training has not been rigorously tested
in clinical settings, and exact cardiovascular and coagulation
responses were not clearly presented to this date, the duration
of exercise intervention was chosen based on previous resistance
training research in CAD patients. Nevertheless, longer
exercise interventions (>12 weeks) might have provoked
additional muscle gains and vascular function improvements.
Lastly, virtually all patients were on secondary preventive
medications, which may have confounded heart rate (beta-
blockers), and blood pressure and vascular function (statins
and ACE-inhibitors).
Our results have shown that BFR resistance training is
efficient only in terms of improving muscle strength and
blood pressure, whereas the effect on muscle size and
biomarkers failed to reach statistical significance and needs
to be addressed in larger and longer studies. Moreover, BFR
resistance training seems to be potentially safe, with beneficial
impact on hemodynamic responses, but not on vascular
function. Therefore, it may be provided as an additional
exercise option to safely and effectively improve skeletal muscle
functioning and general health. Nonetheless, the current study
reveals a need for future studies to evaluate the current
findings on larger samples with longer training duration.
Thus, such training effect on different health parameters
can be exaggerated and later translated into early phase of
cardiac rehabilitation.
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Background: Electrocardiogram (ECG) contamination is present in diaphragm
electromyography (EMGdi) recordings. Obtaining EMGdi without ECG contamination
is crucial for EMG amplitude analysis. Manually selecting EMGdi in between QRS
complexes has been most commonly applied in recent years (manual method). We
developed a semi-automated analysis method based on Least Mean Square Adaptive
Filtering combined with a synchronously recorded separate ECG channel to remove
ECG artifacts from the EMGdi signals. We hypothesized that this approach would
shorten analysis duration and might minimize the potential for inter-rater disagreement.
Aims: We aimed to evaluate agreement between the semi-automated method and the
manual method and inter-rater reliability of the manual method.
Methods: Electromyography signals of seven patients with COPD were recorded using
an esophageal catheter during an exercise test on a cycle ergometer. Four patients
subsequently participated in an inspiratory muscle training (IMT) program for 8 weeks.
After IMT, the tests were repeated. EMGdi/EMGdiMax as obtained either manually by
the two assessors or retrieved from the semi-automated method were compared.
Results: Semi-automated EMGdi/EMGdiMax agreed well with values obtained by one
of the two manual assessors (assessor 1) both at pre-intervention measurements (mean
difference −0.5%, 95% CI: −19.6 to 18.6%) and for the pre/post IMT differences (mean
difference 1.2%, 95% CI: −16.8 to 19.2%). Intra-class correlation coefficients between
methods were 0.96 (95% CI: 0.94–0.97) at pre-intervention measurements and 0.78
(95% CI: 0.58–0.89) for pre/post IMT differences (both p < 0.001). EMGdi/EMGdiMax
from assessor 2 was systematically lower than from assessor 1 and agreed less well with
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the semi-automated method both at pre-intervention measurements (mean difference:
9.3%, 95% CI: −11.4 to 29.9%) and for pre/post IMT differences (mean difference
7.0%, 95% CI: −20.4 to 34.4%). Analysis duration of the semi-automated method was
significantly shorter (29 ± 9 min) than the manual method (82 ± 20 min, p < 0.001).
Conclusion: The developed semi-automated method is more time efficient and will be
less prone to inter-rater variability that was observed when applying the manual analysis
method. It is, therefore, proposed as a new standard for objective EMGdi amplitude
analyses in future studies.
Keywords: electromyography, electrocardiography, diaphragm electromyography, chronic obstructive pulmonary
disease, respiratory muscle training
INTRODUCTION
Electromyography (EMG) is an assessment of muscle activation
by recording the electrical activity of the muscle tissue.
Assessments of diaphragm EMG (EMGdi) amplitude are
frequently applied in both clinical and research settings, where
they can serve as an indirect measure of neural respiratory drive
(NRD) during different conditions such as resting breathing,
exercise breathing, or during sleep (Luo and Moxham, 2005; Luo
et al., 2011; Xiao et al., 2015; Steier et al., 2017). EMGdi can be
recorded either via surface electrodes placed on the chest wall,
with needle electrodes inserted into the costal diaphragm, or with
an esophageal catheter equipped with EMG electrodes (Sinderby
et al., 1998; Duiverman et al., 2004; Luo et al., 2008). The
EMGdi recording contains artifacts from the power line, from
movement, and from cardiac activity. Movement artifacts are
associated with very low frequencies and can be easily removed
by applying high pass filtering at 20 Hz. However, the cardiac
activity artifacts, as detected by electrocardiogram (ECG), is
more difficult to remove because of the overlapping bandwidth
spectrum between ECG and EMGdi. The majority of the EMGdi
signal is concentrated in the bandwidth between 20 and 250 Hz,
while the bandwidth of the ECG frequency spectrum lies between
0 and 100 Hz (Schweitzer et al., 1979). It is crucial to obtain
the EMGdi signal without the ECG contamination, to ensure
the accuracy of the EMGdi signal (Levine et al., 1986; Zhou and
Kuiken, 2006; Luo et al., 2008). Separating ECG from EMGdi is
particularly challenging in EMG amplitude analyses, especially
during exercise, since the EMGdi amplitude can be larger than
the ECG. This makes it more difficult to identify ECG artifacts
within the EMG signal.
One widely used method to obtain the EMGdi signal without
ECG contamination is to manually select EMGdi data in between
QRS complexes (Luo and Moxham, 2005; Luo et al., 2008; Jolley
et al., 2009; Reilly et al., 2013; Schaeffer et al., 2014; Langer
et al., 2018). By placing a separated time-synchronized ECG
channel next to the EMG channel, the ECG channel is visually
identifiable, thereby allowing to retrieve the EMGdi in between
QRS complexes. However, there are some limitations to this
method. First, this method is time-consuming, especially for
recordings that contain many breathing cycles such as during
exercise. Second, based on the experience in our research group,
it might be subjective to inter-rater variability since the retrieved
data can vary depending on the judgment of the assessor. Inter-
rater variability could arise from the fact that several EMGdi parts
are available to choose from in between QRS complexes during
every inspiration. No specific instructions are currently available
as to which interval should be preferably selected under these
circumstances while selection of either ascending, descending,
or peak intervals of the uncontaminated signal might result in
vast differences in the recorded EMG amplitude. Selection width
of the chosen interval while avoiding artifact to either side of
the selected interval might be another factor that could explains
the inter-rater variability of the obtained EMG amplitude for a
given breath. A final limitation of the manual method is that
EMGdi activity “buried” in the ECG signal cannot be selected.
Depending on the location of the QRS complexes the data outside
of contaminated area might not be the best representation of
the actual EMG amplitude (e.g., the part containing the highest
amplitude of the signal might not be available to select). This
might be especially problematic during exercise, when several
heartbeats typically occur during a single inspiration.
Several methods have been previously applied to automatically
deduct or remove ECG artifacts from EMGdi signals. However,
the majority of methods does not rely on ECG data from
a separately collected ECG channel. These methods typically
suffer from problems with frequency-overlapping, difficulties in
waveform identification, and processing difficulties due to the
sometimes smaller amplitude of the ECG signal in comparison
to the EMG signal (e.g., during near maximal diaphragm
activation throughout exercise hyperpnea) (Schweitzer et al.,
1979; Zhou and Kuiken, 2006; Mak et al., 2010; Willigenburg
et al., 2012). Bloch suggested using a separate and simultaneous
recording of a time-synchronized ECG channel to avoid
these problems (Bloch, 1983). For analysis, he proposed to
initially use the amplitude threshold to identify the QRS
complex of the ECG, followed by applying a least squares
subtraction on the time domain to remove ECG artifacts
(Bloch, 1983). This method introduced by Bloch has not been
extensively evaluated or validated especially not for EMGdi
recordings of resting and exercise breathing obtained with an
esophageal catheter.
Up to now, there is no gold standard method available
for removing ECG artifacts while analyzing EMGdi amplitude
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data. From the reviewed methods above, manually selecting
EMGdi in between QRS complexes has so far been the most
applied method. This method will be mentioned onward as the
“manual” method. Because of the shortcomings of the manual
method, we were interested in developing and evaluating an
alternative method that could potentially shorten the duration
of the analysis and overcome several problems related to
the expected inter-rater ambiguity that seems inherent to the
somewhat subjective judgments that have to be made while
applying the manual analysis method. Therefore, we developed
a custom “semi-automated method” based on a Least Mean
Square (LMS) Adaptive Filtering method (Bloch, 1983) combined
with a synchronously recorded, separated ECG channel. We
aimed to compare this “semi-automated method” with results
obtained from the manual method. In addition, we also aimed
to formally study the degree of inter-rater variability that
can be expected when applying the manual analysis method.
Responsiveness (i.e., the ability of a measure to detect change)
is an important feature of assessment methods that needs to
be evaluated separately from reliability and validity (Husted
et al., 2000).The degree of agreement between methods was
therefore evaluated both cross-sectionally (i.e., of data obtained
at a single point in time) to evaluate validity and reliability
as well as by comparing changes in activation observed after
an intervention period between methods to evaluate and
compare responsiveness.
Accordingly, the aims of this study were the following: (1)
to investigate the inter-rater reliability of the manual method
of EMGdi amplitude analysis and (2) to explore the agreement
between the manual and the proposed semi-automated analysis
method of EMGdi amplitude signals both cross-sectionally (to
evaluate validity) and of changes in response to an intervention
(to evaluate responsiveness).
MATERIALS AND METHODS
Study Design and Subjects
Clinically stable patients with moderate to severe COPD were
included in this study. Data were retrieved from patients
who had been enrolled in a clinical study (ClinicalTrials.gov
Identifier: NCT03240640). The Ethical Committee Research of
KU Leuven/UZ Leuven, Belgium approved the study (S58513).
All participants signed written informed consent. EMGdi
was recorded during a constant work rate cycle ergometer
(CWR) test before and after 8 weeks of inspiratory muscle
training (IMT). The EMGdi data were first analyzed using the
manual method by two independent assessors. The same data
were then analyzed again using the semi-automated method.
Comparisons were made both between the results obtained
by the two assessors using the manual analyzing method as
well as between results obtained by both manual assessors
and from the semi-automated method. The details of each
analysis method are described below. Interim analysis of these
data has been presented at ERS International Congress 2018
(Dacha et al., 2018).
Pulmonary Function and Respiratory
Muscle Function Measurements
Pulmonary function testing (MasterScreen Body, CareFusion,
Höchberg, Germany) was performed according to ERS guidelines
(Miller et al., 2005; Wanger et al., 2005; Graham et al., 2017).
Maximal inspiratory, expiratory mouth pressures (MIP and
MEP) and transdiaphragmatic pressure (PdiMax) during sniff
maneuver were assessed according to international guidelines
(American Thoracic Society/European Respiratory Society
[ATS/ERS], 2002).
EMG Recording and Analysis
Esophageal Catheter and Positioning
A multipair-esophageal electrode catheter (Yinghui Medical
Equipment Technology Co., Ltd., Guangzhou, China) was used
to assess EMGdi. The catheter is approximately 60 centimeters
long, two millimeters in diameter, and is equipped with
five EMG electrode pairs feeding five EMGdi channels. The
catheter was inserted nasally and then swallowed by the patient.
The positioning of the catheter was performed according to
procedures established in previous studies (Luo and Moxham,
2005; Luo et al., 2011). In short, the patient was asked to perform
several slow maximal inspiratory capacity (IC) maneuvers (an
inspiration through the open mouth from the functional residual
capacity to total lung capacity). The best position was determined
as the location which the largest EMGdi amplitudes were
recorded from the outer electrode pairs and the smallest from the
middle pairs (Figure 1; Luo et al., 2001, 2011; Luo and Moxham,
2005). After positioning, the catheter was secured by taping one
end onto the patient’s nose.
EMGdi Sampling and Processing
The EMGdi signals were first amplified (Biomedical amplifier,
Guangzhou, China), sampled at 2000 Hz by a data acquisition
system (Micro1401-3, Cambridge Electronic Design Limited,
Cambridge, United Kingdom) and then processed with a
specific software package (Spike 2, Cambridge Electronic Design
Limited, Cambridge, United Kingdom). During processing the
raw EMGdi data were first high pass filtered at 20 Hz to
minimize motion artifacts and then transformed into “Root
Mean Square” (RMS). The EMGdi signals recorded during
breathing were then normalized by presenting the recorded
value relative to the signal obtained during maximal activation;
EMGdi/EMGdiMax%. The highest EMGdi signal obtained from
any of the five channels during each subsequent breath was
retrieved for analyses. Maximal activation of the diaphragm
was obtained during typical (i.e., fast) exercise IC maneuvers,
either during resting breathing or during exercise breathing
(Sinderby et al., 1998). The patients were asked to perform these
IC maneuvers every minute during the three resting minutes
preceding the cycling test, and every other minute during the
cycling test. The largest RMS amplitude obtained during any of
the recorded IC maneuvers was selected as EMGdiMax.
ECG Removal With the Manual Method
From the processed data, both assessors were instructed to
perform the manual analysis of the EMGdi signals in agreement
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FIGURE 1 | A five diaphragm EMG (EMGdi) channel recording contains electrocardiogram (ECG) artifacts during resting breathing. From top to bottom the channels
are as follow; Channel 1: respiratory flow (l/s; negative flow indicating the inspiratory cycle), Channel 2: ECG recording (volt), Channels 3–7: EMGdi recordings. The
correct positioning of the catheter is shown when the largest EMGdi amplitudes are in the outer EMGdi channels (3 and 7), and the smallest amplitude is in the
middle channel (5). The inspiratory capacity (IC) maneuver is highlighted in the red box indicated by the higher flow, which accompanies the maximal activation of the
diaphragm (EMGdiMax).
with previously published methods. They were instructed to
extract the EMGdi signals from segments of inspiratory cycles
between QRS complexes (Luo et al., 2001, 2011; Luo and
Moxham, 2005; Reilly et al., 2013); however, reflecting previously
published methods, no instructions were given with regards
to handling possible residual interference by P, T, or U
waves (Figure 2). Thus, we cannot exclude the possibility of
such interference within the manually derived EMGdi signal.
Noteworthy, the values that have been extracted between QRS
complexes in most previous literature is the peak RMS EMGdi
signal of a given breath (Sinderby et al., 1996; Luo and Moxham,
2005; Reilly et al., 2011, 2012, 2013). However, as we were
interested in measuring an estimate of the integral (i.e., mean)
respiratory neural drive of the inspiratory cycle of a given breath,
the mean value between QRS complexes that would represent
the integral activation was used for analysis instead of the peak
value (Langer et al., 2018). The time-synchronized flow and
ECG channels were used as a guide for EMGdi selection. Five
representative (preferably consecutive) breaths toward the end
of each minute were selected. The choice of using five breaths
toward the end of a given minute is based on in-house previous
analysis that shows the mean value obtained from the last five
breaths of a given minute being similar to the average of the
values obtained from the last 30 s of the same minute. Breaths
were disregarded in case they represented short sighs or included
visible noise (e.g., from coughing) or if they were visibly different
compared to surrounding breaths. The average of EMGdi of these
five breaths was used as representative of diaphragm activation of
each minute of the cycling test.
ECG Removal With the Semi-Automated Method
To perform semi-automated ECG exclusion using the newly
developed algorithm several steps had to be executed. First, in
the data acquisition software (Spike 2, Cambridge Electronic
Design Limited, Cambridge, United Kingdom), the following
recording channels were selected and exported at 1000 Hz into
a text file using the export option from the data acquisition
software: ECG, EMGdi (five channels),respiratory flow and
volume, and a channel including event markers. These markers
were manually inserted during the test to spot the transition from
one condition to another during the test. The entire length of
the data file, including the resting period before cycling, 1 min
of unloaded cycling and all minutes of loaded cycling until
symptom limitation were exported. The exported file was then
imported into LABVIEW (National Instruments, Austin, TX,
United States) software. The waveforms of the recorded channels
was also visible in LABVIEW for inspection.
To reduce the ECG content of the diaphragm EMG channels
we used a method called “adapted filtering.” The LMS Adaptive
Filter is a pattern recognition algorithm, which is available in
the LABVIEW software. This method is a filtering method in
the frequency domain that aims to remove the ECG frequency
content out of the total signal. The filter was tuned to comply
with the minimum error and consequently delivered the best
Frontiers in Physiology | www.frontiersin.org 4 July 2019 | Volume 10 | Article 88529
fphys-10-00885 July 8, 2019 Time: 16:8 # 5
Dacha et al. Comparing Diaphragm EMG Analysis Methods
FIGURE 2 | Illustration of the diaphragm EMG (EMGdi) recordings toward the end of the (symptom limited) cycling test. Channel 1: respiratory flow (l/s; negative flow
indicating the inspiratory cycle), Channel 2: electrocardiogram (ECG) recording (volt), Channels 3–7: RMS EMGdi recordings. For the data analysis using the manual
method, the mean values of EMGdi in between QRS complexes during the inspiratory cycle were selected. The periods highlighted in light blue are the possible
periods that could be chosen without ECG contamination in each inspiratory cycle. The average of EMGdi of five consecutive breaths was used as a representative
value of EMGdi of that minute. Vertical cursors 1, 2, 3, and 4 were used as a tool during manual analysis to retrieve mean values of EMGdi in the selected period.
results to remove the ECG component from the recorded signal.
We used a filter length of 70 and a step size of 0.01 as the most
optimal coefficients for this analysis. A separate channel was used
to record the ECG synchronously to tune the coefficients of the
Finite Impulse Response (FIR) filter continuously. In this way,
the removal was very precise, even though the heart rhythm was
changing throughout the test. More detail concerning the LMS
Adaptive Filtering can be found in this link http://www.ni.com/
example/31220/en/.
The ECG filtering algorithm was pre-set in the LABVIEW
software, the ECG channel was recognized automatically by the
algorithm. After importing the data, the assessor selected the
ECG exclusion option on all EMGdi channels. The algorithm
then automatically ran and the assessor was notified when
the “cleaned” EMGdi data were ready to be retrieved. These
results were then saved in a separate text file. This text file
containing the cleaned EMGdi data was then re-imported into
the data acquisition software (Spike 2). The assessor then used
a respiratory script application (commercially available upon
purchase of the software) available in the data acquisition
software (spike 2) to further process the data. The respiratory
script automatically marks the inspiratory and the expiratory
cycle of each breath throughout the selected recording interval
based on the respiratory flow signal (i.e., based on zero-flow
points). The mean of the integrated EMGdi signal (RMS) during
every inspiratory cycle (marked periods) throughout the cycling
test was then automatically calculated and exported to an excel
sheet. The values of these mean integrated EMGdi signals of
every breath could not be manipulated by the assessor. The
assessor then identified the resting and exercise period of each
test and each minute of the test was manually marked. The
average of the mean of integrated RMS from every inspiratory
cycle in each minute was then manually calculated and used as a
representative diaphragm activation of each minute of the cycling
test (Figure 3). In a similar way, IC maneuvers were manually
identified and activation data retrieved. In summary, while the
method involves some manual steps it is not possible to manually
manipulate EMGdi amplitude signals within separate breaths.
The method is therefore (in contrast to the manual method) not
prone to inter rater variability. Differences in outcomes could
only occur in case of not selecting appropriate minute intervals
or IC maneuvers.”
The reported results used for analysis were taken from one of
the five channels that (on average) contained the largest EMGdi
signals during IC maneuvers.
Exercise Testing
All patients underwent constant work rate (CWR) cycling
tests consisting of 3 min of resting, 1 min of unloaded cycling
and immediately followed by cycling against 75% of the
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FIGURE 3 | Illustration of the diaphragm EMG (EMGdi) recordings toward the end of the (symptom limited) cycling test (period comparable to Figure 2). For the data
analysis using the semi-automated method. Channel 1: respiratory flow (l/s; negative flow indicating the inspiratory cycle), Channel 2: ECG recording (volt); The
absolute ECG values (volt) from this re-imported data after having been processed in LABVIEW using the semi-automatic algorithm were transformed into an
abstract unit. Therefore, the signal appeared to be distorted and cannot be compared directly to the pre-processed ECG signal, Channels 3–7: the processed
EMGdi data from our customized algorithm without ECG contamination in the diaphragmatic EMG signal (EMGdi). Channel 8: br.#, beginning of the inspiratory cycle
and Channel 9: T exp., beginning of the expiratory cycle indicates the inspiratory and expiratory cycle of each breath which was marked automatically by the
program. The EMGdi during a full inspiratory cycle can be selected (highlighted in light blue). The average of the mean EMGdi from every inspiratory cycle in each
minute was analyzed. Vertical cursors 1 and 2 indicate a longer period that the value of EMGdi could be retrieved compare to the same breath in Figure 2 that only
shorter periods were available.
patient’s peak work rate achieved during a maximal incremental
cardiopulmonary exercise test (CPET) (American Thoracic
Society/American College of Chest Physicians [ATS/ACCP],
2003) until symptom limitation. The tests were conducted on an
electrically braked cycle ergometer (Ergometrics 900, Ergoline,
Blitz, Germany) with detailed metabolic (SensorMedics Vs229d,
Acertys Healthcare, Aartselaar, Belgium) and cardiopulmonary
measurements (Cardiosoft, Acertys Healthcare, Aartselaar,
Belgium). The respiratory flow signal was recorded during
the exercise to be able to identify the respiratory cycle. ECG
recordings were obtained via an impedance cardiography device
(PhysioFlow, Manatec Biomedical, Folschviller, France) validated
for COPD patients and recorded as a separate channel (Louvaris
et al., 2019). Analog outputs of all variables (i.e., respiratory
flow, five EMGdi and ECG) were collected in separate channels
with a data acquisition unit (Micro1401-3, Cambridge Electronic
Design Limited, Cambridge, United Kingdom). Data channels
were synchronously collected by the same system and processed
with the same acquisition software (Spike 2, Cambridge
Electronic Design Limited, Cambridge, United Kingdom). The
system was a priori checked for potential time delays between
the different systems providing the signals of the different
channels (e.g., ECG and EMGdi). No time delays were present
and therefore, no additional post collection synchronization of
data had to be performed.
Inspiratory Muscle Training (IMT)
Inspiratory muscle training was performed daily by four
subjects using an electronic POWERbreathe R©KH2 device (HaB
International Ltd., Southam, United Kingdom) for 8 weeks,
according to a previously published protocol (Langer et al.,
2015). In short, the patients trained at the highest tolerable
intensity, 30 breaths per session and two sessions per day.
Progression of training intensity and MIP measurements were
performed weekly.
Statistical Analyses
Comparisons of diaphragm activation at pre-measurement and
pre/post IMT differences obtained from two assessors using
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the manual signal processing method and with the semi-
automated signal processing method were made. Pearson’s
correlation coefficient (r) was used to establish associations
between measurements. The intra-class correlation coefficient
(ICC) based on a mean-rating, absolute-agreement, 2-way
mixed-effects model was used to quantify agreement between two
assessors (inter-rater reliability) and between the two methods.
Agreement of the results from two assessors and between
the two methods was assessed by plotting mean differences
between assessors or methods against average values (Bland-
Altman plots) (Bland and Altman, 1986). Limits of agreement
were defined as ±1.96 × standard deviation of the difference
between the two methods, corresponding to 95% confidence
intervals (CI). The interaction over time between the two
assessors and the two methods was assessed using repeated
measures ANOVA. Within rater Coefficient of Variation (CV)
for the two raters was calculated from five representative
breaths during resting and at the end of exercise. For the
semi-automated method, the CV was also calculated at the
same time points. Statistical analyses were performed using
GraphPad Prism version 8 for Windows (GraphPad Software,
La Jolla, CA, United States) and IBM SPSS Statistics 25.0
Desktop (IBM Corp., Armonk, NY, United States). Statistical
significance was considered at p < 0.05. Data are presented
as means ± SD.
RESULTS
Datasets supporting the conclusions of this manuscript are
available on request. Characteristics of included patients
are presented in Table 1. Patients exhibited moderate to
severe airway obstruction with static hyperinflation, reduced
exercise capacity, and inspiratory muscle strength. There are
approximately four heartbeats during one inspiratory cycle both
at rest and during exercise (Table 1).
Comparisons of EMGdi/EMGdiMax%
Obtained by Either the Two Assessors or
as Processed With the Semi-Automated
Method From Data Collected During a
Constant Work Rate Cycling Task
The intra-class correlation coefficients (ICC) between diaphragm
activation signals obtained with the manual methods by two
assessors at pre-measurement was 0.94, p < 0.0001, 95% CI:
0.17–0.98 (Figure 4A). The ICC between EMGdi signals from
the semi-automated method and the results obtained by using
the manual method from assessor 1 and 2 at pre-measurement
were 0.96, p < 0.0001, 95% CI: 0.94–0.97 (Figure 4B) and 0.91,
p < 0.0001, 95% CI: 0.60–0.97 (Figure 4C), respectively.
Bland – Altman plots for the agreement of
EMGdi/EMGdiMax% for the above-mentioned comparisons
are presented in Figures 5A–C. On average, the
EMGdi/EMGdiMax% obtained from the manual method
by assessor 2 resulted in lower values than those obtained
from assessor 1 (average bias of the differences: −9.9%; CI:
TABLE 1 | Patient characteristics: pulmonary function, respiratory muscle
strength, maximal, and endurance exercise capacity.
All subjects (n = 7)
General characteristic
Male:female 4:3
Age, years 66 ± 5
BMI, kg/m2 25 ± 7
Pulmonary function
FEV1, L (%pred) 1.37 ± 0.57 (56 ± 31)
FEV1/FVC, % 42 ± 15
IC, L (%pred) 1.96 ± 0.44 (76 ± 27)
FRC, L (%pred) 5.14 ± 1.85 (161 ± 42)
RV, L (%pred) 3.64 ± 1.48 (149 ± 57)
TLC, L (%pred) 7.10 ± 1.73 (122 ± 19)
DLCO, mmol/min/Kpa (%pred) 4.63 ± 2.01 (59 ± 25)
Respiratory muscle strength
MIP at RV, cmH2O (%pred) −77 ± 11 (85 ± 18)
Pdimax, cmH2O 89 ± 19
MEP at TLC, cmH2O (%pred) 167 ± 55 (99 ± 34)
Symptom-limited peak incremental cycling ergometer exercise test
Cycling duration (minutes) 7.7 ± 1.5
Peak work rate, W (%pred) 82 ± 27 (64 ± 24)
VO2, L/min (%pred) 1.40 ± 0.60 (74 ± 33)
HR, bpm (%pred HRmax) 118 ± 16 (76 ± 9)
Ventilation, L/min (%MVV) 44.6 ± 7.6 (88 ± 13)
Constant work rate cycling test (CWR cycling)
Cycling work rate, W (%Wmax) 59 ± 20 (72 ± 3)
Cycling duration, min 8.0 ± 3.7
Resting HR, bpm (%pred HRmax) 80 ± 10 (52 ± 16)
HR at end exercise, bpm (%pred HRmax) 124 ± 17 (80 ± 10)
Resting BF, bpm 22 ± 8
BF at end exercise, bpm 32 ± 8
HR:BF at rest, per min 3.9 ± 1.1
HR:BF at end exercise, per min 4.1 ± 1.2
Ventilation, L/min (%MVV) 38.3 ± 8.4 (80 ± 11)
Resting Ti, s 1.1 ± 0.5
Ti at end exercise, s 0.8 ± 0.2
Resting Te, s 2.1 ± 0.7
% change from rest Ti −25 ± 22
% change from rest Te −36 ± 23
FEV1, forced expiratory volume in one second; FVC, forced vital capacity; IC,
inspiratory capacity; FRC, functional residual capacity; RV, residual volume; TLC,
total lung capacity; DLCO, diffusing capacity of the lung for carbon monoxide;
MIP at RV, maximal inspiratory mouth pressure at residual volume; PdiMax,
maximal transdiaphragmatic pressure during sniff maneuver; MEP at TLC, maximal
expiratory mouth pressure at total lung capacity; VO2, oxygen consumption;
HR, heart rate; MVV, maximal voluntary ventilation; BF, breathing frequency; Ti,
inspiratory time; Te, expiratory time; %pred, %predicted.
−22.9 to 3.0%, Figure 5A). The plot of agreement between
EMGdi/EMGdiMax% values from the semi-automated method
and results of the manual method obtained by assessor 1
showed that on average the values from the semi-automated
method were very similar with the values obtained from the
manual method by assessor 1 (average bias of the differences:
−0.5%; CI: −19.6 to 18.6%, Figure 5B). The plot of agreement
between the values from the semi-automated method and
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FIGURE 4 | The correlation between EMGdi/EMGdiMax% calculated from the manual method by two assessors during the pre-measurement CWR cycling test (A);
the semi-automated method and the manual method by assessor 1 (B); and the semi-automated method and the manual method by assessor 2 (C). Line of
identity, linear regression coefficients, intra-class correlation coefficients (ICC), and significances are presented in each figure. Each of the data points represents the
activation of diaphragm EMG (EMGdi/EMGdiMax%) of each patient in every minute during the pre-measurement CWR cycling test.
those obtained by the manual method from assessor 2
showed higher values from the semi-automated method
(average bias of the differences: 9.3%; CI: −11.4 to 29.9%
Figure 5C).
Average EMGdi/EMGdiMax% obtained from the
manual method by two assessors and values obtained with
the semi-automated method were plotted against time
for each minute during CWR cycling are presented in
Figures 6A–C. There were no significant method by time
interactions observed neither between the values from two
assessors (Figure 6A; P = 0.24), nor between values from
the semi-automated method and assessor 1 (Figure 6B;
P = 0.30), or the semi-automated method and assessor 2
(Figure 6C; P = 0.11).
Average absolute maximal activation values (obtained during
IC maneuvers) obtained by assessor 1 and 2 with the manual
analysis method of were 0.146 ± 0.062 volt and 0.150 ± 0.060
volt, respectively. No significant differences were found between
the maximal activation values obtained by assessor 1 and
2 (P = 0.25).
The CV of assessor 1 was 22% at rest and 13% at the end of
exercise at pre-measurement. At post-measurement, the CV was
21% at rest and 26% at end exercise. For assessor 2 the CV was
54% at rest and 11% at the end of exercise. At post-measurement,
the CV was 28 and 20% at rest and end exercise, respectively.
The CV calculated from the semi-automated were 13 and 11%
at rest and end exercise, respectively, at pre-measurement. At
post-measurement, the CV was 10 and 12% at rest and end
exercise, respectively.
Comparisons of the Pre/Post
Intervention Differences in
EMGdi/EMGdiMax% Obtained by Either
the Two Assessors or as Processed With
the Semi-Automated Method From Data
Collected During a Constant Work Rate
Cycling Task
After 8 weeks of IMT, inspiratory muscle function was improved
in four patients that had completed the IMT protocol [two
men and two women, age 64 ± 4 years, BMI 25 ± 7 kg/m2,
FEV1 1.56 ± 0.69 L (63 ± 41 %predicted)] who participated
in the IMT intervention. Maximal inspiratory pressure (MIP)
improved from −77 ± 15 cmH2O (84 ± 16 %predicted)
to −91 ± 25 cmH2O (100 ± 30 %predicted). Maximal
transdiaphragmatic pressure (Pdi) measured during maximal
inspiratory sniff maneuvers improved from 93 ± 21 cmH2O to
105 ± 24 cmH2O. The average cycling duration was 8.4 ± 2.5 min
at pre-measurement and 16.4 ± 7.8 min at post-measurement.
The pre/post IMT differences in EMGdi/EMGdiMax% during
cycling before and after IMT, were calculated. The correlations
between the pre/post IMT differences in EMGdi/EMGdiMax%
calculated from the manual method by two assessors and the
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FIGURE 5 | The results from the manual method by two assessors and the semi-automated method are compared in seven patients in each minute during the
pre-measurement CWR cycling test. Bland-Altman plots of EMGdi/EMGdiMax% calculated from the manual method by two assessors (A); the semi-automated
method and the manual method by assessor 1 (B); the semi-automated method and the manual method by assessor 2 (C).
FIGURE 6 | Average diaphragm activation (EMGdi/EMGdiMax%) of seven patients during CWR cycling test at pre-measurement calculated from the manual method
by two assessors (A); the semi-automated method and the manual method by assessor 1 (B); the semi-automated method and the manual method by
assessor 2 (C).
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FIGURE 7 | The correlation between the pre/post difference in four participants EMGdi/EMGdiMax% calculated from the manual method by two assessors (A); the
semi-automated method and the manual method by assessor 1 (B); the semi-automated method and the manual method by assessor 2 (C). Line of identity, linear
regression coefficients and intra-class correlation coefficients (ICC) and significances are presented in each figure. Each of the data points represents the pre/post
differences of diaphragm EMG activation (EMGdi/EMGdiMax%) pre and post the intervention of each patient in every minute during CWR cycling test.
semi-automated method during the CWR cycling test before and
after the intervention are presented in Figures 7A–C.
The ICC between the values of pre/post differences from
assessor 1 and assessor 2 was 0.40, P = 0.02, 95% CI: −0.09 to 0.68
(Figure 7A). The ICC between the pre/post IMT differences from
the semi-automated method and assessor 1 was 0.78, p < 0.0001,
95% CI: 0.58–0.89 (Figure 7B), while the ICC between the
pre/post IMT differences from the semi-automated method
assessor 2 was 0.04, P = 0.44, 95% CI: −0.58 to 0.46 (Figure 7C).
Bland – Altman plots for the agreements of pre/post
IMT differences in EMGdi/EMGdiMax% calculated from two
analyzing methods are presented in Figures 8A–C. On
average, the pre/post IMT differences in EMGdi/EMGdiMax%
obtained from the manual method from assessor 2 was
lower than assessor 1 (average bias of differences: −8.2%; CI:
−30.9 to 14.5%, Figure 8A). The pre/post IMT differences
in EMGdi/EMGdiMax% obtained from the semi-automated
method was on average similar to values obtained with the
manual method by assessor 1 (average bias of differences: 1.2%;
−16.8 to 19.2%, Figure 8B). The pre/post differences values from
the semi-automated method are higher than the values from the
manual method by assessor 2 (average bias of differences: 7.0%;
CI: −20.4 to 34.4%, Figure 8C).
Average EMGdi/EMGdiMax% values obtained from the
manual method by the two assessors and the semi-automated
method were plotted against time for each minute during CWR
cycling performed pre and post the IMT intervention period
(Figures 9A–C). There were no significant method by time
interactions observed between the values from two assessors
(Figure 9A; P = 0.29), the semi-automated method and assessor
1 (Figure 9B; P = 0.55) and the semi-automated method and
assessor 2 (Figure 9C; P = 0.50).
Average absolute maximal activation values (during IC
maneuver) obtained with the manual analysis method by assessor
1 and 2 were 0.121 ± 0.075 volt and 0.124 ± 0.072 volt,
respectively, at pre-measurement, and 0.158 ± 0.101 volt and
0.142 ± 0.92 volt, respectively, at post-measurement (P = 0.62
and P = 0.20, respectively).
Duration of Analysis Between Manual
and Semi-Automated Method
The average duration of 11 CWR cycling tests (seven at pre-
measurement and four at post measurement), including resting
and unloaded cycling, was 13 ± 6 min (range 4.2 to 22.0 min).
The analyzing time using the manual method was 82 ± 20 min
(range 63 to 115 min) for assessor 1 and for the semi-automated
method was 29 ± 9 min (range 18–49 min). Difference between
methods 53 ± 15 min (p < 0.0001).
DISCUSSION
Main Findings
We validated a custom developed ECG removal method for EMG
amplitude analysis against a commonly used manual approach.
The main findings of this study are that the newly developed
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FIGURE 8 | The results from the manual method by two assessors and the semi-automated method are compared in four patients in each minute during CWR
cycling test pre and post the intervention. Bland-Altman plots of the pre/post differences in EMGdi/EMGdiMax% calculated from the manual method by two
assessors (A); the semi-automated method and the manual method by assessor 1 (B); the semi-automated method and the manual method by assessor 2 (C).
semi-automated EMGdi analysis method is more time efficient
and that it will be less prone to the inter-rater variability that
was observed when the manual method was applied by two
independent assessors. EMGdi amplitudes obtained with the
semi-automated method agreed well with values obtained by one
of the two manual assessors. The findings suggest that EMGdi
analysis using the proposed semi-automated method can be
used to evaluate changes in EMG amplitudes over a wide range
of minute ventilations recorded at rest and during exercise in
patients with COPD.
Inter-Rater Reliability of the Manual
Method
Resting diaphragm activation (EMGdi/EMGdiMax%) values
obtained by both assessors using the manual method ranged
from 10 to 20% (Figures 6A,B, 9A,B). During the CWR
cycling exercise, this activation increased steeply at the beginning
of the exercise and reached a plateau until the exercise was
terminated by patients’ symptom limitation (Figures 6A,B,
9A,B). Similar patterns were observed in previous studies
(Luo and Moxham, 2005; Luo et al., 2011; Langer et al.,
2018). The observed differences of 8–9% in EMGdi amplitudes
between raters are, however, substantial and might impact
on the ability to detect differences in EMG amplitudes after
interventions (Figures 5A, 8A). Along these lines the pre/post
IMT differences manually obtained by assessor 1 resulted in a
reduction of approximately 20% of EMGdi/EMGdiMax at iso-
time (Figures 9A,B), whereas analyses performed by assessor
2 resulted in a much smaller reduction of approximately only
10% (Figures 9A,C). In an attempt to explain these differences
we looked into the manual analyses as performed by the two
assessors in more detail.
Since EMGdiMax (volt) values obtained by the two assessors
were similar, the differences in the EMGdi/EMGdiMax ratio
between the two assessors must have originated from the
selection of the EMGdi signal between QRS complexes of the tidal
breaths. Retrospectively, we observed that in most cases there
were several intervals between QRS complexes that assessors
could select for their analyses (Figure 2). Upon closer inspection
we further realized that assessor 1 systematically tended to choose
the period that resulted in the “highest” EMGdi value of each
inspiratory cycle (frequently occurring toward the very end of
an inspiratory cycle), while assessor 2 always chose intervals that
contained the “widest” available signal typically located more
“centrally” within each inspiratory phase. This is illustrated in
Figure 2. While assessor 1 systematically selected the period
between cursor 3 to 4, assessor 2 tended to choose the period
between cursor 1–2. We noticed that especially during pre-
IMT assessments the amplitude of EMGdi was higher toward
the end of each inspiratory cycle, indicating more pronounced
diaphragm activation toward the end of the inspiratory cycle
(Figure 10A). Since the given illustrative example occurred
frequently during the tests the intervals selected by assessor 1
often resulted in higher values than the intervals chosen by
assessor 2 (Figures 5A, 8A).
As stated earlier the values of EMGdiMax were not
significantly different between two assessors. This initially seems
surprising given the different approaches taken by the two
assessors as described above. It can be explained, however,
based on the shorter inspiratory period (Ti) during the IC
maneuvers (during which the EMGdiMax signals were obtained)
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FIGURE 9 | Average diaphragm activation (EMGdi/EMGdiMax%) of four patients during CWR cycling test pre and post the intervention calculated from the manual
method by two assessors (A); the semi-automated method and the manual method by assessor 1 (B); the semi-automated method and the manual method by
assessor 2 (C).
in comparison to the tidal breaths (during which the EMGdi
intervals were selected). As illustrated in Figure 11 during
the short inspiratory periods of the IC maneuvers there
was frequently only a single EMG interval between QRS
complexes available to select. This can most likely explain the
smaller differences in EMGdiMax values between assessors in
comparison to EMGdi.
Interestingly there was also less disagreement between the
results from assessor 1 and 2 during the post-intervention
analyses in comparison to pre-intervention comparisons
(Figure 9A). Despite both assessors treating the EMGdi data with
the same approach as for the pre-intervention measurements
(i.e., one rater looking for the highest while the other looked
for the widest available signal interval), the values from assessor
2 were closer to the values from assessor 1. This finding can
probably be explained by previously reported pre/post differences
in EMG amplitude signal patterns over time, during muscular
activation, in response to muscle training (Oliveira Ade and
Goncalves, 2009). Known effects of muscle training, including
inspiratory muscle training, are improvements in force output
and motor learning, thereby decreasing muscle activation levels
at iso-loads (Campos et al., 2002; Lay et al., 2002). In fact, higher
EMGdiMax and decreased relative activation of the diaphragm
(i.e., lower muscle activity) after training at iso-loads were
previously reported by our group (Langer et al., 2018).
As shown in Figure 10A and as mentioned earlier, during
pre-IMT assessments, the EMGdi signal from the diaphragm
increased from the beginning toward the end of the inspiration.
The EMGdi values (volt) between cursors 1–2 were always lower
than those between cursors 3–4 (Figure 10A). The numbers
marked in red are the values taken as a representative mean
EMGdi of that breath (Figures 10A,B). After inspiratory muscle
training, however, EMGdi values earlier during inspiration were
less different from those toward the end of the inspiratory phase
(Figure 10B). It therefore seems like patterns that had previously
been observed after resistance training of peripheral muscles
(reduced EMG/time slopes after training) (Oliveira Ade and
Goncalves, 2009), were also detected in our diaphragm EMG
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FIGURE 10 | Example of EMGdi recordings during cycling exercise toward the end of the (symptom limited) cycling test at the pre- (A) and post- (B) measurement
for the analysis using the manual method. Channel 1: respiratory flow (l/s; negative flow indicating the inspiratory cycle), Channel 2: ECG recording (volt), Channels
3–7: diaphragm EMG (RMS EMGdi) recordings. The periods highlighted in light blue are the possible periods that could be chosen without ECG contamination in an
inspiratory cycle. Numbers in cursors regions boxes show the mean EMGdi values between two vertical cursors. The numbers in red indicate that the differences in
the mean values between cursors 1–2 are closer to the values between cursor 3–4 at post-measurement.
data. These findings can probably help to explain why inter-
rater differences, despite of using similar approaches, were less
pronounced after the resistance training period.
Comparisons Between Manual and
Semi-Automated EMGdi Analyses
Data from the manual analyses of assessor 1 (who searched
for the intervals containing the EMGdi signal with highest
amplitude for every breath) resulted in good agreement with
the results from the semi-automated method. We assume that
the semi-automatically processed data are most representative
of the “real” EMGdi values since the ECG contamination was
eliminated from the signal. Based on these findings the analysis
strategy of assessor 1 should probably be favored (i.e., selecting
the EMGdi interval in between QRS complexes that provides
the “highest” amplitude) should probably be favored above the
approach taken by assessor 2. This is further supported by the
fact that magnitude of pre-post intervention differences of both
assessor 1 and from the semi-automated method are in line
with findings from a previous study that assessed diaphragm
activation during the CWR cycling test before and after a similar
IMT intervention (Langer et al., 2018).Therefore, if the manual
method should be used, we would recommend to manually select
EMG parts between QRS complexes that result in the “highest”
average EMGdi (i.e., selecting intervals toward the end of each
inspiratory period). This strategy of manual analysis showed a
good agreement with the semi-automated method on a group
level, suggesting that both methods can be used interchangeably.
The discussion onward will focus on the comparisons between
the results of the semi-automated method and values obtained
with the manual method from assessor 1.
Bland – Altman plots of both pre-intervention measurements
and pre/post IMT differences in EMGdi/EMGdiMax% showed
good overall agreement. Considering the differences, which
scattered randomly above and below zero, it did not appear as
if there were systematic over- or underestimations present, or
that differences between methods became larger when activation
was higher (i.e., at higher minute ventilation during cycling)
(Figures 5B, 8B).
Two factors probably contribute to the relatively wide (±20%)
limits of agreement that were observed between methods. Firstly,
during manual analyses QRS complexes occurring during the
inspiratory cycles can cover major parts of the inspiratory EMG
signal. These parts (which might contain the highest activation
portion during a given inspiration) are consequently not available
for analysis (Figure 12). This limited availability of EMGdi signal
probably contributed to either over- or underestimation of the
manual signal in contrast to the semi-automatically processed
signal which could always take the full inspiratory period (i.e.,
from zero flow to zero flow) into consideration.
A second factor that probably contributes to the width of
the limits of agreement between methods is the fact that the
average EMGdi from the manual method is obtained from a
representative sample of five consecutive breaths toward the end
of each exercise minute. In contrast during the semi-automated
method, all breaths performed during each minute are analyzed
(Luo and Moxham, 2005). It might very well be that the sample
of five breaths is not always a perfect representation of average
EMGdi during a given minute of breathing resulting in between
method differences on a minute-by-minute basis. The overall
agreement of the EMGdi/EMGdiMax between two methods on
a group level was, however, good, and no significant method
by time interaction effects were observed (Figures 6B, 9B).
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FIGURE 11 | Example of EMGdi recordings during a cycling exercise toward the end of the (symptom limited) cycling test for the analysis using the manual method.
Channel 1: respiratory flow (l/s; negative flow indicating the inspiratory cycle), Channel 2: ECG recording (volt), Channels 3–7: Diaphragm EMG (RMS EMGdi)
recordings. The IC maneuver is highlighted in the red circle indicated by the higher flow, which accompanies the maximal activation of the EMGdi. The periods
highlighted in light blue are the periods that could be chosen without ECG contamination in an inspiratory cycle during IC maneuver. With the short inspiratory time
during the IC maneuver, it left only one available (light blue) period that EMGdi could be retrieved.
This suggests that both methods can be used interchangeably
on a group level.
Degree of Variation
The CV were calculated from the manual analyses performed
by two raters were mostly higher than the CV calculated
from the semi-automated method. This lower degree of
variability when using the semi-automated method will
probably increase the ability to detect true differences between
measurement conditions. The reduction in variability
is most likely due to both the absence of noise within
breaths as well as the fact that instead of a representative
sample of five breaths all breaths of each minute were
used for analyses.
Clinical Implications
The EMGdi/EMGdiMax ratio is currently being used as a
surrogate of neural respiratory drive (NRD) and both magnitude
as well as changes in NRD have been shown to be closely
related to (changes in) dyspnea sensation (Jolley et al., 2015;
Langer et al., 2018) which is an important symptom in
patients with chronic obstructive and restrictive lung diseases
(Parshall et al., 2012). It is essential to obtain correct values of
diaphragm activation to be able to interpret the results linked
with the patient’s symptoms and also to reliably detect changes
induced by different interventions. A reliable and objective
method to process these data is beneficial for breathlessness
management in patients with COPD both in research and
clinical routine.
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FIGURE 12 | Illustration of the EMGdi recordings during cycling exercise toward the end of the (symptom limited) cycling test when the inspiratory time (Ti) is shorter.
Channel 1: respiratory flow (l/s; negative flow indicating the inspiratory cycle), Channel 2: ECG recording (volt), Channel 3–7: diaphragm EMG (RMS EMGdi)
recordings. Several QRS complexes appear during the inspiratory cycle which is already a short period. The QRS complexes take up a large part during the
inspiratory cycle resulting in less “clean” EMGdi to be selected. The red circle shows one inspiratory cycle when the QRS complex appears precisely at the peak of
the amplitude of the EMGdi. The EMGdi buried under this QRS complex cannot be retrieved. Therefore, the assessor must choose the part outside of the QRS
complex, which results in lower mean EMGdi value, thus underestimates the diaphragm activation. The blue highlight shows a small period of peak EMGdi. The
mean EMGdi value of this period will be higher (average of high values in the short time) therefore the EMGdi being overestimated.
Strengths and Limitations
The semi-automated method was designed to overcome several
shortcomings of the manual method. By automatically removing
ECG artifacts throughout the recording, the analysis time is
shortened by more than half. After the ECG artifact was removed
the resulting “clean” EMGdi signal could be integrated over
the full inspiratory cycle. This integration of EMG activity over
the course of a contraction is a common practice for other
skeletal muscles but was not possible with the manual EMGdi
analysis methods available so far. In addition it facilitates the
performance of breath-by-breath analyses which allows all data
points to be considered. This is the first time that the inter-rater
reliability of the often used “manual method” has been evaluated.
We were for the first time able to identify several sources for
inter-rater variability which should be eliminated by the more
objective, semi-automated processing of full inspirations that
have previously been cleaned of ECG artifacts by our newly
developed method.
Limitations of our study are the relatively small sample
size and the absence of an age-matched control group. The
results would need to be confirmed in a larger sample of
subjects performing different types of exercise tests resulting
in a large variability of heart rate and ventilation responses.
In addition, inclusion of a healthy age-matched control group
and comparisons of findings with COPD patients would have
allowed further investigations into the validity of the semi-
automated method at rest and during exercise. Since our
methods were only compared in a specific group of patients
future studies might be required to further validate the use of
the semi-automated EMGdi analysis in other populations. In
our study EMGdi signals were evaluated only at the extremes
of activation (i.e., resting breathing and close to maximal
activation). The model/approach has not been tested over a
range of intensities (and as such diaphragm activity). It would
have been preferable to evaluate the responses over a broader
range of minute ventilations and heart rate (e.g., during a
stepwise maximal incremental exercise test). Further study
is also needed with regard to responsiveness of the signals
and reproducibility of findings both before and after different
pharmacological and non-pharmacological interventions that
are supposed to reduce respiratory effort and symptoms
of breathlessness.
CONCLUSION
The semi-automated ECG artifact removal method for EMGdi
analyses will be helpful to eliminate sources of inter-rater
variability that were observed between different raters applying
the manual method. Therefore the semi-automated method
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offers a more objective approach for analyzing EMGdi data while
at the same time requiring significantly less analyzing time. We
propose this method as a new standard for objective EMGdi
amplitude analyses in the future.
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Background: We hypothesized that a 2-week twice daily aquatic endurance
plus calisthenics exercise training program: (i) increases aerobic exercise capacity
(peak oxygen uptake/V̇O2peak), (ii) improves endothelium-dependent flow-mediated
vasodilation (FMD), and (iii) reduces circulating markers of low-grade inflammation and
hemostasis, as compared to land-based endurance plus calisthenics exercise training
or no exercise in patients undergoing short-term residential cardiac rehabilitation after a
recent coronary artery disease (CAD) event.
Methods: Patients with a recent myocardial infarction or revascularization procedure
were randomized into two interventional groups and a control group. The interventional
groups underwent supervised aerobic endurance plus calisthenics exercise training
either in thermo-neutral water or on land at moderate intensity (60–80% of the peak
heart rate achieved during symptom-limited graded exercise testing) for 30 min twice
daily for 2 weeks (i.e., 24 sessions). The control group was deferred from supervised
exercise training for the 2-week duration of the intervention, but was advised low-to-
moderate intensity physical activity at home while waiting. At baseline and after the
intervention period, all participants underwent estimation of aerobic exercise capacity,
brachial artery flow-mediated dilatation (FMD, measured ultrasonographically at rest and
during reactive hyperemia after 4.5 min of forearm cuff inflation), markers of cardiac
dysfunction (NT-proBNP), inflammation (hsCRP, IL-6, IL-8, IL-10), cell adhesion (ICAM,
P-selectin), and hemostasis (fibrinogen, D-dimer).
Results: A total of 89 patients (mean age 59.9 ± 8.2 years, 77.5% males,
V̇O2peak at baseline 14.8 ± 3.5 ml kg−1 min−1) completed the study. Both exercise
modalities were safe (no significant adverse events recorded) and associated with
a significant improvement in V̇O2peak as compared to controls: age and baseline
V̇O2peak-adjusted end-of-study V̇O2peak increased to 16.7 (95% CI 16.0–17.4) ml
kg−1 min−1 with land-based training (p < 0.001 for change from baseline) and to
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18.6 (95% CI 17.9–19.3) ml kg−1 min−1 with water-based training (p < 0.001 for
change from baseline), but not in controls (14.9 ml kg−1 min−1; 95% CI 14.2–15.6;
p = 0.775 for change from baseline). FMD also increased in both intervention groups
(from 5.5 to 8.8%, p < 0.001 with land-based, and from 7.2 to 9.2%, p < 0.001
with water-based training, respectively), as compared to controls (p for change 0.629).
No significant changes were detected in biomarkers of inflammation, cell adhesion or
hemostasis, whereas levels of NT-proBNP (marker of cardiac dysfunction) decreased in
the water-based training group (p = 0.07 vs. controls).
Conclusion: Endurance plus calisthenics exercise training in thermo-neutral water
is safe, and improves aerobic exercise capacity and vascular function in patients
undergoing short-term residential cardiac rehabilitation after a recent CAD event.
Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT02831829.
Keywords: coronary artery disease, cardiac rehabilitation, aquatic exercise, myocardial infarction, exercise
training
INTRODUCTION
Exercise-based cardiac rehabilitation remains a cornerstone of
management and secondary prevention in patients with coronary
artery disease (CAD) (Piepoli et al., 2010; Anderson et al., 2016).
Acute coronary events – such as a recent myocardial infarction
and/or coronary artery bypass grafting (CABG) procedure – may
impair the ability of individuals to engage in exercise because
of cardiac dysfunction, risks associated with the acute effects
of exercise, post-procedure recovery, or immediate post-event
psychological concerns (Anderson et al., 2016). In this respect,
cardiac rehabilitation – either in outpatient settings or as an
intensive short-term residential program – provides sufficient
monitoring and reassurance to patients in the immediate
aftermath of a recent CAD event, thus empowering them to
confidently adopt long-term regular exercise and a healthy
lifestyle (Mampuya, 2012; Menezes et al., 2014).
Aerobic exercise training on land (such as cycling, walking,
jogging, or rowing) – either alone, or supplemented by non-
weight bearing exercises (calisthenics) or low-weight resistance
training – has been the most studied and therefore the most
widely implemented (Bjarnason-Wehrens et al., 2010) exercise
modality in cardiac rehabilitation programs. On the one hand,
this exercise modality is safe in CAD patients, purportedly
because it provides a regulated cardiac output increase to
meet the perfusion demand of large exercising muscle groups,
thus minimizing safety concerns over raised pre- and after-
load in high-risk cardiac patients with low aerobic exercise
capacity – such as those after a recent myocardial infarction or
revascularization procedure (Balady et al., 2007). On the other
hand, this exercise modality has been shown to mitigate risk
factors and metabolic abnormalities (Casillas et al., 2007; Ismail
et al., 2013), which contribute to CAD and its progression,
as well as to improve endothelial dysfunction, which plays a
central role in all stages of atherosclerosis. In patients with
CAD, endothelium-dependent vascular dysfunction may be
associated with impaired systemic (skeletal muscle) and coronary
(myocardial) perfusion, resulting in exercise intolerance and
myocardial ischemia at exertion, respectively (Bruning and
Sturek, 2015). Moreover, endothelial dysfunction in CAD is
associated with low-grade inflammation and increased monocyte
adhesion, which promote atherosclerotic plaque build-up and
rupture, as well as with increased hemostatic activity, which
promotes coronary thrombosis (Kokkinos and Myers, 2010;
Winzer et al., 2018). Conversely, land-based exercise training has
been shown to revert or reduce these abnormalities. In a seminal
study by Hambrecht et al. (2000), 4 weeks of in−hospital bicycle
ergometer training improved endothelium−dependent arterial
vasomotion in patients with CAD, likely through restoring
the balance between synthesis and depletion of vasoactive and
vasoprotective nitric oxide (NO) (Hambrecht et al., 2003).
Mechanistically, this is largely due to a response to exercise-
induced shear stress (Kokkinos and Myers, 2010; Bruning and
Sturek, 2015). In addition, regular aerobic exercise training on
land is associated with a reduction in low-grade inflammation [as
assessed by high-sensitive C-reactive protein (hsCRP) levels], cell
adhesion (as assessed by cell adhesion molecules, such as ICAM
and P-selectin) and hemostatic activity (as assessed by markers
of coagulation and fibrinolysis, such as fibrinogen and D-dimer)
(Womack et al., 2003; Pedersen, 2017), suggesting an interplay
between the effects of aerobic exercise on the endothelium, low-
grade inflammation, cell adhesion, and hemostasis in patients
with CAD (Kokkinos and Myers, 2010; Winzer et al., 2018).
In contrast to exercise on land, the implementation of aquatic
exercises in cardiac rehabilitation programs remains debated
(Lazar et al., 2013). Concerns have been traditionally raised over
possible adverse cardiovascular effects of exercising in water –
namely, an increased preload due to water immersion (i.e.,
hydrostatically driven raise in venous return and central venous
pressure, possibly yielding ventricular dysfunction) (Meyer,
2006; Pendergast et al., 2015; Shah et al., 2017) and/or an
increased afterload due to temperatures below thermo-neutrality
(i.e., vasoconstriction in cold water associated with a risk
of dysrhythmias) (Schmid et al., 2009). On the other hand,
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the very same hemodynamic effects of thermo-neutral water
immersion in patients with CAD have been associated with
favorable improvements in cardiac performance and peripheral
vascular reactivity after as little as 3 weeks of aquatic cardiac
rehabilitation, suggesting pronounced exercise-induced shear
stress as a possible mechanism (Mourot et al., 2010). Yet, previous
research on the impact of aquatic exercise in patients with CAD
is limited when compared with land-based modalities (Schmid
et al., 2007, 2009; Volaklis et al., 2007; Laurent et al., 2009;
Teffaha et al., 2011; Choi et al., 2015), and marred by small
number of participants, selective patient inclusion [limited to
stable CAD (Volaklis et al., 2007; Teffaha et al., 2011) or to
patients achieving > 7 METs at exercise testing, (Tokmakidis
et al., 2008) thus not reflecting the patient populations referred
for cardiac rehabilitation in the immediate aftermath of a CAD
event], and inferior study design [e.g., pre-post studies without
comparator groups (Korzeniowska-Kubacka et al., 2016) or non-
randomized patient separation] (Tokmakidis et al., 2008), with
four notable exceptions. Volaklis et al., 2007 randomized 24
patients with stable CAD to 16 weeks of either water cycling
plus water games, land cycling plus resistance training, or no
exercise at all, and showed that water- and land-based protocols
comparably improved exercise test time, muscle strength and
blood lipid profiles. Conversely, Lee et al. (2017) randomized
60 older (>65 years old) patients with CAD and osteoarthritis
to 24 weeks of either aqua walking or treadmill walking,
and showed that both protocols comparably improved aerobic
exercise capacity, but the improvements in body composition
and lipid levels were significantly more pronounced with aqua
walking. Teffaha et al. (2011) randomized 24 patients with
CAD and 24 patients with heart failure to 3 weeks of cardiac
rehabilitation, comprising land cycling plus calisthenics either
on land or in water; both protocols were associated with
significant increase in aerobic exercise capacity in patients
with CAD. Similarly, Laurent et al. (2009) randomized 24
patients with CAD and 24 patients with heart failure to
3 weeks of cardiac rehabilitation, comprising land cycling
plus gymnastics either on land or in water; both protocols
improved aerobic exercise capacity in patients with CAD,
but only water training was associated with increased levels
of NO metabolites after the intervention period – indirectly
suggesting an improvement in endothelial function with aquatic
exercise. Given the specific hemodynamic responses to exercising
in xiphoid-level water, with increased peripheral blood flow
and enhanced shear stress yielding endothelial nitric oxide
synthase up-regulation (Di Francescomarino et al., 2009; Ayme
et al., 2014), improvements in endothelium-dependent vascular
function may be hypothesized, and have indeed been confirmed
with aquatic exercise in prehypertensive adults (Nualnim et al.,
2012) and in patients with osteoarthritis (Alkatan et al., 2016),
but not in patients with CAD. Thus, while several studies
confirmed the relative cardiovascular safety of thermo-neutral
water immersion in patients with CAD, only a limited number
of trials assessed the efficacy of aquatic training modalities on
aerobic exercise capacity, and none appraised the effect of such
training on vascular function or explored its interplay with low-
grade inflammation and hemostasis.
Therefore, we sought to compare the effect of a land- and
a water-based exercise training program on aerobic exercise
capacity and vascular function. In addition, we assumed that
the improvements in endothelium-dependent vascular function
would be accompanied by a reduction in markers of low-
grade inflammation, endothelial adhesion and coagulation,
given the association between inflammation and endothelial
dysfunction, and the central role of endothelial integrity
in promoting cell adhesion and coagulation. Hence, we
hypothesized that a 2-week, twice-daily aquatic endurance plus
calisthenics exercise training program would (i) increase aerobic
exercise capacity (peak oxygen uptake/V̇O2peak), (ii) improve
endothelium-dependent flow-mediated vasodilation (FMD), and
(iii) reduce markers of low-grade inflammation, cell adhesion,
and hemostasis as compared to land-based endurance plus
calisthenics exercise training and to no exercise in patients
undergoing short-term residential cardiac rehabilitation after a
recent CAD event.
MATERIALS AND METHODS
Study Design, Setting, and Patients
The study was designed as a prospective, randomized, open-label
clinical trial with three parallel groups (two intervention groups
and one control group) (Figure 1).
The study was carried out at the Centre for Cardiac
Rehabilitation in Šmarješke Toplice, Slovenia. The center
provides residential cardiac rehabilitation for patients after a
myocardial infarction or open-heart surgery, with a live-in
14-day program encompassing twice-daily supervised exercise
training sessions, education, dietary and smoking cessation
advice, medical supervision, and psychological counseling for
individuals without access to outpatient rehabilitation services.
Patients after a recent CAD event [2–4 weeks after myocardial
infarction, percutaneous coronary intervention (PCI) and/or
coronary artery by-pass surgery (CABG)] with a left ventricular
ejection fraction (LVEF) above 40% were invited to participate.
Recruitment took place between May and October 2016. Patients
with uncontrolled/decompensated valve diseases necessitating
specific (surgical or percutaneous) management, patients after
valve replacement, with uncontrolled dysrhythmias or presence
of a permanent pacemaker, with contraindications to exercise,
unable to perform exercise testing or to swim, with mental
impairment, severe anemia, severe obstructive/restrictive lung
disease, recent thromboembolic events, hepatic dysfunction,
and/or age over 80 years were excluded.
Patients were randomized into (a) a water-based exercise
training group, (b) a land-based exercise training group,
or (c) a control group, using adaptive urn-randomization
with sealed envelopes and allocation concealment from the
recruiting investigator.
Before and after the intervention period (on Day 0 and
Day 14), all participants underwent cardiopulmonary exercise
testing, ultrasonographic assessment of FMD of the brachial
artery, and blood sample collection. The primary outcomes
were change from baseline of V̇O2peak and FMD. Exploratory
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FIGURE 1 | Patient selection and study design flowchart.
outcomes included change from baseline of biomarkers of low-
grade inflammation (hsCRP, IL6, IL8, IL10) and endothelial
activation (ICAM, P-selectin), hemostasis (D-dimer, fibrinogen),
and neurohormonal activity (NT-proBNP).
Written informed consent was obtained for each participant.
The study complied with the World Medical Association
Declaration of Helsinki on ethics in medical research and
was approved by a local medical research ethics committee
(0120-655/2016-2). This study is registered at ClinicalTrials.gov,
number NCT02831829.
Intervention
The intervention was designed as either a water- or a land-
based endurance plus calisthenics exercise program during 2-
week residential cardiac rehabilitation. The exercise programs
consisted of 30-min training sessions twice daily, 6 days a week
(24 sessions in total).
Other aspects of rehabilitation (including lifestyle education
and provision of a Mediterranean-style diet, medical supervision,
psychological support) were identical for both intervention
groups. The principles of treatment were not changed over the
intervention period, but medication adjustment was allowed at
the discretion of the treating cardiologist to ensure optimal
control of risk factors.
Water-based exercise training comprised two daily training
sessions in a heated swimming pool (32.8◦C), with water depth
at the xiphoid process level (1.5 m). The exercise program
consisted of two 30-min sessions daily, namely aerobic endurance
and calisthenics. Aerobic endurance exercise comprised 5 min of
warm-up, 20 min of conditioning (water walking, side-stepping,
cycling with arms) at 60–80% peak heart rate achieved during
symptom limited graded exercise testing, and 5 min of cool-
down. Calisthenics comprised 5 min of warm-up, 20 min of
conditioning (engaging muscle groups of the upper and lower
limbs, such as triceps extensions, triceps dips, modified leg press,
leg abduction/adduction, wall push-ups at 60–80% peak heart
rate), and 5 min of cool-down.
Land-based exercise training comprised two 30-min sessions
daily, namely bicycle ergometer training (5 min warm-up, 20 min
at 60–80% peak heart rate, and 5 min of cool-down) and
calisthenics (5 min of warm-up, 20 min of exercises engaging
muscle groups of the upper and lower limbs at 60–80% peak
heart rate with a progressive increase in speed and the number
of repetitions), and cool-down.
Patients in the control group were given lifestyle advice, and
made aware of the beneficial effects of exercise and advised to
engage in regular physical activities (i.e., usual daily activities,
such as walking), but were asked to refrain from enrolling in a
supervised exercise program for the duration of the intervention
period (i.e., 2 weeks).
Assessment of Aerobic Exercise
Capacity
Aerobic exercise capacity was determined by measuring V̇O2peak
by cardiopulmonary bicycle exercise testing (CPET) using the
cycle-ergometer Schiller CS-200 (Schiller A.G. Baar, Switzerland)
with the Ganshorn Power Cube gas analysis unit (Ganshorn
Deutschland GmbH). Calibration of primary sensors for flow,
O2 and CO2 gas measurement were performed before each
exercise test. All the participants underwent a symptom-limited
exercise test. They were advised to adhere to normal medical
regimes, avoid exercise and heavy meals on the day of testing.
Resting data including ECG were monitored 3 min before starting
the test. Participants were tested using a maximal incremental
protocol: after 3 min of unloaded cycling (“0 W”), the work
rate was continuously increased on the computer-controlled
cycle ergometer in a ramp-like fashion to achieve the predicted
maximal workload after 10 min. Predicted maximal workload
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on the bicycle ergometer was estimated based on age, gender,
and body surface area. The test was considered completed if the
respiratory exchange ratio achieved was ≥1.1. During exercise,
participants wore a mouthpiece connected with the gas analysis
unit, thus measuring oxygen and carbon dioxide flow (V̇O2
and V̇CO2, respectively). ECG and heart rate were continuously
monitored, and records were made every 2 min. Blood pressure
was measured at rest and every 2 min during the test and cool-
down period. Monitoring of the participants and the mentioned
parameters continued for 6 min after test termination. There were
no clinically relevant adverse effects during the exercise testing.
To assess the reproducibility of exercise testing, 10 subjects
were selected randomly and tested twice before the intervention
started. The intra-class correlation coefficient (ICC for single
measure) for V̇O2peak was 0.861, p = 0.004.
Assessment of Endothelial Function
Endothelial function was assessed by flow-mediated dilatation
(FMD) of the right brachial artery with ultrasound scanning
(Philips ultrasound system iE 33 with a high resolution
linear-array vascular probe with a frequency of 10 MHz),
under standardized conditions and in accordance with
current recommendations (Flammer et al., 2012). The
brachial artery was imaged 2–10 cm above the elbow fossa.
To determine the endothelium-dependent vasodilatation,
the forearm was tightened with the sphygmomanometer
cuff until a pressure of 50 mmHg higher than the systolic
pressure value was achieved. The grip was released after
4.5 min. Flow was measured within 15–20 s, and artery
diameter 60–90 s after releasing the grip. After 15 min of
rest, endothelium-independent vasodilatation was measured,
induced by 0.4 mg of nitroglycerin (Nitrolingual spray R©)
upon sublingual spray application. The diameter of the
brachial artery and the average velocity of blood flow were
measured 3–4 min after dosing. FMD was expressed as
percentage change from rest [(brachial artery diameter at peak
hyperemia – diameter at rest) × 100/diameter at rest]. To
assess the reproducibility of FMD, 10 subjects were selected
randomly. The intra-class correlation coefficient for FMD was
0.855, p = 0.004.
Blood Markers
All patients had venous blood samples taken in the fasting state,
in the morning, after 30 min of rest in the supine position,
from the cubital vein into 4.5 mL vacuum tubes containing
0.11 mol/L sodium citrate (Becton Dickinson, Vacutainer
System Europe, Germany). Plasma was prepared within 30 min
with 20-min centrifugation at 2,000 × g. In fresh plasma,
the concentrations of fibrinogen (Dade R© Thrombin Reagent)
and D-dimer (Innovance D-dimer, both Siemens Healthcare
Diagnostics, Marburg, Germany) were determined on an
automated coagulation analyzer CS2100i (Sysmex, Kobe, Japan).
The remaining plasma was aliquoted, snap frozen in liquid
nitrogen and stored at –75◦C until analysis. In thawed plasma,
NT-proBNP was determined on a Stratus R© CS Acute CareTM
analyzer based upon solid phase Radial Partition Immunoassay
(RPIA) technology (Siemens Healthcare Diagnostics, Marburg,
Germany). Plasma CRP, ICAM-1, IL-6, IL-8, IL-10, and P-selectin
were measured with the xMAP R© Technology utilizing magnetic
beads coupled with specific antibodies (all R&D Systems,
Minneapolis, United States) on a MagPix instrument (Luminex
Corporation, Austin, United States).
Statistical Analysis
Data are presented as mean (standard deviation) for normally
distributed continuous variables and as median (interquartile
range) otherwise. Differences in the baseline characteristics
of patients between groups were tested by ANOVA or
Kruskal–Wallis test, as appropriate. Differences in the primary
objective, end-of-study VO2 max, between study groups
were tested using ANCOVA, controlling for baseline VO2
max and age of patients. ANCOVA with age and baseline
measurement included as a covariate was used for all other
normally distributed variables. Post hoc differences were
tested by Sidak test. Variables, measured in percentages
(FMD and NMD) were logarithmized prior the analysis.
For the logarithmized FMD, the assumption of homogeneity
of regression slopes was violated, therefore, between and
within group ANOVA with age as a covariate was used
to test the between-group differences. In all other non-
normally distributed variables, the change from baseline for
each patient was calculated and Kruskal–Wallis test was used
to test the differences in change from baseline between the
study groups. When statistically significant differences between
groups were found, Mann–Whitney U test was used to test
pairwise differences. The differences with p < 0.05 were treated
as statistically significant. All analyses were done using the
software SPSS, v. 21.
Sample size calculation suggests an 80% power at 0.05
significance level for the detection of a between-group
difference (and assumed between-subject standard deviation)
of 1 MET (3.5 ml kg−1 min−1) with the inclusion of 90
patients (30 per group).
The differences with p < 0.05 were treated as statistically
significant. All analyses were done using the software SPSS, v. 21.
RESULTS
Baseline Characteristics
Eighty-nine patients completed the study: 30 patients in the
land-based training group, 29 in the water-based training
group, and 30 in the control group; one participant dropped
out during the course of the study due to upper respiratory
tract infection (Figure 1). Mean age of the participants who
completed the study was 59.9 ± 8.2, and 77.5% were male.
All the participants had CAD, and 77 (86.5%) had suffered a
myocardial infarction. Patients randomized to the land-based
group were significantly older and achieved a lower V̇O2 peak at
baseline (Table 1).
Aerobic Exercise Capacity
Both exercise modalities were associated with a statistically
significant increase in V̇O2peak as compared with controls
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TABLE 1 | Baseline characteristic of the patients who completed the study.
Variables Patients who completed
the study (n = 89)
Land-exercise group
(I) (n = 30; 33.7%)
Water-exercise group
(II) (n = 29; 32.6%)
Control group (III)
(n = 30; 33.7%)
P∗
Age Mean(SD), years 59.9 (8.2) 62.4 (7.6) 56.7 (8.4) 60.6 (8.3) 0.026 (I–II)
Gender m/f, n (%) 69 (77.5)/20 (2.5) 21 (70)/9 (30) 24 (82.8)/5 (17.2) 24 (80)/6 (20) 0.464
0.523
MI + PCI n (%) 60 (67.4) 19 (63.3) 17 (58.6) 24 (80)
PCI n (%) 3 (3.4) 1 (3.3) 2 (6.9) 0 (0)
CABG n (%) 9 (10.1) 3 (10) 3 (10.3) 3 (10)
MI + CABG n (%) 17 (19.1) 7 (23.3) 7 (24.1) 3 (19)
HBP n (%) 52 (58.4) 18 (60) 14 (48.3) 20 (66.7) 0.350
Dyslipidemia n (%) 65 (73) 19 (63.3) 22 (75.9) 24 (80) 0.318
Family history n (%) 53 (59.6) 19 (63.3) 18 (62.1) 16 (53.3) 0.692
Obesity n (%) 20 (22.5) 6 (20) 7 (24.1) 7 (23.3) 0.921
DM n (%) 15 (16.9) 3 (10) 5 (17.2) 7 (23.3) 0.385
Low physical activity level n (%) 44 (49.4) 17 (56.7) 15 (51.7) 12 (40) 0.415
Smoking status n (%) 48(53.9) 15 (59) 16 (55.2) 17 (53.9) 0.863
Aspirin n (%) 86 (96.6) 29 (96.7) 29 (100) 28 (93.3) 0.366
β blockers n (%) 76 (85.4) 26 (86.7) 24 (82.8) 26 (86.7) 0.887
Statins n (%) 79 (88.8) 26 (86.7) 26 (89.7) 27 (90) 0.906
ACE/ARB n (%) 72 (80.9) 24 (80) 22 (75.9) 26 (86.7) 0.566
SD, standard deviation; IQR, interquartile range; CI, confidence interval; CAD, coronary artery disease; MI, myocardial infarction; PCI, percutaneous coronary
intervention; CABG, coronary artery by-pass graft; HBP, high blood pressure; DM, diabetes mellitus; ACE, angiotensin-converting enzyme inhibitor; ARB, angiotensin
II receptor blockers. ∗Annotations for groups that differ as found by post hoc tests are provided in the brackets.
(Figure 2). After controlling for baseline V̇O2peak and patients’
age (ANCOVA), mean estimate end-of-study V̇O2peak increased
by 15.3% (16.7 ml kg−1 min−1; 95% CI 16.0–17.4 ml kg−1
min−1; p < 0.001 for change from baseline) with land-based
training, and by 27.4% (18.6 ml kg−1 min−1; 95% CI 17.9–19.3 ml
kg−1 min−1; p < 0.001 for change from baseline) with water-
based training, but not in controls (a 0.6% increase, i.e., 14.9 ml
kg−1 min−1, 95% CI 14.2–15.6; 14.9 ml kg−1 min−1; p = 0.775
for change from baseline). The effect size (d) was moderate in
the land-based group (d = 0.61), and large in the water-based
group (d = 1.02). Time-to-exhaustion and peak workload also
increased significantly in both intervention groups compared to
controls (Table 2).
Vascular Function
End-of-study FMD increased from 5.5 to 8.8% (p < 0.001)
in the land-based training group, and from 7.2 to 9.2%
(p < 0.001) in the water-based training group; no significant
change was observed in the control group (p = 0.629).
NMD increased in both intervention groups (with larger
increments in the land-based exercise group); the increase
in the intervention groups was statistically significant
in comparison to controls (p < 0.001). See Table 2
and Figure 2.
Biomarkers
No significant changes were detected in biomarkers of low-
grade inflammation, whereas levels of NT-proBNP and D-dimer
decreased in the water-based training group (p = 0.01
for both; Table 2).
DISCUSSION
Supervised short-term exercise training – either water-based or
land-based – is safe, and improves aerobic exercise capacity
and vascular function in patients with CAD. Despite concerns
about the safety and effectiveness of aquatic exercise in patients
after a recent CAD event, our study in patients undergoing
residential cardiac rehabilitation demonstrated that a 2-week,
twice-daily water-based training program was not associated with
adverse cardiovascular events, and improved aerobic exercise
capacity (as determined by V̇O2peak) and endothelial function
(as determined by FMD). To our knowledge, this is the largest
study of water- vs. land-based training in patients after a
recent CAD event, and the first to address vascular function
in this context. Our results contribute to the growing body
of evidence on the safety and effectiveness of aquatic exercise
in cardiovascular patients, and suggest that aquatic exercise
modalities may be a suitable option for cardiac rehabilitation of
selected patients after a recent CAD event, such as those with
concomitant musculoskeletal conditions, frailty or at risk of falls,
or for those who might prefer aquatic exercise.
Aerobic Exercise Capacity
In our study, both land- and water-based training were associated
with a significant increase in exercise capacity (V̇O2peak, time-
to-exhaustion, and peak workload) as compared to controls.
The magnitude of baseline-adjusted V̇O2peak increase – in
the range of 2–4 ml kg−1 min−1, roughly corresponding to
1 MET – was comparable in the two intervention groups,
and represents a clinically significant achievement (Conraads
et al., 2015). V̇O2peak improvements in our study were larger


















TABLE 2 | Measurements for the three study groups at baseline and after training, and between group differences.
Variables Land-exercise group (I) Water-exercise group (II) Control group (III) P∗
Baseline After 1% p Baseline After 1% p Baseline After 1% p
VO2 peak ml kg−1 min−1 13.1 (2.8) 15.1 (3.2) 15.3 0.001 14.6 (3.3) 18.6 (3.9) 27.4 0.001 16.6 (3.6) 16.5 (3.8) −0.6 0.775 0.001
VO2 (L min−1) 1.07 (0.27) 1.25 (0.33) 16.8 <0.001 1.31 (0.34) 1.67 (0.41) 27.4 <0.001 1.47 (0.38) 1.45 (0.40) −1.3 0.265 <0.001 (all)
TTE (sec) 605 (91) 710 (128) 17.3 <0.001 710 (123) 864 (158) 21.6 <0.001 796 (150) 800 (145) 0.5 0.493 <0.001 (all)
RER 1.10 (1.10–1.10) 1.12 (1.1–1.16) 1.8 0.001 1.10 (1.10–1.11) 1.15 (1.10–1.19) 4.5 0.001 1.10 (1.10–1.11) 1.10 (1.10–1.13) 0.0 0.026 0.026 (II vs. III)
Peak workload (Watt) 70 (15) 88 (21) 25.7 <0.001 88 (21) 113 (26) 28.4 <0.001 103 (25) 104 (24) 0.9 0.755 <0.001 (all)
FMD (%) 5.5 (3.1–8.6) 8.8 (5.3–11.4) 37.7 <0.001 7.2(4.0–8.7) 9.2 (7.4–12.9) 44.9 <0.001 7.0 (3.7–8.6) 6.4 (3.7–8.5) −1.5 0.692 <0.001 (I–III, II–III)
NMD (%) 10.6 (7.0–13.3) 11.1 (9.0–14.3) 11.6 <0.001 10.5 (8.5–14.0) 11.4 (7.6–13.4) 5.4 0.042 10.9 (6.0–13.4) 11.6 (7.4–14.2) 2.9 0.579 0.013 (I–III)
Fibrinogen g L−1 3.0 (3.0–3.4) 3.2 (3.0–3.5) 6.7 0.875 3.3 (3.0–3.9) 3.0 (2.7–3.8) −9.1 0.248 3.0 (2.7–3.4) 3.0 (2.6–3.3) 0.0 0.791 0.565
D dimer µg L−1 625 (280–1220) 465 (2701070) −25.6 0.066 400 (270–810) 370 (260–590) −7.5 0.001 310 (200–510) 270 (200–380) −12.9 0.129 0.099
CRP mg/L 0.7 (0.4–1.7) 0.6 (0.4–2.0) −9.1 0.734 0.9 (0.6–1.8) 0.5 (0.3–1.0) −50.0 0.133 0.5 (0.4–1.3) 0.5 (0.3–2.0) 10.2 0.829 0.256
IL6 ng L−1 10.1 (7.5–11.7) 10.9 (8.5–12.4) 7.9 0.211 9.6 (7.5–11.3) 9.3 (7.2–11.0) −3.1 0.380 7.5 (6.9–9.6) 7.4 (6.2–9.9) −1.3 0.041 0.090
IL8 ng L−1 19.6 (16.4–21.3) 18.4 (16.4–22.9) −6.1 0.755 17.8 (16.6–20.7) 19.2 (16.0–20.5) 7.9 0.927 19.5 (16.6–23.0) 19.0 (16.6−20.1) −2.6 0.034 0.187
IL10 ng L−1 17.6 (12.7–21.7) 17.2 (12.7–25.7) −2.3 0.703 16.8 (12.7–25.7) 15.8 (10.6–21.0) −6.0 0.710 14.7 (12.7–15.8) 14.2 (11.6–16.7) −3.4 0.038 0.360
ICAM µg L−1 372 (270–506) 362 (275– 567) −2.7 0.642 523 (362–873) 514 (362–801) −1.7 0.554 662 (507–806) 667 (520–787) −0.8 0.325 0.515
Selectin mg L−1 27.0 (6.8) 27.9 (7.9) 3.3 0.140 25.4 (4.9) 25.1 (4.9) −1.2 0.626 27.8 (5.6) 26.9 (5.9) −4.3 0.101 0.060
NT-pro-BNP ng L−1 707 (401–1604) 669 (335–1360) −5.4 0.074 396 (296–541) 1308 (187–394) −1.2 0.001 111 (66–221) 111 (52–297) −4.3 0.681 0.007 II–III
BMI kg m−2 median (IQR) 29 (26.5–31.6) 28.9 (26.9–30.7) −0.3 0.104 30 (27.1–32.6) 29.1 (27.0–31.5) −3.0 0.001 29.3 (26.8–30.9) 29.2 (26.8−32.0) −0.3 0.144 0.082
Data are shown as mean and standard deviation (SD) or median and 25th percentile – 75th percentile. TTE, time-to-exhaustion; RER, respiratory exchange ratio; FMD, flow-mediated dilatation; NMD, nitroglycerin-
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FIGURE 2 | Changes in aerobic exercise capacity (V̇O2peak) and flow-
mediated dilatation (FMD) expressed on the logarithmic scale.
than those reported in previous randomized trials of short-
term (3 weeks) aquatic rehabilitation (in the range of 2.0–
2.4 ml kg−1 min−1) (Laurent et al., 2009; Teffaha et al., 2011).
Both Laurent et al. (2009) and Teffaha et al. (2011), however,
enrolled more stable and younger CAD patients (mean age
52 and 54 years, respectively), which was reflected in higher
baseline V̇O2peak (20 and 22 ml kg−1 min−1, respectively) and
therefore possibly disposed the study population to diminishing
returns in aerobic exercise capacity improvements. In fact, the
end-of-study V̇O2peak in our population (16.7 and 18.4 ml
kg−1 min−1, respectively) was still lower than that reported in
studies with CAD patients (Casillas et al., 2007; Winzer et al.,
2018), but nonetheless higher when compared to studies of
water-based training in patients with chronic heart failure. This
likely reflects the specifics of our patient population (i.e., after a
recent myocardial infarction and/or revascularization procedure
in the risk spectrum between stable CAD at one end, and
clinically manifest cardiac dysfunction on the other); of note, our
patient population represents the population of CAD patients
traditionally referred for cardiac rehabilitation.
End-of-study V̇O2peak in our trial was also significantly
higher in the aquatic exercise group (p < 0.001 after co-
variance analysis adjusting for age and baseline capacity). Larger
improvements with water- vs. land-based exercise training
in CAD were observed previously (Teffaha et al., 2011; Lee
et al., 2017). However, the magnitude of difference (2 ml
kg−1 min−1) was larger in our study when compared to
previous reports (1 ml kg−1 min−1) (Mourot et al., 2010;
Teffaha et al., 2011), but the confidence intervals for our
estimations were large and the study was underpowered to
provide a definite conclusion as to whether differences in end-
of-study V̇O2peak between aquatic and land-based training
are indeed relevant. Methodologically, the difference favoring
water-based over land-based exercise in our study may still be
attributable to randomization failure (with patients in the land-
based group being older and having lower baseline V̇O2peak).
Alternatively, larger improvements may derive from either the
specific physiology of water immersion or the higher intensity of
aquatic exercise. In terms of specific physiology, water immersion
is linked with hemodynamic and peripheral responses associated
with improved myocardial efficiency and endurance (DiCarlo
et al., 1991; Tei et al., 1995; Mourot et al., 2010). Previous
studies (Teffaha et al., 2011; Lee et al., 2017) compared water-
vs. land-based calisthenics on top of land-based endurance
training (cycling), whereas our aquatic training protocol (both
endurance and calisthenics) was entirely carried out in xiphoid-
level water. In terms of the intensity, exercise prescription was
based on peak heart rate achieved during symptom-limited
graded exercise testing on a land bicycle ergometer. On the
one hand, the hypothesized intensity may not be directly
interchanged between aerobic exercise in water and cycling
on ambient air. On the other hand, peak heart rate-derived
intensity may not provide a precise measure of metabolic
stress in comparison to, for instance, ventilatory thresholds,
especially in patients with cardiovascular disease (Carvalho
and Mezzani, 2010). The challenges of threshold appraisal in
clinical practice, however, partially explain why the majority of
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research – including ours – continues to favor the use of peak
heart rate to prescribe exercise (Mann et al., 2013). Moreover,
our intervention protocol did employ the aquatic heart rate
adjustment (i.e., to a maximum rate 13% or 10 bpm lower than
in land-based exercise) (Gabrielsen et al., 2000). In this respect,
previous research yielded inconclusive results: some studies have
corroborated the higher intensity (and thus the rationale for
heart rate adjustment) of aquatic exercise (Lee et al., 2017),
while others – including research in CAD populations exercising
to up to 75% V̇O2peak – have not (Tokmakidis et al., 2008;
Laurent et al., 2009; Teffaha et al., 2011). These inconclusive
results may be reconciled by addressing the specific protocols
of aquatic exercise, suggesting that the level of water may play
an important role. In our study, deeper water (xiphoid process
level) – which increases buoyancy and decreases resistance (Cider
et al., 2003) – may have provided comparable intensity of aquatic
exercise, but a significant hydrostatically induced hemodynamic
response to immersion.
Vascular Function
Both water- and land-based exercise training improved
vascular function (between 2 and 3 absolute percentage change
improvements). Similar improvements have been reported with
land-based aerobic training (Di Francescomarino et al., 2009),
but not yet with aquatic exercise in patients with CAD. FMD –
a marker of endothelial function and thus cardiovascular health
(Flammer et al., 2012) – increased significantly after 2 weeks
of exercise training in both intervention groups. While most
previous studies employed exercise programs of longer duration,
our intervention was relatively short-term and suggests that
an increase in endothelial function can be detected as soon as
2 weeks after exercise training initiation; these results are in
line with previous reports in both human trials (Tinken et al.,
2008) and animal models (Graham and Rush, 2004). Improved
endothelial function – as determined indirectly by increased
levels of plasma nitric oxide metabolites – has been reported in
water-based exercise training in patients with CAD (Conraads
et al., 2015), while FMD increases have been documented in
prehypertensive adults (Nualnim et al., 2012) and patients with
osteoarthritis undergoing aquatic exercise training (Alkatan et al.,
2016). Contrary to our findings, however, Alkatan et al. (2016) –
in the only previous study comparing water-based training
(swimming) with land-based training (cycling) – reported on
larger improvements in endothelial function with the former
(4 vs. 1% absolute percentage change improvement). Exercise
type (swimming) and duration (8 weeks) may partly explain
such differences; alternatively, Alkatan et al. (2016) enrolled
cardiovascular disease-free individuals with osteoarthritis,
whereas in our CAD population the vascular damage may have
been too pronounced for a discernible difference between water-
and land-based training to be detected.
Inflammation, Neurohormonal Activity,
Hemostasis, and Endothelial Activation
Contrary to the increased aerobic exercise capacity and vascular
function, neither inflammation nor endothelial activation
markers improved. Atherosclerosis in general, and CAD in
particular, are characterized by low-grade inflammation, which
may be reduced with regular long-term exercise training
(Nimmo et al., 2013). We hypothesized that improvements
in endothelium-dependent vascular function would be
accompanied by a reduction in the markers of low-grade
inflammation, endothelial adhesion and coagulation, given the
association between inflammation and endothelial dysfunction,
and the central role of endothelial integrity in promoting cell
adhesions and coagulation. However, 2 weeks of exercise training
may have been too short to achieve such changes; aquatic
exercise trials of longer duration in osteoarthritis (Alkatan
et al., 2016) have reported improved vascular function and
inflammation markers with water-based exercise. Adding to
these observations, our study suggests that improvements
in FMD – unparalleled by a reduction in the markers of
inflammation (interleukins and hsCRP) and inflammation-
induced endothelial activation (P-selectin and ICAM) – more
likely derive from immediate exercise-induced hemodynamic
changes rather than from a reversal in inflammation-caused
vascular dysfunction. Alternatively, it is also possible that
exercise-induced long-term changes in body mass, composition
and metabolism might in the long run reverse low-grade
chronic inflammation in cardiovascular disease; however,
neither our 2-week exercise program nor longer 12-week
trials (Mohammadi et al., 2018) achieved significant changes
in the body mass index, and did not appraise potential
body composition changes, which may be brought about by
aquatic exercise.
Limitations
We have identified several limitations. Firstly, this was a
single-center study involving a limited number of patients
with a recent CAD event. The results can therefore not be
extrapolated to other cardiovascular patients. Secondly, we
assessed relevant but surrogate endpoints, and the clinical
relevance of our findings should be confirmed in larger
clinical trials. Also, our study focused on exercise capacity,
vascular function and low-grade inflammation; whilst providing
some insight into aquatic exercise in patients with CAD,
our findings convey only limited inferences about the
potential (patho)physiologic responses to water- vs. land-
based exercise training in this patient population. Specific
impacts of aquatic exercise in patients with CAD – such as
on body composition and metabolism – should therefore be
addressed in further studies. Thirdly, baseline between-group
differences suggest randomization failure and have required
statistical adjustment, which calls for our study to be regarded
as pilot and hypothesis-generating. Fourthly, while both
intervention groups underwent residential cardiac rehabilitation
(controlling for some confounders, such as diet), the control
group did not, which may have yielded overestimation of
the effect of both interventions as compared to controls.
Lastly, we chose a specific type (xiphoid-level endurance
plus calisthenics training) and duration of exercise (2-week
intervention), which can only address immediate physiological
responses, but not sustainable effects of regular training.
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CONCLUSION
Aquatic exercise is a safe and effective training modality for
patients undergoing short-term residential cardiac rehabilitation
after a recent CAD event. As compared to land-based exercise,
endurance plus calisthenics exercise training in thermo-
neutral water provides comparable improvements in exercise
capacity and vascular function in patients with CAD. Our
pilot study therefore represents a starting point for further
research into optimal exercise modalities in CAD patients,
with water-based training likely emerging as a suitable
exercise option.
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(2019) The Physiological Effect of n-3
Polyunsaturated Fatty Acids (n-3
PUFAs) Intake and Exercise on
Hemorheology, Microvascular
Function, and Physical Performance
in Health and Cardiovascular
Diseases; Is There an Interaction
of Exercise and Dietary n-3 PUFA
Intake? Front. Physiol. 10:1129.
doi: 10.3389/fphys.2019.01129
The Physiological Effect of n-3
Polyunsaturated Fatty Acids (n-3
PUFAs) Intake and Exercise on
Hemorheology, Microvascular
Function, and Physical Performance
in Health and Cardiovascular
Diseases; Is There an Interaction of
Exercise and Dietary n-3 PUFA
Intake?
Marko Stupin1,2,3, Aleksandar Kibel1,2,3, Ana Stupin1,2,4, Kristina Selthofer-Relatić3,5,
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Physical activity has a beneficial effect on systemic hemodynamics, physical strength,
and cardiac function in cardiovascular (CV) patients. Potential beneficial effects of
dietary intake of n-3 polyunsaturated fatty acids (n-3 PUFAs), such as α-linolenic
acid, eicosapentaenoic acid, and docosahexaenoic acid on hemorheology, vascular
function, inflammation and potential to improve physical performance as well as
other CV parameters are currently investigated. Recent meta-analysis suggests no
effect of n-3 PUFA supplementation on CV function and outcomes of CV diseases.
On the other hand, some studies support beneficial effects of n-3 PUFAs dietary
intake on CV and muscular system, as well as on immune responses in healthy
and in CV patients. Furthermore, the interaction of exercise and dietary n-3 PUFA
intake is understudied. Supplementation of n-3 PUFAs has been shown to have
antithrombotic effects (by decreasing blood viscosity, decreasing coagulation factor
and PAI-1 levels and platelet aggregation/reactivity, enhancing fibrinolysis, but without
effects on erythrocyte deformability). They decrease inflammation by decreasing IL-6,
MCP-1, TNFα and hsCRP levels, expression of endothelial cell adhesion molecules
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and significantly affect blood composition of fatty acids. Treatment with n-3 PUFAs
enhances brachial artery blood flow and conductance during exercise and enhances
microvascular post-occlusive hyperemic response in healthy humans, however, the
effects are unknown in cardiovascular patients. Supplementation of n-3 PUFAs may
improve anaerobic endurance and may modulate oxygen consumption during intense
exercise, may increase metabolic capacity, enhance endurance capacity delaying the
onset of fatigue, and improving muscle hypertrophy and neuromuscular function in
humans and animal models. In addition, n-3 PUFAs have anti-inflammatory and anti-
nociceptive effects and may attenuate delayed-onset muscle soreness and muscle
stiffness, and preserve joint mobility. On the other hand, effects of n-3 PUFAs were
variably observed in men and women and they vary depending on dietary protocol,
type of supplementation and type of sports activity undertaken, both in healthy and
cardiovascular patients. In this review we will discuss the physiological effects of n-3
PUFA intake and exercise on hemorheology, microvascular function, immunomodulation
and inflammation and physical performance in healthy persons and in cardiovascular
diseases; elucidating if there is an interaction of exercise and diet.
Keywords: n-3 PUFAs, exercise, cardiovascular, endothelium, inflammation, hemorheology, muscle,
microcirculation
INTRODUCTION
It is well-accepted that physical activity has a beneficial effect
on systemic hemodynamics, physical strength and cardiac
function in cardiovascular (CV) patients (Joyner and Green,
2009; Smith et al., 2011c; Piepoli et al., 2016). The strength
of such evidence is evident from the fact that regular physical
activity and exercise are accepted as essential components for
reducing the severity of CV risk factors and are incorporated
in guidelines for primary and secondary cardiovascular disease
(CVD) prevention by both European Society of Cardiology
and American Heart Association (Smith et al., 2011c; Piepoli
et al., 2016). Even though the effects of regular exercise are
more difficult to apprehend in secondary than in primary
CVDs prevention (studies performed as part of rehabilitation
programs), the current position is that mild-to-moderate regular
physical activity can be recommended to CVD patients with no
exception (Smith et al., 2011c; Piepoli et al., 2016). In the last few
decades, potential beneficial effects of dietary or supplementary
daily intake of n-3 polyunsaturated fatty acids (n-3 PUFAs), such
as α-linolenic fatty acid (ALA), eicosapentaenoic acid (EPA), and
docosahexaenoic acid (DHA), on CV function and outcomes of
CVDs (Auger et al., 2016), particularly hemorheology, vascular
function, immunomodulation, inflammation and potential to
improve muscular strength, have been investigated in different
study populations (e.g., healthy, sedentary, athletes, CV patients).
On the other hand, recent Cochrane review assessed the effects
of intake of fish- and plant-based n-3 PUFA supplements,
or in some cases enriched food or dietary advice (n-3
PUFAs doses ranged from 0.5 to >5 g/day) on CV events,
adiposity, lipids, and all-cause mortality (Abdelhamid et al.,
2018). That review evaluated 79 randomized controlled trials
(RCTs) (with subsequent excluding of 25 RCTs), which included
approx. 100,000 adults at different CV risks, mainly from
high-income countries. Authors concluded that meta-analysis
and sensitivity analyses in their review suggested little or no
effect of increased DHA/EPA intake on all-cause mortality
(high-quality evidence), CV mortality, CV events (high-quality
evidence), coronary heart disease (CHD) mortality, stroke or
arrhythmia. They may reduce CHD events; however, according
to sensitivity analyses – this is small effect. All evidence was
of moderate GRADE quality, except ones noted as high quality
evidence. However, increased ALA may slightly reduce risk
of CV events (low-quality evidence) and probably reduces
risk of arrhythmia, while effects on stroke are unclear. Taken
together, it seems that n-3 PUFAs and exercise per se may
affect hemorheology and thrombotic as well as inflammatory
status of the body and have protective effect, for example in
atherosclerosis, which was not assessed in the aforementioned
Cochrane review. Interaction of n-3 PUFA intake and life style
(such as physical activity) was not included in the scope of the
review by Abdelhamid et al. (2018).
This, in fact, brings some controversies in the field,
since the consumption of such remedies is rather high in
United States (Hopp and Shurtleff, 2018), while in EU countries
the recommendations for daily n-3 PUFA intake are not always
met in all population subgroups (Sioen et al., 2017). According to
the 2012 National Health Interview Survey in the United States;
7.8% of adults (18.8 million) and 1.1% of children age 4 to 17
(664,000) had taken a fish oil supplement in the previous 30 days
(Hopp and Shurtleff, 2018).
The aim of the present review was to summarize, in an
orderly manner, current knowledge on the effect of exercise and
dietary intake of n-3 PUFAs (in food stuff or in the form of
supplements) on vascular function and physical performance in
healthy persons and in CV patients, with particular attention paid
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to hemorheology and coagulability, inflammation and vascular
and muscular function.
To obtain a comprehensive review of current data, original
research studies, narrative reviews and systematic reviews
and meta-analyses were collected and analyzed. A search of
PubMed database was performed by using the following search
terms: omega-3 supplementation, n-3 PUFA supplementation,
exercise, functional food, cardiovascular, healthy, vascular,
endothelium, microcirculation, inflammation, hemorheology,
and muscle (Figure 1). Only the English language literature
pertaining to both humans and experimental animals with no
time restriction were reviewed. Literature search algorithms
and obtained results (number of articles) are described in
Figure 1. From the literature search it is evident that a
respective number of studies investigated the effect of n-3
PUFA supplementation on hemorheology, vascular/endothelial
function/microcirculation, inflammation, and skeletomuscular
system in both CV patients and healthy population (panel
A). However, a significantly smaller number of studies dealt
with the effect of n-3 PUFA supplementation in the form
of functional food (panel C), or the potential combination
intervention effect of n-3 PUFAs and regular exercise on
mentioned parameters (panel B). Importantly, there is no
available data (total of 5 research results) on the combined effect
of n-3 PUFA supplementation in the form of functional foods and
regular aerobic exercise on hemorheology, vascular/endothelial
function/microcirculation and inflammation in both healthy
population and CV patients (panel D).
METABOLISM OF POLYUNSATURATED
FATTY ACIDS
EPA and DHA are present in phospholipids of the cell membrane,
contributing to the n-3/n-6 ratio, and share the same enzymes
with arachidonic acid (AA) in the eicosanoid-producing process
(Wang et al., 2017; Gammone et al., 2018; Philipsen et al.,
2018). EPA and DHA are metabolized into numerous eicosanoids
and docosanoids, respectively, by cyclooxygenases (COX),
lipoxygenase (LOX), and cytochrome P450 (Figure 2). Because
n-3 PUFAs can compete for the same metabolic pathways against
n-6 PUFAs, n-3 PUFAs supplementation may also affect the
metabolism of AA, thereby shifting the profile of metabolites
derived from AA (Figure 2) (Drenjančević et al., 2017).
The AA-derived prostaglandins and leukotrienes are
potent pro-inflammatory mediators (Samuelsson et al., 1987),
whereas the AA-derived metabolites lipoxins are potent anti-
inflammatory and pro-resolving molecules (Serhan, 1994;
Wallace and Fiorucci, 2003; McMahon and Godson, 2004). On
the other hand, anti-inflammatory lipid mediators or specialized
pro-resolving mediators (SPM), such as lipoxins, resolvins,
protectins, and maresins, are endogenous n-3 PUFA-derived
oxygenated metabolites of EPA, docosapentaenoic acid (DPA)
and especially DHA. They are released upon specific stimuli
and mediate cell signaling and cell-to-cell interactions. Mostly,
they are responsible for regulating inflammation and specific
immune responses (Calder, 2017). Addition of n-3 PUFA,
particularly EPA and DHA supplements into the diet leads to
their increased incorporation into cell membrane phospholipids
at the expense of n-6 PUFAs, such as AA. EPA as a 20-carbon
chain fatty acid competes directly with AA as a substrate for
COX and LOX and leads to production of anti-inflammatory
(less inflammatory) prostaglandins and leukotrienes (i.e., LTB3
and PGE3), while DHA, together with EPA, has been associated
with production of counter-regulatory lipid mediators such
as resolvins, protectins, and maresins (Calder, 2017; Molfino
et al., 2017). Maresin 1 is biosynthesized via LOX by DHA
to generate 14S-hydroperoxydocosa-4Z,7Z,10Z,12E,16Z,19Z
hexaenoic acid, which undergoes further conversion via
epoxidation in macrophages and is subsequently converted to
7R,14S-dihydroxydocosa-4Z,8Z,10E,12Z,16Z,19Z-hexaenoic
acid, known as maresin 1 (MaR 1) (Serhan et al., 2012).
Sun et al. (2017) recently showed that MaR 1 exhibited its
protective effects, at least in part, via the Nrf-2-mediated
heme oxygenase-1 (HO-1) signaling pathway. MaR 1 can
directly modulate the inflammatory responses by affecting
the function of already activated and clonally expanded Th1
and Th17 cells, and additionally influence immune responses
by acting on their transcription factor-induced activation
programs to prevent their generation from naïve CD4 + T
cells. Furthermore, MaR 1 can enhance the differentiation
of CD4 + T cells into Treg cells (Chiurchiù et al., 2016).
They also showed that the protective effect of MaR 1 relied
on its downstream antioxidative stress capabilities and and
capability to maintain the balance between oxidative and
antioxidative stress. MaR 1 significantly reduced reactive
oxygen species, malondialdehyde, and 15-F2t-isoprostane
generation and restored the activity of antioxidative enzymes
(superoxide dismutase, glutathione peroxidase, catalase)
(Sun et al., 2017).
Beside reduced production of potent pro-inflammatory AA-
derived eicosanoids such as PGE2, anti-inflammatory action
of EPA-derived eicosanoids is reflected in the fact that they
have reduced affinity for eicosanoid receptors. For example,
Wada et al. (2007) described that PGE3 has 50 to 80% lower
potency compared with PGE2 toward the EP1, EP2, EP3, and
EP4 receptors. In addition, increased EPA and DHA cellular
content results in decreased expression of COX-2 enzyme
(Jeromson et al., 2015; Gammone et al., 2018). Figure 2 shows
the metabolism of n-3 and n-6 PUFAs and the most important
eicosanoids involved in the processes of inflammation, vascular
reactivity, thrombosis, and similar.
EFFECTS OF n-3 PUFAs AND EXERCISE
ON HEMORHEOLOGY AND
COAGULABILITY
Supplementation or Dietary Intake of n-3
PUFAs Affects Hemorheology and
Coagulability
Dietary n-3 PUFAs are associated with a hypocoagulable profile.
In the Atherosclerosis Risk in Communities (ARIC) Study, four
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FIGURE 1 | Algorithms of literature search. From literature search it is evident that a respective number of studies investigated the effect of n-3 PUFA
supplementation on hemorheology, vascular/endothelial function/microcirculation, inflammation, and skeletomuscular system in both cardiovascular patients and
healthy population (A). However, a significantly smaller number of studies dealt with the effect of n-3 PUFA supplementation in the form of functional food (C), or the
potential combined interaction effect of n-3 PUFAs and regular exercise on the mentioned parameters (B). Importantly, there is no available data (a total of 5 search
results) on the combined effect of n-3 PUFA supplementation in the form of functional foods and regular aerobic exercise on hemorheology, vascular/endothelial
function/microcirculation and inflammation in both healthy population and CV patients (D).
FIGURE 2 | Metabolism of n-3 and n-6 PUFAs and the most important eicosanoids. The present figure summarizes the metabolism of n-3 PUFAs and n-6 PUFAs by
cyclooxygenases (COX), lipoxygenase (LOX), and cytochrome P450.
population-based samples amounting to over 15,000 participants,
blacks and whites, have been studied (Shahar et al., 1993).
This study assessed if dietary fatty acid ingestion leads to
changes in blood concentrations of relevant coagulation factors.
The investigators analyzed concentrations of fibrinogen, factor
VII, factor (vWF), protein C, and antithrombin III. A food
frequency questionnaire was used to document dietary intake.
Multiple linear regression was used to assess cross-sectional
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associations, with adjustments for age, race, gender, smoking
and alcohol use, diabetes, body mass index, and field center.
Dietary n-3 PUFAs have been shown to be negatively associated
with concentrations of fibrinogen, factor VIII, and (vWF) (in
black and white individuals) and are positively associated with
protein C (in white subjects only). The ingestion of fish, which
represented the predominant source of dietary n-3 PUFAs, was
similarly related to the hemostatic profile. Namely, fish ingestion
that was 1 serving higher per day showed an association with
these predicted differences (95% confidence interval): factor
VIII, −3.3% (−5.4, −1.3); fibrinogen, −2.9 mg/dL (−6.3, 0.5);
vWF, −2.7% (−5.2, −0.1) (in black and white subjects); and
protein C, +0.07 µg/mL (0.03, 0.11) (white subjects only).
Other analyzed nutritional items were variably correlated with
the levels of hemostatic factors. The results of the ARIC study
with its associations that are population-based, albeit cross-
sectional, imply that elevations in dietary intake of n-3 PUFAs
from fish might lead to alterations of blood concentrations
of several important coagulation factors. These associations
are tied to the hypocoagulable profile (Shahar et al., 1993).
Phang et al. (2014) performed a double-blinded, placebo-
controlled randomized trial in 94 healthy adults, assessing
platelet coagulation parameters such as factors I, II, V, VII,
VIII, IX, X, vWF and endogenous thrombin potential, as well
as platelet aggregation. They found that supplementation with
EPA in healthy men and DHA in women leads to reduction in
platelet aggregation. Similarly, plasma concentrations of factor
II, factor V and vWF were reduced primarily in men with
EPA supplementation, while reduction in platelet aggregation
mediated by DHA in women was not associated with substantial
changes in the assessed parameters of coagulation (Phang et al.,
2014). This brings to light an interesting sex-specific difference in
the antithrombotic effects of n-3 PUFAs.
The addition of n-3 PUFAs to simvastatin treatment in
patients with combined hyperlipidemia lead to a reduction of the
fraction of the free tissue factor pathway inhibitor in the fasting
state. This n-3 PUFA addition also inhibited factor VII activation
during post-prandial lipemia, as found by Nordøy et al. (2000) on
a sample of 41 patients. A double-blind, cross-over study using
olive oil as placebo, assessed the influence of a daily dosage of 6 g
of fish oil on CV risk markers of 20 healthy young volunteers (10
men and 10 women). This study implicated a reduction in factor
X (as a result of fish oil ingestion in women, compared to placebo)
(Oosthuizen et al., 1994), but there are also inconsistencies in
the findings, since some studies did not detect clear changes in
the levels of coagulation factors (Vanschoonbeek et al., 2004)
or platelet function with n-3 PUFA ingestion (Lee et al., 2006;
Poreba et al., 2017).
A decrease in thromboxane A2 synthesis, which is an
important platelet aggregation facilitator, contributes to the
hypocoagulable state induced by n-3 PUFAs (Véricel et al.,
2015; Lands, 2016; Jeansen et al., 2018). EPA and DHA
are also antagonists of human platelet thromboxane A2 and
prostaglandin H2 receptors (Véricel et al., 2015; Lands, 2016;
Jeansen et al., 2018). In addition, n-3 PUFAs lead to a decrease in
plasma viscosity in patients with hypolipoproteinemia by altering
the protein pattern of the plasma (Ernst, 1989).
There is evidence that the n-3 PUFA ALA, which is converted
to EPA and DHA, impairs formation of arterial thrombus,
expression of tissue factor, and platelet activation in male C57Bl/6
mice who were fed a high-ALA diet for 2 weeks (Holy et al.,
2010). Furthermore, there is also clinical evidence regarding the
influence of n-3 PUFAs on clot properties. For instance, a study
by Gajos et al. (2011) assessed the effects of n-3 PUFAs on top of
dual antiplatelet therapy in stable coronary artery disease patients
undergoing percutaneous coronary intervention. The addition of
n-3 PUFAs (supplementation 1 g/day for 1 month) to standard
therapy (30 treated subjects and 20 patients on placebo) lead
to a decrease in thrombin formation and oxidative stress and
favorably altered fibrin clot properties in the treated patients
(Gajos et al., 2011).
Regarding the safety of n-3 PUFA consumption, when its
antithrombotic effects are taken into consideration, it has been
analyzed in various patient populations in clinical settings. An
assessment of 8 clinical intervention studies (with over 600
treated individuals) that used nutritional supplements with fish
oil as a source of n-3 PUFAs did not find any increased
bleeding risk as a result of n-3 PUFA intake. Additionally,
no significant changes in crucial parameters of coagulation
(partial thromboplastin time and prothrombin time) were
observed. Therefore, the authors concluded that n-3 PUFA
intake seems to be safe even at a short-term dosage of up to
10 g/day of EPA + DHA or consumed for up to 52 weeks
at higher than 1.5 g/day, in selected vulnerable and sensitive
patient populations including individuals with gastrointestinal
malignancies or intensive care patients (Jeansen et al., 2018).
The potential protective antithrombotic effects of PUFAs are
summarized in Figure 3.
Effects of Exercise on Hemorheology
and Coagulability in CV Patients
Regarding the influence of exercise on platelet function in
patients with CV disease, it is not entirely clear in which way
exercise may influence platelets. In their systematic review, Hvas
and Neergaard-Petersen analyzed a total of 18 studies from
various databases (including PubMed, Embase, Scopus, and
Cochrane Library). Of the 18 studies, 7 were with coronary
artery disease patients, 5 with angina pectoris patients, 5
with hypertensive patients, and 2 with subjects who have
peripheral artery disease (Hvas and Neergaard-Petersen, 2018).
They found that conflicting results were reported, with certain
studies reporting increased platelet aggregation and/or platelet
activation, some studies found no difference, while several
reported a reduction in platelet aggregation after exercise
(compared with controls). Therefore, more conclusive research
is needed to finally elucidate potential effects of exercise on
platelet function.
Exercise per se has been related to beneficial changes of
rheological characteristics of the blood. In a meta-analysis
of available studies which investigate the effects of exercise
on rheological characteristics of blood, Romain et al. (2011)
concluded that regular exercise decreases hematocrit and red
blood cell aggregation. However, the main criticism of Romain’s
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FIGURE 3 | Schematic representation of potential antithrombotic effects of n-3 PUFAs and exercise. Potential effects of n-3 PUFAs may include influence on specific
coagulation factors of the coagulation cascade (with antithrombotic tendency), effects on arachidonic acid metabolites, blood rheology and (directly and indirectly)
platelet aggregation (leading to a decrease in the latter). Other unknown or insufficiently investigated effects might also be involved.
analysis was the small number and a large heterogeneity of
the available studies (methodology, study design, etc.) which
hampered final conclusions (Romain et al., 2011), resulting in
uncertainty of interpretation of data and necessity of future
randomized controlled clinical studies for final conclusions.
Combined Interaction Effect of n-3 PUFA
Consumption and Exercise on
Hemorheology and Antithrombic Status
of Blood in CV Patients
The search for combined interaction effect of n-3 PUFA
consumption and exercise on hemorheology and coagulability of
blood in CV patients rendered scarce results. It is reported that in
previously sedentary, obese people (N = 22; 12 women, 10 men,
BMI 26.6± 0.7 kg/m2) 4 weeks of dietary and exercise protocols,
exercise training [brisk walking and (or) jogging at 60% VO2
maximum for 45 min/day, 5 days/week] has no interference or
additive effects with 4 g/day of n-3 PUFA supplementation in
attenuating post-prandial lipemia, but combined treatments may
be additive in raising high-density lipoprotein (LDL) cholesterol
(Thomas et al., 2007), which may help maintain antithrombotic
and anti-atherosclerotic status of blood. Obviously, well-planned,
controlled trial of combined dietary and exercise protocols
focused on blood hemorheology could provide new evidence on
interactions of interest.
THE EFFECT OF n-3 PUFAs AND
EXERCISE ON VASCULAR FUNCTION IN
HEALTHY SUBJECTS AND IN
CARDIOVASCULAR PATIENTS
Since it is widely accepted that n-3 PUFA consumption reduces
CV risk (Auger et al., 2016), numerous studies set their focus
on investigating whether n-3 PUFA intake may prevent or delay
the initial steps in the pathogenesis of various CV diseases,
e.g., changes in endothelium and vascular function, in both
healthy and diseased population. In particular, n-3 PUFAs may
improve endothelial function by increasing the bioavailability of
endothelial nitric oxide (NO) (through increasing its production
by stimulating endothelial NO synthase gene and protein
expression) (Lo et al., 2004; Gortan et al., 2013; Zhang et al.,
2013) or by reducing the level of oxidative stress (through
attenuating reactive oxygen species, which indirectly increases
NO bioavailability) (Gortan et al., 2013; Zhang et al., 2013;
Drenjančević et al., 2017). Additionally, vascular function could
be improved by reducing inflammation (by affecting mediators
of local endothelial and/or systemic inflammation) (Wang et al.,
2011). All of these interactions are summarized in Figure 4.
While there is paucity of data on the effect of n-3 PUFAs on
microvascular function in both healthy and diseased population
(Pe et al., 2008; Stupin A. et al., 2018), there is large inconsistency
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FIGURE 4 | Functional pathways and molecular mechanisms mediating interaction between n-3 PUFAs and exercise on the one side and endothelial function on the
other. The present figure summarizes the results of studies conducted on experimental animals, healthy subjects, and patients (CV, diabetic, obese) on the effect of
n-3 PUFA supplementation or regular exercise on endothelial function (NO bioavailability, oxidative stress level and inflammation), vascular function (functional
vascular experiments in both macro- and micro-circulation), and traditional cardiovascular risk factors (e.g., blood pressure, serum triglyceride level). It is evident that
studies on the effect of regular exercise on the abovementioned parameters provided more uniform results and yielded clear conclusions on the beneficial effect of
regular exercise on CV health. On the other hand, studies on the effect on n-3 PUFAs on vascular and endothelial function, especially studies in patients and healthy
subjects, provided very divergent and inconclusive results, evidently due to the heterogeneity in experimental design with the emphasis on different form, dose and
duration of n-3 PUFA supplementation used in these studies. There is a paucity of data on the combined effect of n-3 PUFAs and regular exercise on CV function in
general.
of functional vascular studies which evaluated the effects of n-3
PUFAs on macrovascular function, mainly assessed by flow-
mediated dilation (FMD) of brachial artery as a gold standard
method, in both healthy individuals and CV patients (Egert et al.,
2014; Merino et al., 2014; Tousoulis et al., 2014; Yagi et al., 2015).
Beneficial Effect of n-3 PUFAs on
Vascular Function in CV Patients
Studies in CV patients (e.g., coronary artery disease,
metabolic syndrome, chronic heart failure) or individuals
with increased CV risk (e.g., obesity, diabetes mellitus type 2,
hyperlipidemia, cigarette smoking) strongly suggest that n-3
PUFA supplementation improves vascular and endothelial
function (e.g., brachial artery FMD, venous occlusion strain-
gauge plethysmography, microvascular endothelial cells)
(Morgan et al., 2006; Egert et al., 2014; Yagi et al., 2015). For
example, oral intake of 2 g of n-3 PUFAs per day for 12 weeks
significantly improved FMD of brachial artery and pulse wave
velocity in adults with metabolic syndrome (Tousoulis et al.,
2014). A recent cross-over study in overweight individuals
reported that a walnut-rich diet (23.1% energy from n-3 PUFAs)
compared to an almond-rich diet significantly improved FMD
of brachial artery and decreased soluble vascular cell adhesion
molecule level (Bhardwaj et al., 2018). Furthermore, increased
serum DHA level was a positive contributor to an increased
FMD of brachial artery in 160 consecutive Japanese patients
with coronary artery disease (Yagi et al., 2015). FMD of brachial
artery was improved following intake of 1.8 g/day n-3 PUFA
supplementation for 12 weeks in hypertensive patients with
hypertriglyceridemia and high CV risk as demonstrated by
interventional study (Casanova et al., 2016). Similar results
were also reported in overweight dyslipidemic patients and
type 2 diabetics (Egert et al., 2014; Tousoulis et al., 2014),
along with decrease of soluble thrombodulin, the marker of
vascular endothelial damage, in patients with the presence of
one or more risk factors for atherosclerosis (Kawauchi et al.,
2014). Kondo et al. (2014) reported that a 4-week diet period
rich in n-3 PUFAs significantly improved reactive hyperemia
measured by strain-gauge plethysmography in post-menopausal
women with diabetes mellitus type 2. Furthermore, n-3
PUFA supplementation in patients with chronic heart failure
improved endothelium-dependent vasodilation measured by
venous occlusion strain-gauge plethysmography (Morgan et al.,
2006). Beneficial effect of n-3 PUFAs on microvasculature was
confirmed in the model of inflammatory bowel disease on a
primary culture of human intestinal microvascular endothelial
cells (Ibrahim et al., 2011).
Beneficial Effect of n-3 PUFAs on
Vascular Function in Healthy Subjects
There is inconsistency in the results of studies investigating
whether the same beneficial effect of n-3 PUFA consumption is
also present in healthy population. Although the results of several
studies demonstrated that n-3 PUFA supplementation improved
brachial artery FMD in healthy individuals (Walser et al., 2006;
Shah et al., 2007; Rizzaa et al., 2009), others failed to observe
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such effect (Sanders et al., 2011; Skulas-Ray et al., 2011; Singhal
et al., 2013). The most evidence for the benefits of n-3 PUFAs
to vascular function in healthy individuals was observed in the
post-prandial state, in both macrocirculation (using FMD) (Fahs
et al., 2010; Miyoshi et al., 2014) and microcirculation (using
LDF) (Armah et al., 2008; Pe et al., 2008). Supplementation of
fish oil (rich in n-3 PUFAs) for 8 months improved endothelial
function in normal healthy subjects (Khan et al., 2003). A recent
study by our research group reported that young healthy subjects
who consumed n-3 PUFA enriched eggs for 3 weeks (777 mg
of n-3 PUFAs/day) had improved skin microvascular reactivity
in response to vascular occlusion (Stupin A. et al., 2018). On
the contrary, a single Mediterranean meal (rich in n-3 PUFAs;
2.29 g of n-3 PUFAs per meal) did not significantly alter FMD in
healthy men, while a high-saturated fatty acid meal induced post-
prandial endothelial dysfunction (Lacroix et al., 2016) and only
n-3 PUFA supplementation higher than 1.8 g per day improved
FMD in healthy adults (Sanders et al., 2011).
The results of two large meta-analyses (including both healthy
individuals and CV patients) demonstrated that n-3 PUFA
supplementation significantly increases FMD of brachial artery,
but also showed that the health status of the study population,
as well the dose of n-3 PUFA supplementation may modify the
effect of n-3 PUFAs on vascular function (Wang et al., 2012;
Xin et al., 2012). Furthermore, when the analysis included only
double-blinded, placebo-controlled studies, the supplementation
of n-3 PUFAs had no significant effect on vascular endothelial
function (Wang et al., 2012). Consequently, the results of the
abovementioned studies should still be interpreted cautiously,
due to the large heterogeneity of these studies in terms of
selection of participants, their age and health status, as well as
in terms of the dose and form of n-3 PUFA supplementation
used in the trials.
Beneficial Effects of Exercise on
Vascular Function in CV Patients and
Healthy Persons
Positive effects of moderate physical activity in preserving general
health and preventing CV disease and age-related deterioration
have been very well-established (Warburton and Bredin, 2017).
Regular exercise significantly contributes to lowering arterial
blood pressure or reducing blood lipid concentration (Joyner and
Green, 2009). Functional vascular studies on the conductance
and resistance arteries in CV patients showed decreased
inflammation and endothelial dysfunction of the blood vessels
(Hambrecht et al., 2003), while 4 weeks of exercise improved
FMD of brachial artery in patients with stable coronary disease
(Hambrecht et al., 2003).
Similarly, regular exercise has a beneficial effect on vascular
function, even in healthy people. For example, athletes have
better FMD of brachial artery compared to healthy sedentary
individuals (Clarkson et al., 1999; Kasikcioglu et al., 2005).
Several mechanisms may be involved in these positive effects
of long-term regular physical activity, such as increased NO
bioavailability, increased antioxidative defense in the vascular
system and reduced levels of locally or systemically derived
mediators of inflammation (Padilla et al., 2011). It has been
demonstrated that the repeated increase in blood flow (e.g.,
vascular shear stress) during physical activity is probably a
key mechanism that induces a positive adaptation of vascular
function to regular physical activity by stimulating the NO-
dependent vasodilatory pathway (Laughlin et al., 2008; Birk
et al., 2012). Nevertheless, production of COX-derived vascular
metabolites, including increased synthesis of prostacyclin, is
involved in endothelial shear stress adaptations. Furthermore,
increasing evidence suggests that increased shear stress is a
signal that will reduce the level of endothelin 1, soluble cell
adhesion molecules and various markers of endothelial activation
(Himburg et al., 2007), all together contributing to improved
macrovascular function.
Functional vascular studies on microcirculation of the skin
showed that regular body activity lasting several weeks to several
months resulted in the adaptation of skin microcirculation
which is manifested by improved vasodilation-dependent
endothelium in both healthy population and CV patients. The
main evidence derives from vascular experiments studying
the microcirculation response to the endothelium-dependent
[acetylcholine (ACh)] and/or endothelium independent
[sodium nitroprusside (SNP)] vasodilator. Kvernmo et al.
(1998) demonstrated better response in terms of microvascular
flow in the forearm skin following ACh administration in
professional athletes compared with appropriate controls that
had moderate body activity, while there was no difference in SNP
response between these two experimental groups, suggesting
that endothelial function was affected. Similarly, Stupin M.
et al. (2018) reported that professional rowers had significantly
better response of forearm skin microcirculation to vascular
occlusion and ACh, but not SNP compared to sedentary healthy
controls. Furthermore, Wang (2005) investigated endothelium-
dependent and endothelial-independent vascular response in
microcirculation of the skin in healthy sedentary individuals
before and after 8 weeks of exercise. The results of this study have
also shown a marked improvement in endothelium-dependent
vascular response, but without any change in endothelium-
independent response of skin microcirculation. Interestingly, in
the further course of the study after 8 weeks without exercise
such enhanced endothelium-dependent response was no longer
present. In general, skin microvascular endothelial function was
not different between adult and young active individuals (Black
et al., 2008; Tew et al., 2010). On the other hand, older individuals
practicing exercise have better endothelial vascular function in
microcirculation of the skin compared to their sedentary peers
(Black et al., 2008). Similar effects have been reported in patients
with type 2 diabetes (Colberg et al., 2002) and chronic venous
disease (Klonizakis et al., 2009).
Interactive Effects of n-3 PUFAs and
Long-Term Exercise on Vascular
Function in Humans
Taken together, it is evident that both n-3 PUFA supplementation
and regular physical activity improve endothelial function in both
macro- and microcirculation of healthy individuals, individuals
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with increased CV risk and CV patients (Morgan et al., 2006;
Joyner and Green, 2009; Egert et al., 2014). However, there is
a paucity of data on the combination of these two divergent
interventions on vascular function in these populations. The only
available study at the moment of preparation of the manuscript is
one on an experimental animal model by Barbeau et al. (2017),
who reported that combining ALA and endurance exercise
resulted in additional reduction of CV disease risk compared
to individual interventions in the obese Zucker rat. However,
there are many potentially common steps and outcomes that have
been demonstrated to be modified by exercise and diet per se,
as schematized in Figure 4. For example, arterial blood pressure
and serum lipid concentration are both affected by n-3 PUFAs
and exercise. Similarly, oxidative stress, inflammatory, and
biomarkers of vascular function are affected independently by n-3
PUFAs and exercise. On the other hand, the interactive effect of n-
3 PUFAs and exercise on functional responses of microcirculation
is still unknown. Thus, it is tempting to speculate that these two
stimuli which both individually result in improved endothelial
function would have additive effect on endothelial function and
may be a new challenging avenue of research.
IMMUNOMODULATORY AND
ANTI-INFLAMMATORY PROPERTIES OF
n-3 PUFAs AND EXERCISE IN ATHLETES
AND CARDIOVASCULAR PATIENTS;
MUSCLE SORENESS, MUSCLE
STIFFNESS, AND JOINT MOBILITY
Immunomodulatory and
Anti-inflammatory Properties of n-3
PUFAs
It is widely accepted that inflammation underlies many
chronic non-communicable diseases, such as CV diseases,
atherosclerosis, Alzheimer’s disease, and cancer (Coussens and
Werb, 2002; Libby, 2002; Weiner and Selkoe, 2002). In general,
n-3 PUFAs are considered to have anti-inflammatory effects on
various biological systems, including skeletal muscles, respiratory
mucosa and CV system, all of which have an important role
in exercise physiology (Biltagi et al., 2009; Tecklenburg-Lund
et al., 2010; Mori, 2014; Jeromson et al., 2015; Gammone et al.,
2018). However, our knowledge of immunomodulatory effects
of n-3 PUFAs in humans is scarce (Chen et al., 2018; Dátilo
et al., 2018; Phitak et al., 2018). Although much is known about
the molecular basis of initiating signals and pro-inflammatory
chemical mediators in inflammation (Samuelsson, 2012), it
has only recently become interesting to explore endogenous
stop signals such as lipid mediators. Most inflammatory
reactions are self-limited, and, besides leukocytes withdrawal,
the process of resolution includes a switch in synthesis of AA-
derived pro-inflammatory mediators to anti-inflammatory pro-
resolving n3-PUFA-derived mediators. Previous studies have
demonstrated that n-3 PUFAs alleviate inflammation by affecting
the production of inflammatory mediators such as eicosanoids,
reactive oxygen species and cytokines [i.e., tumor necrosis
factor α (TNFα), interleukin 1β and interleukin 6 (IL-6)],
responsible for release of other inflammatory factors and acute-
phase proteins from the liver (Northoff and Berg, 1991; Calder,
2006; Ambrozova et al., 2010; Jouris et al., 2011).
Increased consumption of EPA and DHA has been linked
to decreased serum levels of hsCRP in a heterogeneous set
of clinical trials (Reinders et al., 2012; Kubota et al., 2015).
For example, one interesting observation is that increased n-
3 PUFA intake has increased apolipoprotein A1 and decreased
high-sensitivity C reactive protein (hsCRP) concentration and
serum concentration of soluble cell adhesion molecules and
other pro-inflammatory factors in patients at intermediate-high
CV risk, resulting in improved peripheral vasoactivity (Merino
et al., 2014). In a cross-sectional study on 992 patients with
stable coronary artery disease, a multivariable linear regression
model demonstrated that levels of n-3 PUFAs (DHA + EPA)
were inversely and independently associated with CRP and IL-
6 concentration (Farzaneh-Far et al., 2009). Regarding other
inflammatory parameters that were assessed, results are mixed
and dependent on the extent of obesity, as beneficial effects were
only observed in severely, but not moderately obese individuals
(Itariu et al., 2012; Kratz et al., 2013). Furthermore, n-3
PUFAs affect the life and function of lymphocyte subpopulation;
administration of n-3 PUFAs decreases lymphocyte proliferation,
and alters neutrophil and natural killer (NK) cell function
(Varming et al., 1995; Thies et al., 2001a,b).
Transcription factor nuclear factor κB (NF-κB) has a central
role in the initiation of an immune response by inducing
transcription of genes encoding various cytokines (i.e., IL-1, IL-
6, TNFα), chemokines, cell adhesion molecules, anti-apoptotic
factors, cell cycle regulators (i.e., cyclin D), and other cell-type
specific mediators of inflammation (i.e., inducible NO synthase,
COX2) (Afonina et al., 2017). EPA and DHA are natural agonists
of transcription factor peroxisome proliferator-activated receptor
γ (PPAR-γ), whose activation potently inhibits cytokine-induced
NF-κB transcriptional activity in skeletal muscles in a time- and
dose-dependent manner, as evidenced by significantly reduced
levels of TNFα, IL-8, intercellular adhesion molecule 1 and
chemokine (C-X-C motif) ligand 1 (Grygiel-Górniak, 2014).
Immunomodulatory and
Anti-inflammatory Properties of Exercise
Prolonged and exhaustive exercise, but not moderate exercise,
leads to a transient increase in frequencies in peripheral blood
lymphocytes during the exercise, possibly due to the mobilization
of CD4 + T cells, CD8 + T cells, CD19 + B cells, CD16 + NK
cells, and CD56 + NK cells from the peripheral lymphoid
organs, which is followed by a significant decline in total blood
lymphocyte numbers immediately after cessation of exercise.
Some of these changes have been attributed to elevated levels
of catecholamines during intense training. Furthermore, heavy
training loads inhibit NK and B cells activity, and promote
Th2 response characterized by Th2 cells and Treg expansion.
Levels of pro-inflammatory cytokines and chemokines (i.e., IL-
1, IL-6, TNF-α, MIP-1, IL-8) rise during intense training and
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some remain elevated for hours after the acute intense bout of
training. In the humoral immune response, reduced antibody
production and secretion of antibodies to the mucosa have been
observed (Pedersen, 2000; Shaw et al., 2018). These changes
could lead to defective immune responses and make athletes
prone to infection.
The effect of exercise on NF-κB transcriptional activity is
dependent on the type and intensity of physical activity. An acute
bout of exercise activates myocardial NF-κB and increases toll-
like receptor 4 signaling leading to inflammation (Balan and
Locke, 2011; Cristi-Montero et al., 2012; Vella et al., 2012), while
moderate exercise reduces NF-κB signaling and activates the
SIRT1-AMPK-PGC1α axis, resulting in decreased inflammation
and reduced muscle loss (Liu and Chang, 2018). All of this has
been summarized in Figure 5.
Combined Interaction Effect of n-3
PUFAs and Exercise on
Immunomodulation
It is interesting that n-3 PUFAs from fish oil have been found to
reduce serum cortisol levels and the production of TNF-α and IL-
8 after strenuous exercise. Fish oil supplementation has no effect
on lymphocytosis observed during strenuous exercise; however,
it prevented the post-exercise decrease in CD8 + T cells (Peres
et al., 2018). Four weeks of n-3 PUFA supplementation attenuates
the increase in serum inflammatory markers during a period of 1
to 4 days after eccentric exercise (DiLorenzo et al., 2014). DHA
supplementation reduces exercise-induced muscle soreness and
stiffness, which could be beneficial for improving tolerance to
new and/or strenuous exercise programs and achieving better
training adaptations (DiLorenzo et al., 2014; Corder et al., 2016).
Furthermore, n-3 PUFAs exhibit an antinociceptive effect by
binding to the receptors in nervous tissue (Nakamoto et al., 2011).
Additional mechanisms of n-3 PUFA-mediated pain control
include decreased pro-inflammatory cytokine secretion (Zaloga
and Marik, 2001) and/or blockage of cationic channels (Xiao
et al., 1995). Other possible mechanisms of decreased nociception
include direct stimulation of opioid receptors or alteration of
plasma levels of endogenous opioid peptides (Nakamoto et al.,
2011). Based on these findings, it seems plausible that n-3 PUFA
supplementation could be useful for preventing inflammation
and delayed-onset muscle soreness (DOMS) resulting from
exhausting exercise (Corder et al., 2016).
In athletes, n-3 PUFAs have potentially beneficial effects on
the immune system and inflammation, in terms of alleviation
of the observed post-exercise immunosuppression and anti-
inflammatory effects that reduce exercise-induced DOMS and
muscle stiffness. The consumption of omega 3 fatty acids
modulates Th1/Th2 balance and leads to an increase in the
plasma levels of ALA, EPA and DHA, and proportionally to
the reduction in the levels of AA. Such system leads to a
decrease in the production of inflammatory lipid mediators
which provide a high-level immune response after exhaustive
training. Consumption of fish-oil supplementation at a dose of
1.8 g/day during 6 weeks significantly reduced prostaglandin
E2, interferon-γ, and TNFα concentration in elite swimmers
(Andrade et al., 2007). Consumption of 1.6 g/day of n-3 PUFAs
combined with a single bout of endurance exercise increased the
level of IL-2 production and NK cell cytotoxic activity 3 h after
the exercise in healthy men, suggesting interactive effects of n-
3 PUFAs and exercise on the native immune system (Benquet
et al., 1994; Kawabata et al., 2014; Da Boit et al., 2017). Reduced
pro-inflammatory production of cytokines, decreased neutrophil
function, and NK cell cytotoxicity is established in cases of a
single bout of high-intensity or long-duration endurance exercise
(Gleeson et al., 2011; Gammone et al., 2018).
Increased oxidative stress induced by exercise is accompanied
by a reduced immune response and decreased resistance
to infection (Sen, 1995) and makes athletes prone to upper
respiratory tract infections. Furthermore, exercise-induced
oxidative stress and inflammation, if prolonged, might give
rise to systemic inflammation, insulin resistance, and diabetes
mellitus type 2 (Bogdanovskaya et al., 2016). At that point, n-3
PUFAs may become important mediators in the prevention of
infection (Gray et al., 2012). This is supported by the findings
that 6 weeks of consumption of 3 g/day of fish oil (double-blind,
randomized, placebo-controlled trial) increased post-exercise
production of IL-2 in peripheral blood mononuclear cells and
NK cell activity (Gray et al., 2012). In another study, n-3 PUFA
dietary supplementation reduced bronchial inflammation by
altering immune cell composition in the sputum and reduced
pro-inflammatory eicosanoids and IL-1 and TNFα production
(Schubert et al., 2009). In addition, activated muscles secrete
myokines and cytokines such as IL-6 and TNFα which, under
some circumstances and at low levels, have been shown to have
anti-inflammatory effects (Bruunsgaard, 2005).
Unfortunately, there is a lack of similar data in CV patients,
e.g., combined effect of n-3 PUFAs and exercise on immune status
in CV patients has not been studied yet.
n-3 PUFAs ENHANCE ENDURANCE
CAPACITY DURING EXERCISE IN
ANIMAL MODELS AND IN HUMANS
Numerous studies show that n-3 PUFAs may have effects on
skeletal muscle metabolism (You et al., 2010; Smith et al.,
2015), indicating that n-3 PUFAs regulate signaling pathways
related to growth and hypertrophy (Smith et al., 2011a), while
animal studies demonstrated that n-3 PUFAs diminished skeletal
muscle protein breakdown (Whitehouse et al., 2001). Gingras
et al. (2007) demonstrated that food enriched in menhaden oil
enhances the activation of anabolic signaling proteins in bovine
muscle, and muscle protein synthesis is increased as well (Smith
et al., 2011a). Consumption n-3 PUFAs may increase some
pathways involved in modulation of mitochondrial activity and
extracellular matrix organization and decrease the inhibition of
mTOR, which is the key anabolic regulator (Yoshino et al., 2016).
Animal studies suggest that transcriptional changes in muscle are
responsible for anabolic effects of n-3 PUFAs, such as Akt/FOXO,
TLR4, and NOD signaling (Castillero et al., 2009; Liu et al.,
2013) and enhance the gene expression of key modulators of
mitochondrial function (Baillie et al., 1999; Philp et al., 2015).
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FIGURE 5 | Schematic representation of potential immune mechanisms affected by n-3 PUFAs and exercise in CV patients (outcomes). The effect of exercise and
n-3 PUFAs on NF-κB transcriptional activity. Effect of exercise is dependent on the type and intensity level of physical activity. An acute bout of exercise activates
myocardial NF-κB and increases toll-like receptor 4 signaling leading to inflammation while moderate exercise reduces NF-κB signaling and activates the
SIRT1-AMPK-PGC1α axis, resulting in decreased inflammation and reduced muscle loss.
Results of an vitro study show a general amelioration in energy
metabolism of skeletal muscle after n-3 PUFA intake (Hessvik
et al., 2010), and a recent animal study on mice has showed that
n-3 PUFAs inhibit metabolic dysfunction in skeletal muscle, since
a high saturated fat intake increases accumulation of lipids in red
muscle, which in turn increases mediators of lipolysis, oxidation,
and thermogenesis (e.g., fatty acid transporter genes Fatp4 and
Fat/Cd36, fatty acid storage-related gene Dgat1 and Hsl were
increased) and suppresses lipogenic genes (Philp et al., 2015).
Furthermore, n-3 PUFAs can modify the membrane fluidity
of proteins and lipids within the cell membrane, reducing
oxygen consumption and thus improving endurance capacity
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(Philpott et al., 2019). Different studies on healthy animals (for
example birds – semipalmated sandpipers Calidris pusilla or
rats) showed that n-3 PUFA supplementation supports recovery
of muscle damage caused by exercise and changes muscle lipid
composition (Ayre and Hulbert, 1997; Ruf et al., 2006; Maillet
and Weber, 2007; Nagahuedi et al., 2009). Similarly, n-3 PUFAs
prevent metabolic dysfunction in mice skeletal muscle by limiting
the accumulation of intramyocellular lipids in type I muscle fibers
(Philp et al., 2015).
It seems that enhanced aerobic capacity is the result of
significant exploitation of n-3 PUFAs, which have similar effects
in mammalian cells in vitro and in vivo (Nagahuedi et al.,
2009). Certain animals, like migratory birds, salmons and rats,
when consuming n-3 PUFAs enriched foods exhibited increased
endurance and a large increase in aerobic capacity (“natural
doping”) (Ayre and Hulbert, 1997; McKenzie et al., 1998;
Guglielmo et al., 2002; Maillet and Weber, 2007). Natural
doping is mediated by the incorporation of n-3 PUFAs into the
membrane phospholipids and their binding to nuclear receptors
which are necessary for regulation of genes which control lipid
metabolism. In addition to that, n-3 PUFAs participate in oxygen
delivery to skeletal muscle and increase exercise performance
(Bruckner et al., 1987). Daily supplementation of n-3 PUFAs
in older people, in combination with physical activity, resulted
in a significant increase in muscle strength (Rodacki et al.,
2012; Smith et al., 2015). Moreover, it has been demonstrated
that consumption of 3 g/day of n-3 PUFAs decreases eccentric
exercise-induced soreness as a marker of inflammation and
minimizes the severe DOMS that results from strenuous strength
exercise (Jouris et al., 2011). Supplementation of n-3 PUFAs
decreased post-exercise soreness in healthy adults (Jouris et al.,
2011) manifested as decreased blood markers of muscle damage
and inflammatory markers (Mickleborough et al., 2015).
Combined Effect of n-3 PUFAs and
Exercise on Cardiac Function and
Endurance Capacity in Healthy Humans
and CV Patients
There is a lack of well-controlled studies on the interaction
of n-3 PUFA intake and exercise, particularly in CV patients.
In regard to healthy humans, an increase in anaerobic
endurance capacity (but not in 20 m sprint performance),
explosive leg power, and 1RM knee extensor strength was
observed in competitive soccer players who took n-3 PUFA
supplementation during 4 weeks of training, suggesting an
interaction of n-3 PUFA intake with exercise that requires
further study (Gravina et al., 2017). Also, there is a certain
level of interaction of dietary n-3 PUFA intake and the level
of concomitant habitual exercise in healthy adult subjects,
benefiting cardiac autonomic control, measured as heart rate
variability (Harbaugh et al., 2013).
Fish oil-enriched diet might cause changes in some systemic
hemodynamic parameters and cardiac function (e.g., mean
aortic pressure and heart rate) related to stress (moderate
exercise), suggesting increased production of endothelium-
derived relaxing factor (Lortet and Verger, 1995). For example,
rats that were consuming fish oil had decreased vascular
resistance (Demaison et al., 2000). Also, n-3 PUFAs exhibited
several potential anti-arrhythmic effects in animal models (Den
Ruijter et al., 2007). Furthermore, a cross-sectional study in 992
patients with stable coronary artery disease demonstrated that
levels of n-3 PUFAs (DHA + EPA) were strongly associated with
heart rate recovery, exercise capacity, and exercise time. Increased
levels of n-3 PUFAs were also associated with decreased risk of
impaired heart rate recovery and exercise time in these patients
(Moyers et al., 2011).
EFFECTS OF n-3 PUFAs ON THE
SKELETOMUSCULAR SYSTEM IN
HEALTHY PEOPLE
Skeletal muscle is a plastic tissue, sensitive to changes in dietary
lipids, capable of adapting to diet and physical activity, with a
high level of ability to alter its phenotype, depending on prior
nutritional status of the muscle. As the main component of
cellular membranes, n-3 PUFAs participate in enzyme regulation
and act as signaling molecules (Jeromson et al., 2015).
Increased physical activity, such as intense training,
competition situations in elite athletes and rehabilitation
physiotherapy (e.g., in CV patients), is followed by muscle
microtrauma, oxidative stress, inflammation, neutrophilia,
dehydration, lactic acid accumulation, fatigue of central nervous
tissue, nutrient stores catabolism, and soreness. Muscle stem
cells, tissue satellite cells, are important for the process of growth
and recovery of skeletal muscles, reacting to the regeneration
process due to mechanical stress induced by exercise (Hawley
et al., 2014; Tachtsis et al., 2018). Potential consequences of
reducing inflammation after exercise would be faster recovery
time, pain reduction, minimization of post-exercise pain,
facilitation of exercise training in individuals ranging from
patients who are starting exercise programs, medical treatments
(physical therapy, cardiac rehabilitation), or athletes undergoing
heavy conditioning (Hawley et al., 2014; Tachtsis et al., 2018).
Anti-inflammatory effects of n-3 PUFAs could promote muscle
stem cell responsiveness to injury by attenuating systemic
inflammation (Apolinário et al., 2015; Mackey et al., 2016).
Athletes’ diet may contain n-3 PUFAs considering that they
may have an impact on muscle remodeling, muscle recovery,
and immune surveillance; however, a small number of studies
were conducted in elite athletes. Studies in young and middle-
aged (Smith et al., 2011b) or older adults (Smith et al., 2011a)
have demonstrated that 8 weeks of n-3 PUFA supplementation
(1.86 g of EPA and 1.50 g of DHA) increased muscle protein
synthesis rates by sensitizing skeletal muscle to potent anabolic
stimuli, such as amino acids and insulin. This effect of n-3
PUFAs includes direct incorporation of n-3 PUFAs into the
muscle phospholipid membrane (Smith et al., 2011b; McGlory
et al., 2014). Another interesting finding is that n-3 PUFAs
may have an effect on preventing and faster healing of slighter
soft-tissue injuries caused by exercise (Calder, 2012). Direct
incorporation of n-3 PUFAs in the muscle cell membrane
(McGlory et al., 2014) and their ability to modify the structural
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integrity of the cell membrane, together with anti-inflammatory
properties of n-3 PUFAs, indicate a protective role of n-3
PUFAs in reducing the effect of eccentric muscle strain on
muscle damage (Calder, 2012). Several examples confirm that
speculation. Patients with rotator cuff-related shoulder pain
taking 1.53 g EPA and 1.04 g DHA for 8 weeks exhibited
improvements in disability and pain after 3 months (Sandford
et al., 2018). The double-blind study of Lewis and Sandford
has shown significant pain reduction after 32 days of n-
3 PUFA supplementation and administration of antioxidant
pills in recreational athletes with tendinopathies (Lewis and
Sandford, 2009). Moderate beneficial effect of n-3 PUFAs (551 mg
EPA and 551 mg DHA) on muscle soreness with improved
explosive power was observed in elite rugby players (Black et al.,
2018). In healthy elderly women, a diet containing n-3 PUFAs
improved dynamic explosive strength capacity in resistance
training (Edholm et al., 2017). However, not all examples had
positive effects. For example, there was no effect of n-3 PUFAs
on strength, power and speed improvement, although there was
an increment in anaerobic endurance capacity in soccer players
(Gravina et al., 2017).
The effect of EPA and DHA on muscle mass in humans
is limited. While Smith and colleagues reported increment in
muscle protein synthesis after 1.86 g of EPA and 1.5 g of DHA
per day for 8 weeks (Smith et al., 2011b), and increment in tight
muscle mass in a group of elderly persons (Smith et al., 2015),the
same effect was not observed in young athletes. In summary,
positive effects of n-3 PUFAs on muscle mass are demonstrated
in sedentary people, while effects in trained subjects are still
unclear. Improvement in muscle function was also observed
by using electromyography and measuring electrical mechanical
delay in sedentary and trained people (Rodacki et al., 2012;
Lewis et al., 2015). The use of EPA and DHA can have an effect
after training on neuromuscular adaptation by implementing n-
3 PUFAs in muscle and nerve cells (Bourre, 1989), resulting
in improvement of acetylcholine sensitivity and fluidity of
the membrane (Lauritzen et al., 2001; Rodacki et al., 2012;
Da Boit et al., 2017).
Most of the previous studies investigated the effect of n-
3 PUFAs on inflammatory processes and muscle metabolism
during exercise, and only a few evaluated their effect on exercise
performance (Armstrong et al., 1991; Balvers et al., 2010; Jouris
et al., 2011; Mickleborough et al., 2015; Da Boit et al., 2017).
For example, for people starting with new exercise programs in
order to improve tolerance to new and/or stressful exercises, for
those who are performing more intense exercises to reduce pain
and stiffness of the muscles, and thus for greater adaptability
to training and preparation for competition, supplementation of
DHA in diet is justified (Corder et al., 2016).
Data obtained through studies on humans about n-3 PUFA
supplementation and its effects in exercise response are still
inconclusive, possibly due to the differences in definitions
of heterogeneity in study designs; setting, mode, intensity,
and duration of exercise; definition of population; different
types, dosage, and duration of n-3 PUFA supplementation; the
timing of measurements and selections of biomarkers; individual
responsiveness and adherence to exercise and dietary protocols,
and variation in disease substrates (Mickleborough et al., 2015;
Calvo et al., 2017; Da Boit et al., 2017; Kones et al., 2017).




A long-term CV effect of exercise training is a decrease in
heart rate and heart rate variability due to increased vagal tone
(Routledge et al., 2010). Obesity is a known CV risk factor.
Since, it was established that dietary intake enriched with fish oil
containing n-3 PUFAs may extend life expectancy, many theses
about their anti-obesity properties have arisen. Moreover, studies
in animal models consistently report that n-3 PUFAs reduce fat
mass, particularly in the retroperitoneal and epididymal regions.
However, such effects in humans are still under debate. Moreover,
despite the thesis on the anti-obesity effect of n-3 PUFAs, human
studies on this issue did not demonstrate their positive effects
on adiposity and body composition with certainty, but instead
they reported that n-3 PUFAs may not aid weight loss (Albracht-
Schulte et al., 2018). Moreover, completely contradictory results
were brought by a recent study which demonstrated that a
higher n-3/n-6 PUFAs ratio in healthy middle-aged women led
to adiposity (increased waist circumference) and higher levels of
triglycerides, glucose and insulin (Torres-Castillo et al., 2018).
Another study showed that consumption of n-3 PUFAs is not
associated with total body fat and body fat distribution in the
same group of women (Muka et al., 2017). Large meta-analysis
from 2018 on the effect of n-3 PUFAs on primary and secondary
prevention of CV diseases, which included a total of 7100 both
healthy participants and participants with existing illness from 12
trials, reported that increasing n-3 PUFA intake probably causes
slight weight gain (Abdelhamid et al., 2018).
Dietary n-3 PUFA intake combined with lifestyle
modifications (including increase in regular exercise) leads to
improvement of the clinical signs of peripheral vascular disease
(claudication) in these patients (N = 24 male patients). Also,
significant changes in lipid lipoprotein composition, specifically
decreased LDL cholesterol, were observed (Nestares et al.,
2003). In patients with non-ischemic dilated cardiomyopathy
(N = 133, randomized to experimental and placebo group),
intake of n-3 PUFAs at a dose of 2 g/day for 12 months increased
the left ventricular systolic function and cardiac functional
capacity, compared to placebo treatment, which might reduce
hospitalizations for heart failure (Nodari et al., 2011). However,
there is a lack of data on the combined effect of n-3 PUFAS and
exercise on physical performance in CV patients. One may only
speculate that they may have positive additive effects, particularly
in CV patients that develop cachectic conditions.
SUMMARY AND CONCLUSION
This manuscript aimed to provide a comprehensive review
of less studied effects of diet and lifestyle on hemorheology,
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inflammation, and vascular function in healthy persons and
CV patients. Since n-3 PUFA supplements are widely used
in the general population and prescribed to CV patients, the
focus of this review was on n-3 PUFAs effects complementary
or interactive with physical activity. It turned out that the
field is inconsistent, due to a wide spectrum of conducted
studies claiming opposite results (from little or no effect on
CV parameters to beneficial effects on micro and macrovascular
function, inflammation and potentially prevention of thrombosis
and atherosclerosis. Considering that CV and metabolic diseases
have underlying low-grade inflammation at the level of
endothelium, it is of particular interest to evaluate all lifestyle
factors that can affect these conditions. In this sense, n-3 PUFAs
and exercise appear to be good candidates. Major limitations
in analysis were the following: heterogeneous study approach,
including (a) human and animal studies using transgenic mice
or inbred animals subjected to specific challenge; (b) age and
health status of the studied population (obese, suffering of
CV, autoimmune, inflammatory disorders, focus on primary or
secondary prevention of CV events); (c) acute or chronic and
moderate or extreme physical activity; (d) dose, composition,
and duration of n-3 PUFA supplementation. Dietary intake
of n-3 PUFAs is mainly by supplements and very seldom
there are studies on functional (enriched) food involved.
Nevertheless, results suggest that there is an open space for
evaluating the impact of consumption of n-3 PUFAs and exercise
on characteristics of blood composition and hemorheology,
antithrombic effects, and microvascular function. In the field of
functional food in particular, there is a lack of RCT obtained data.
Hence, more translational controlled clinical studies with defined
experimental protocol are necessary for better understanding of
the effects of n-3 PUFA supplementation in health and disease.
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Physical activity is an efficient strategy to delay development of obesity and insulin
resistance, and thus the progression of obesity/diabetes-related cardiomyopathy. In
support of this, experimental studies using animal models of obesity show that
chronic exercise prevents the development of obesity-induced cardiac dysfunction
(cardiomyopathy). Whether exercise also improves the tolerance to ischemia-reperfusion
in these models is less clear, and may depend on the type of exercise procedure as
well as time of initiation. We have previously shown a reduction in ischemic-injury in
diet-induced obese mice, when the exercise was started prior to the development of
cardiac dysfunction in this model. In the present study, we aimed to explore the effect
of exercise on ischemic-tolerance when exercise was initiated after the development
obesity-mediated. Male C57BL/6J mice were fed a high-fat diet (HFD) for 20–22 weeks,
where they were subjected to high-intensity interval training (HIT) during the last
3 weeks of the feeding period. Sedentary HFD fed and chow fed mice served as
controls. Left-ventricular (LV) post-ischemic functional recovery and infarct size were
measured in isolated perfused hearts. We also assessed the effect of 3-week HIT on
mitochondrial function and myocardial oxygen consumption (MVO2). Sedentary HFD
fed mice developed marked obesity and insulin resistance, and demonstrated reduced
post-ischemic cardiac functional recovery and increased infarct size. Three weeks of
HIT did not induce cardiac hypertrophy and only had a mild effect on obesity and
insulin resistance. Despite this, HIT improved post-ischemic LV functional recovery
and reduced infarct size. This increase in ischemic-tolerance was accompanied by an
improved mitochondrial function as well as reduced MVO2. The present study highlights
the beneficial effects of exercise training with regard to improving the ischemic-tolerance
in hearts with cardiomyopathy following obesity and insulin resistance. This study also
emphasizes the exercise-induced improvement of cardiac energetics and mitochondrial
function in obesity/diabetes.
Keywords: obesity, exercise, mice, Langendorff, mitochondria, MVO2, infarct size, functional recovery
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INTRODUCTION
Cardiovascular disease is a major cause of morbidity and
mortality in type 2 diabetic patients (Kannel and McGee,
1979). Obese and diabetic patients are also at risk of
developing a specific cardiomyopathy. The pathogenesis of this
cardiomyopathy is multifactorial and complex, including fibrosis,
inflammation, mitochondrial dysfunction, altered substrate
utilization, oxidative stress and altered Ca2+ handling (Bugger
and Abel, 2014; Jia et al., 2018). An early hallmark is also
elevated myocardial oxygen consumption (MVO2), leading
to cardiac inefficiency (Boudina et al., 2007; Wright et al.,
2009; Cole et al., 2011; Hafstad et al., 2013; Lund et al.,
2015). Diabetes also increases the risk of acute myocardial
infarction as well as death following infarction (Haffner
et al., 1998). In accordance, experimental studies using animal
models of obesity, insulin resistance and/or diabetes generally
show less tolerance to ischemic-reperfusion injury. Although
the pathophysiological mechanisms contributing to ischemic
injury in normal hearts has been subject to a comprehensive
investigation, the underlying mechanisms leading to the higher
ischemic susceptibility in the diabetic heart are not well
known. As increased oxygen consumption will be particularly
disadvantageous under conditions of limited oxygen availability,
there is reason to suggest that the obesity/diabetes-induced
increase in MVO2 contributes to a higher susceptibility to
ischemic-reperfusion injury.
Exercise training is considered a key element in the
management of type 2 diabetes (Colberg et al., 2010; Zanuso
et al., 2010) as well as in the prevention and treatment of
cardiovascular diseases (Myers et al., 2002). In support of this,
experimental studies have shown that chronic exercise not only
reduces obesity and insulin resistance (Zanuso et al., 2010)
but also prevents or ameliorates the development of cardiac
dysfunction (Bidasee et al., 2008; Lu et al., 2017). Accordingly,
we have previously found reduced obesity and insulin resistance,
accompanied by preserved cardiac function and decreased infarct
size after 10 weeks of high-intensity exercise training (HIT)
in mice fed a high-fat diet (HFD) for 18 weeks (Lund et al.,
2015). As the exercise procedure was initiated prior to the
development of cardiac dysfunction, its effect on the heart
could have been due to delayed progression and severity of
obesity/diabetes-related cardiomyopathy. In the present study,
we aimed to explore the cardiac effect of exercise training with
regard to improving ischemic-tolerance in a model with obesity-
mediated cardiomyopathy.
MATERIALS AND METHODS
Animals and Exercise Protocol
C57BL/6J male mice (5–6 weeks) were purchased from Charles
River Laboratories (Germany). Obesity and insulin resistance
were induced by feeding the mice a (HFD 58V8, TestDiet,
United Kingdom, 60% of calories from fat) for 20–22 weeks.
All mice received chow and drinking water ad libitum and
were housed at 23◦C on a reversed light-dark cycle. Due to
the nocturnal nature of mice, all exercise training occurred
during their dark cycle. During the last 3 weeks of the
feeding regime, the mice were assigned to maintain a sedentary
lifestyle (HFDSED) or high-intensity interval training (HFDHIT)
by treadmill running 5 days/week as previously described
(Hafstad et al., 2011, 2013). The exercise protocol consisted
of 10 bouts of 4-min, high-intensity, treadmill running at 25◦
inclination, corresponding to 85–90% of VO2max, interspersed by
2 min active rest (Hafstad et al., 2011, 2013). Aerobic capacity,
determined as VO2max, was assessed before and after the 3–
wk exercise protocol, using a treadmill in a metabolic chamber
(Columbus Instruments, Columbus, OH) (Hafstad et al., 2011).
Blood was collected from the saphenous vein following a 4-h
fasting period. Blood glucose concentration was measured with
a glucometer (FreeStyle Lite, Alameda, CA, United States), and
plasma insulin was analyzed using commercial kits from DRG
Diagnostics (Marburg, Germany). Animal experiments were
approved by the Norwegian National Animal Research Authority
(FDU ID 3698), which conforms to the National Institute of
Health guidelines (NIH publication No. 85-23, revised 1996) and
European Directive 2010/63/EU.
Assessment of Left Ventricular
Susceptibility to Ischemic Injury
Isolated perfused hearts were subjected to ischemia-reperfusion,
and post-ischemic recovery of left ventricular (LV) function was
assessed using an intra-ventricular fluid-filled balloon where a
vent was also inserted into the LV, through the apex. The volume
of the balloon was adjusted to give an end-diastolic pressure of 5–
10 mmHg. The hearts were perfused in a recirculating mode, with
a modified Krebs-Henseleit bicarbonate buffer supplemented
with 5 mM glucose and 0.4 mM palmitate prebound to 3% BSA.
After 20 min stabilization and 25 min global ischemia, post-
ischemic functional recovery was measured over a 60 min period.
Reperfusion was continued for an additional 40 min to allow
for determination of infarcted tissue. At the end of reperfusion,
hearts were frozen at−20◦C, prior to slicing and staining using a
1% 2,3,5-triphenyl-2H-tetrazolium chloride solution. Infarct size
was determined using ImageJ software (National Institutes of
Health, Bethesda, MD, United States). Fiber-optic oxygen probes
(FOXY-AL300; Ocean Optics, Duiven, Netherlands) were used
to assess PO2 in the perfusion buffer above the aortic cannula
and in the pulmonary artery. Coronary flow and the arterial-
venous difference of PO2 was used to determine myocardial
oxygen consumption (MVO2) as previously described (Lund
et al., 2015; Boardman et al., 2017). In order to assess a work-
independent (unloaded) MVO2, the hearts were subjected to
an unloaded perfusion condition to minimize the workload
(Boardman et al., 2009).
Mitochondrial Respiration
Cardiac mitochondria were isolated from hearts harvested prior
to the ischemic insult. Briefly, tissue from the left ventricle
was homogenized and trypsinized (5 mg/mL) in isolation buffer
(250 mM sucrose, 0.5 mM EDTA, 10 mM Tris; pH 7.4).
After a further homogenization, and differential centrifugation,
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mitochondrial pellets were suspended in respiration buffer
containing 0.5 mM EGTA, 3 mM MgCl2, 60 mM K-lactobionate,
20 mM taurine, 10 mM KH2PO4, 20 mM HEPES, 110 mM
sucrose, 1 g/L BSA, 280 U/mL catalase, 20 mM histidine,
20 µM vitamin E succinate, 3 mM glutathione, 1 µM leupeptin,
2 mM glutamate, 2 mM malate, and 2 mM ATP; pH 7.1.
Mitochondria were kept on ice for 1 h prior to mitochondrial
respiration experiments. Oxygen consumption was measured
using an oxygraph (O2-k, Oroboros Instruments, Austria), where
pyruvate (5 mM) and malate (2 mM) or palmitoyl-CoA (25 µM),
L-carnitine (5 mM), and malate (2 mM) served as substrates. V0
was defined as the respiration in the presence of substrates before
ADP was added. An oxidative phosphorylation state (Vmax) was
defined as the respiration peak after adding 100 µmol/L ADP.
Respiration rates were adjusted to protein content (Bradford
Protein Assay Kit). The respiratory coupling ratio (RCR) was
calculated as Vmax/V0.
Statistical Analysis
All data are presented as mean ± standard error of means.
Numbers of observations are presented as “n.” Differences
between three groups were analyzed using one-way ANOVA with
multiple comparisons (Holm-Sidak method as post hoc test).
Where the normality test failed (Shapiro–Wilk test), a Mann–
Whitney rank-sum test was performed.
RESULTS
The Effect of HFD and 3-Week HIT on
Obesity, Insulin Resistance and Aerobic
Capacity
Sedentary mice fed an obesogenic diet for 20–22 weeks (HFDSED)
developed obesity as indicated by elevated bodyweight and
perirenal fat mass when compared to chow fed control (CON)
mice (Table 1). Diet-induced obesity was accompanied by a
marked insulin resistance (HOMA-IR), as well as reduced aerobic
capacity (VO2max).
As expected, subjecting obese mice to 3-week HIT (HFDHIT)
resulted in increased aerobic capacity and a small but significant
lowering of body weight and perirenal fat mass (Table 1). HIT
also reduced insulin resistance (HOMA-IR), mainly due to a
reduction in circulating insulin levels. It should be noted that
3-week of HIT did not induce cardiac hypertrophy, which was
supported by unaltered gene expression of hypertrophic markers
(data not shown).
The Effect of HFD and 3-Week HIT on
Post-ischemic Functional Recovery and
Infarct Size
Previous reports from our group, have demonstrated delayed LV
relaxation (increased Tau), increased end-diastolic pressure and
an elevated end-diastolic pressure-volume relationship (Pedersen
et al., 2018) in this mouse model following LV pressure-volume
analysis. In the present study, intraventricular pressure was
measured using a fluid-filled balloon in Langendorff perfused
hearts (Table 2). However, this perfusion mode does not allow
for the reliable determination of diastolic function (Pedersen
et al., 2018). Although this represents a clear limitation of
the present study, it should be noted that we have, in this
model, repeatedly documented a diastolic dysfunction at identical
age/feeding duration that is relevant for this study (18–20 week
on obesogenic diets).
The Langendorff perfusion mode is well suited to examine
changes in tolerance to ischemia-reperfusion. Functional
recovery was followed during the first 60 min of reperfusion
after a period of global ischemia. Hearts from HFDSED mice
showed impaired recovery of the rate-pressure-product (RPP,
given as % of the pre-ischemic value) when compared to
hearts from CON mice (Figure 1). As heart rate was not
TABLE 1 | Animal characteristics of control mice (CON) and HFD-fed obese mice
subjected to 3 weeks of high-intensity (HFDHIT) exercise training or a sedentary
(HFDSED) lifestyle.
CON HFDSED HFDHIT
N 20 20 13
Body weight (g) 31.5 ± 0.6∗ 47.6 ± 0.7 43.2 ± 1.2∗
Tibia length (mm) 18.2 ± 0.1 18.2 ± 0.1 18.2 ± 0.1
Perirenal fat mass (g) 0.3 ± 0.1∗ 1.5 ± 0.1 1.3 ± 0.1∗
Blood glucose fasted (mmol/L) 6.3 ± 0.3 7.5 ± 0.2 6.0 ± 0.2∗
Plasma insulin fasted (µg/L) 0.8 ± 0.3∗ 3.2 ± 0.3 2.3 ± 0.4
HOMA-IR 5.5 ± 0.1∗ 26.6 ± 2.6 15.2 ± 2.6∗
VO2max (mL/min/kg) 48.8 ± 0.7∗ 43.2 ± 0.5 47.4 ± 0.3∗
Heart weight (mg wwt) 143 ± 4 150 ± 3 148 ± 3
Heart weight/tibia length 7.81 ± 0.32 8.12 ± 0.25 8.26 ± 0.17
Data are means ± SE. Aerobic capacity (VO2max) was measured in 10 and
8 animals, respectively. Homeostatic model assessment of insulin resistance;
HOMA-IR. ∗p < 0.05 vs. HFDSED.
TABLE 2 | Steady-state parameters of LV function obtained in isolated
Langendorff perfused hearts from control mice (CON) and HFD-fed obese mice
subjected to 3 weeks of high-intensity exercise training (HFDHIT) or a sedentary
lifestyle (HFDSED).
CON HFDSED HFDHIT
N 13 16 16
Coronary flow (mL/min) 3.2 ± 0.1 3.7 ± 0.2 3.6 ± 0.2
Heart rate (bpm) 315 ± 10 307 ± 9 293 ± 9
LV max-systolic pressure
(mmHg)
137 ± 8 151 ± 10 168 ± 12
LV end-diastolic pressure
(mmHg)
9.4 ± 0.7 9.9 ± 0.9 10.2 ± 0.5
LV developed pressure
(mmHg)
128 ± 8 141 ± 11 158 ± 11
dP/dtmax (mmHg/sec) 4624 ± 384 5603 ± 407 6559 ± 376
dP/dtmin (mmHg/sec) −3394 ± 177 −3818 ± 281 −4339 ± 203
RPP (mmHg∗bpm) 40163 ± 2536 43218 ± 3430 45850 ± 2929
Data are means± SE. These data include left ventricular (LV) functional assessment
in hearts subjected to ischemia reperfusion (included in Figure 1) and hearts
used for isolation of mitochondria (included in Figure 3). dP/dtmax and dP/dtmin;
maximum positive and negative first-time derivative of LV pressure. RPP; rate-
pressure-product (developed pressure × heart rate). End-diastolic pressure was
adjusted to be between 5 and 10 mmHg. ∗p < 0.05 vs. HFDSED.
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FIGURE 1 | Rate-pressure product (RPP), LV developed pressure (LVDP), and the maximum and minimum of the pressure derivative (dP/dtmax, dP/dtmin) in isolated
perfused hearts from control mice (CON, n = 8) and HFD fed mice subjected to a sedentary lifestyle (HFDSED, n = 10) or to 3 weeks of high-intensity exercise training
(HFDHIT, n = 6). Bars indicate the calculated post-ischemic recovery (% of pre-ischemic values) of these parameters. Data are means ± SE. ∗p < 0.05 vs. HFDSED.
different between the groups, the reduced recovery of RPP
was primarily due to the reduced recovery of LV developed
pressure (Figure 1). Likewise, we also found a significantly
impaired recovery of both the maximum and minimum of
the pressure derivative (dP/dtmax and dP/dtmin) indicating
increased post-ischemic stunning in HFDSED hearts (Figure 1).
Three weeks of exercise training was found to significantly
improve functional recovery not only of RPP, but also
LV developed pressure, as well as dP/dtmax and dP/dtmin
(Figure 1). HR was not altered by exercise, which emphasized
that exercise increased LV contraction by improving both
contractility and relaxation.
Impaired functional recovery of post-ischemic function in
HFDSED hearts was accompanied by increased infarct size when
compared to CON (Figure 2). In addition, 3-week HIT was found
to reduce ischemia-reperfusion induced cell death (i.e., infarct
size) in hearts from HFD mice.
The Effect of HFD and 3-Week HIT on
MVO2 and Mitochondrial Respiration
This study confirmed that HFDSED hearts demonstrate higher
oxygen consumption (MVO2) compared to CON hearts
when perfused in an unloaded state (Lund et al., 2015).
Further, we examined mitochondrial respiration in isolated
mitochondria from hearts perfused for 30 min, but not
subjected to ischemia-reperfusion. The ADP-dependent
oxidative phosphorylation state (Vmax) in mitochondria
from HFDSED hearts was reduced when compared to CON
hearts, both when using pyruvate as well as palmitoyl-CoA
as respiratory substrates (Figure 3). As ADP-independent
respiration (V0) was also lower in these hearts, the rate-
dependent RCR remained the same in CON and HFDSED
FIGURE 2 | Unloaded MVO2 and infarct size was measured in isolated
perfused hearts from control mice (CON, n = 8) and HFD fed mice subjected
to a sedentary lifestyle (HFDSED, n = 10) or 3 weeks of high-intensity exercise
training (HFDHIT, n = 6). The unloaded MVO2 was obtained by deflating the
balloon in the LV for a short period during baseline conditions and pacing the
hearts at 7 Hz. Data are means ± SE. ∗p < 0.05 vs. HFDSED.
(pyruvate: 5.7 ± 0.3 and 5.6 ± 0.3, palmitoyl-CoA: 5.3 ± 0.1 and
5.2± 0.2, respectively).
We have previously demonstrated that 10 weeks HIT reduced
unloaded MVO2 (Lund et al., 2015). The present study shows
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FIGURE 3 | Respiration in isolated mitochondria (nmol O2/min/mg protein)
from hearts of control mice (CON, n = 5) mice and HFD-fed obese mice
subjected to a sedentary lifestyle (HFDSED, n = 7) or 3 weeks of high-intensity
exercise training (HFDHIT, n = 7). The respiratory medium contained pyruvate
(5 mM) and malate (2 mM) (A,B) or palmitoyl-CoA (25 µM), L-carnitine (5 mM)
and malate (2 mM). V0 respiration, the respiratory state before ADP is added.
Vmax, the respiration peak after adding 100 µmol/L ADP. Data are
means ± SE. ∗p < 0.05 vs. HFDSED.
that 3 weeks of HIT was sufficient to induce this effect (Figure 2).
In isolated cardiac mitochondria, 3-week HIT was also shown to
increase oxidative phosphorylation (Vmax) under both substrate
conditions (Figure 3). Interestingly, exercise also significantly
increased V0, indicating an exercise-mediated induction of a
mitochondrial proton-leak. Due to a concomitant increase in
both the ADP-dependent and -independent O2 consumption,
we did not find exercise to alter RCR (pyruvate: 5.1 ± 0.3,
palmitoyl-CoA: 4.9 ± 0.2). Finally, although 10 weeks of
HIT was previously shown to increase CS activity in cardiac
tissue in normal hearts (Hafstad et al., 2013), 3-week HIT
was not sufficient to alter CS activity in cardiac tissue from
HFD mice (10.6 ± 1.0 vs. 12.3 ± 0.4 IU/g wwt, HFDSED vs.
HFDHIT, respectively).
DISCUSSION
We have previously shown in diet-induced obese mice, that
exercise training initiated prior to changes in cardiac function,
prevented the subsequent development of dysfunction (Hafstad
et al., 2013; Lund et al., 2015) as well as exacerbated infarction
(Lund et al., 2015). As this effect could have been due to delayed
progression of the cardiomyopathy (because of reduced obesity
and insulin resistance), we have now explored the effect of
exercise on cardiac ischemic-tolerance in mice with obesity-
mediated cardiomyopathy. We found that a shorter duration of
exercise, initiated at the end of the feeding protocol, improved
ischemic-tolerance, despite having only mild effects on co-
morbidities. We also found that this effect was associated with an
exercise-mediated reduction in myocardial oxygen consumption
(MVO2) and improved cardiac mitochondrial respiration.
In accordance with previous studies (Lund et al., 2015;
Pedersen et al., 2018), feeding C57BL/6J mice an HFD for
more than 18 weeks led to obesity, insulin resistance and low
aerobic capacity (VO2max). These mice also develop impaired LV
function, primarily manifested as a diastolic dysfunction (Lund
et al., 2015; Pedersen et al., 2018). A hallmark of obesity/diabetes
related cardiomyopathy is mechanical inefficiency (i.e., the
ratio between cardiac work and MVO2) (Cole et al., 2011;
Hafstad et al., 2013; Lund et al., 2015). Cardiac inefficiency occurs
prior to development of dysfunction (Wright et al., 2009; Hafstad
et al., 2013), and is due to a higher oxygen cost for non-
mechanical processes (Hafstad et al., 2013; Lund et al., 2015).
Accordingly, in the present study, hearts from the sedentary
HFD fed mice, showed a higher unloaded MVO2. As a high
O2 consumption is particularly detrimental under conditions
of limited O2 availability, this O2 wasting can contribute to
render these hearts more susceptible to an ischemic-injury.
In support of this, the present study, as well as a range of
other studies (Yi et al., 2011; Pons et al., 2013; Littlejohns
et al., 2014; Lund et al., 2015), have reported a decreased
tolerance to myocardial ischemia-reperfusion in models of
obesity/diabetes.
Chronic exercise training improves obesity and insulin
resistance (Colberg et al., 2010; Qiu et al., 2014), and may thus
delay or ameliorate the severity of diabetic cardiomyopathy.
In accordance, experimental studies from our lab have
demonstrated that 10 weeks of exercise training of diet-
induced obese mice delayed the progression of obesity,
reduced insulin resistance (Hafstad et al., 2013; Lund
et al., 2015), prevented the development of LV dysfunction
(Hafstad et al., 2013; Lund et al., 2015) and decreased
cardiac susceptibility to ischemic-injury (Lund et al., 2015).
Notably, in these studies, exercise was started prior to the
development of dysfunction (i.e., halfway through the 18-
week feeding protocol). The cardiac effects could therefore
be due to a postponed development of cardiomyopathy. In
the present study, we wanted to examine the effect of shorter
exercise period, which did not prevent the development of
cardiomyopathy. Therefore, mice were fed HFD for 20–
22 weeks, and subjected to HIT during the final 3 weeks of
the feeding period.
Compared to the longer exercise protocol (10-week HIT)
(Lund et al., 2015), the systemic effects of 3-week HIT were, as
expected, less marked. Accordingly, while 10-week HIT reduced
perirenal fat by approximately 36–44% (Lund et al., 2015;
Boardman et al., 2017), the corresponding reduction by 3-week
HIT was only 11%. Similarly, 3-week HIT also resulted in a
lesser decrease in HOMA (30 vs. 60%), and a smaller increase in
VO2max (7 vs. 20%). Finally, in contrast to 10-week, 3-week HIT
was not sufficient to develop cardiac hypertrophy.
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We have assessed ischemic susceptibility in hearts perfused
in Langendorff perfusion mode with an intraventricular
balloon. As this perfusion mode cannot detect changes
in diastolic function in mouse hearts (Lund et al., 2015;
Pedersen et al., 2018), the present study could not
confirm the diastolic dysfunction that has been shown
to develop in this model (Lund et al., 2015; Pedersen
et al., 2018). Nor can the present study determine whether
or not 3-week HIT ameliorated LV diastolic dysfunction.
This study, however, clearly demonstrated that 3-week
HIT improved post-ischemic functional recovery as well
as reduced infarct size. Thus, despite a less marked
modification of the associated co-morbidities, these hearts
show improved ischemic-tolerance. This is also supported
by Pons et al. (2013), who demonstrated that 4 weeks of
exercise in ob/ob mice, reduced infarct size without altering
hyperglycemia, hypercholesterolemia, hyperinsulinemia, fat
mass or body weight.
While the mechanisms leading to exercise-induced
cardioprotection in normal hearts have been widely studied,
fewer studies have examined this in models of insulin resistance
and/or type 2 diabetes. The present study supports that
exercise can decrease myocardial O2 wasting found in diabetic
cardiomyopathy. The increased O2-consumption and decreased
efficiency are an early and consistent finding in these hearts
(Wright et al., 2009; Hafstad et al., 2013). Although the
mechanisms for O2 wasting are not fully understood, several
of the reported pathophysiological changes in these hearts
can impair mechanoenergetics, by altering ATP production
and/or utilization. These changes include elevated fatty acid
supply and/or utilization (Belke et al., 2000; Aasum et al.,
2003), structural remodeling (i.e., myocardial stiffness) (How
et al., 2006), impaired mitochondrial function and oxidative
stress (Fauconnier et al., 2007; Anderson et al., 2009), as
well as altered Ca2+ handling (Stolen et al., 2009; Epp
et al., 2013). Importantly, several of these processes, can
also be altered by exercise training (Hafstad et al., 2015).
As a major part of the work-independent O2 consumption
is linked to maintainance of Ca2+ homeostasis, exercise-
mediated effects on myocardial Ca2+ transport (Stolen et al.,
2009; Epp et al., 2013) can lead to decreased MVO2 (Hafstad
et al., 2013). Exercise can also reduce oxidative stress [by
increasing antioxidant capacity (Muthusamy et al., 2012)],
and improve the redox state (Fisher-Wellman et al., 2013).
As we found an exercise-induced mitochondrial proton
leak [in the present study, and previously (Hafstad et al.,
2013)], it could be suggested that obesity-mediated redox
modification of the Ca2+ handling proteins is prevented
by exercise due to leak-induced decrease in mitochondrial
membrane potential.
CONCLUSION
The present study highlights the beneficial effects of exercise
training with regard to improving the ischemic-tolerance in
hearts with obesity-induced cardiomyopathy. This study also
emphasizes exercise-induced improvement of cardiac energetics
and mitochondrial function.
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Background: The correlation between echocardiographic parameters and
hemodynamics data in patients with heart failure with preserved ejection fraction
(HFpEF) is unclear. It is important to find a non-invasive echocardiographic parameter
for predicting exercise pulmonary capillary wedge pressure (PCWP).
Aim: This study sought to determine the correlation between echocardiographic
parameters and hemodynamics data at rest and during exercise in HFpEF patients.
Methods and Results: This study was a cross-sectional cohort exploratory analysis
of baseline data from the ILO-HOPE trial. A total of 34 HFpEF patients were enrolled.
The average age was 70 ± 12 years, and most (74%) were women. The patients
underwent invasive cardiac catheterization and expired gas analysis at rest and during
exercise. Echocardiography including tissue Doppler imaging was performed, and
global longitudinal strain and other novel diastolic function indexes were analyzed at rest
and during exercise. At rest, no significant correlation was noted between resting PCWP
and echocardiographic parameters. However, a significant correlation was observed
between post-exercise PCWP and stress E/e′ (septal, lateral, and mean) ratio (p = 0.003,
0.031, 0.012). Moreover, post-exercise 1PCWP showed a good correlation with stress
E/e′ (septal, lateral, and mean; all p ≤ 0.001) and global longitudinal strain (GLS) during
exercise (p = 0.03). After multivariate regression analysis with adjustment for possible
confounding factors including age and sex, there was still a significant correlation
between post-exercise 1PCWP and E/e′ (r = 0.62, p < 0.001 for E/e′mean).
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Conclusion: Only stress echocardiography derived tissue Doppler E/e′ ratio is closely
correlated with abnormal exercise hemodynamics (PCWP and post-exercise 1PCWP)
in HFpEF. This echocardiographic marker is substantially more sensitive than other novel
echocardiographic parameters during exercise, and may have significant diagnostic
utility for ambulatory HFpEF patients with dyspnea.
Clinical Trial Registration: https://www.clinicaltrials.gov, identifier NCT03620526.
Keywords: HFpEF, stress Doppler echocardiography, hemodynamics, GLS, tissue Doppler and strain
echocardiography
INTRODUCTION
Heart failure with preserved ejection fraction (HFpEF) is
diagnosed using three criteria: signs and symptoms of heart
failure, left ventricular (LV) ejection fraction (LVEF) > 50%,
and objective evidence of diastolic dysfunction including elevated
levels of natriuretic peptide and echocardiographically relevant
structural heart disease or abnormal diastolic parameters
(Ponikowski et al., 2016). The prevalence of HFpEF is
higher than that of heart failure with reduced ejection
fraction (HFrEF), and increases significantly with age. HFpEF
accounts for 50% of heart failure cases in the community
(Dunlay et al., 2017). Physiologically, heart failure can be
defined as an imbalance between the cardiac output and
metabolic demands, which generally results in increased LV
filling pressure (LVFP). However, the diagnosis of HFpEF
is sometimes difficult owing to non-specific symptoms, non-
significantly elevated natriuretic peptide, and the absence of
diastolic dysfunction on resting Doppler echocardiography
(Nagueh Sherif et al., 2017). Invasive cardiac catheterization
for direct hemodynamic measurements can help solve the
problem: elevation of the mean pulmonary capillary wedge
pressure (PCWP) could be the evidence of HFpEF (Paulus
et al., 2007). Further, patients with suspected early HFpEF
with normal LVFP at rest can demonstrate a steep increase
in PCWP during exercise in hemodynamic stress testing. The
response in a stress hemodynamics study indicates whether
the symptoms are of cardiac origin (Kitzman et al., 1991;
Maeder et al., 2010).
Although a hemodynamics study through cardiac
catheterization remains the gold standard, it is impractical
to perform invasive assessments on every patient suspected
to have HFpEF, especially during exercise. Previously,
the most commonly measured parameter for estimating
LVFP was the ratio of early mitral inflow velocity to early
diastolic tissue velocity (E/e′). However, only a few studies
have evaluated the correlation between exercise E/e′ and
invasively measured LVFP. Burgess et al. (2006) found a
correlation between E/e′ and LVFP during exercise. Talreja
et al. (2007) also found that exercise E/e′ was associated with
increased PCWP (> 20 mmHg). Moreover, an abnormal
response was defined as exercise E/e′ > 15 on Doppler stress
echocardiography based on further outcome studies (Holland
et al., 2010; Shim et al., 2011). However, some recent studies
suggested that E/e′ does not reflect the LVFP increase during
exercise (Maeder et al., 2010; Choi et al., 2016). Therefore,
whether non-invasive measurement of E/e′ with stress Doppler
echocardiography can represent increased LVFP remains unclear.
In this study, we analyzed all patients from the ILO-HOPE trial
to determine the relationship between echocardiographic
parameters, including traditional tissue Doppler and novel strain
parameters, and hemodynamics data at rest and during exercise.
We aimed to find applicable echocardiographic parameters
to predict abnormal exercise hemodynamics and validate
the role of stress echocardiography, which may refine the
diagnosis of early HFpEF.
MATERIALS AND METHODS
Study Participants and Study Design
The study is a subgroup analysis of ILO-HOPE trial to
determine the association between echocardiographic
parameters and hemodynamics data. ILO-HOPE is a
prospective, randomized, double-blind, placebo-controlled
trial conducted to evaluate the efficacy of iloprost inhalation
in improving exercise hemodynamics in HFpEF patients.
However, we performed the analysis before iloprost inhalation
to avoid the interference. All the patients were enrolled from
cardiovascular outpatient clinics with high suspicion for
HFpEF. According to the 2016 European Society of Cardiology
heart failure guidelines, the American Heart Association,
and our previous studies (Wu et al., 2010, 2011, 2015, 2017;
Ponikowski et al., 2016), HFpEF is diagnosed according
to the following criteria: (i) presence of typical symptoms
and signs of heart failure, (ii) LVEF > 50%, (iii) elevated
N-terminal pro-B-type natriuretic peptide (NT-proBNP)
level (at least > 125 pg/mL), and (iv) echocardiographic
structural [left atrial volume index > 34 mL/m2 or LV
mass index ≥ 115 g/m2 (men) and ≥ 95 g/m2 (women)]
or functional [E/e′ ≥ 13 and mean e′ (septal and lateral
wall) < 9 cm/s] changes. After confirming the diagnosis of
HFpEF, subjects were hospitalized for cardiac catheterization
(left heart for coronary artery evaluation and right heart for
hemodynamics data acquisition) and subsequent standardized
exercise protocol. Informed consent was obtained before
enrolling in the clinical trial. Patients with chronic renal failure
(creatinine > 250 µmol/L), significant liver disease, significant
coronary artery disease (coronary artery stenosis ≥ 70%
without intervention, or a positive stress test), secondary
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hypertension, pericardial disease, significant valvular heart
disease (> mild stenosis, > moderate regurgitation), cancer,
cor pulmonale, congenital heart disease, left-to-right shunt,
myocardial infarction within 60 days, high-output heart failure,
long-term use of phosphodiesterase 5 inhibitors, or chronic atrial
fibrillation were excluded.
In this subgroup analysis, we evaluated the correlation
between echocardiographic parameters and hemodynamics data
in different phase first (at rest and during exercise). We also
performed correlation study between resting echocardiographic
parameters and exercising hemodynamics in order to determine
whether resting echocardiography can predict hemodynamic
response during exercise.
Standardized Exercise Protocol and
Hemodynamics Data Acquisition
Cardiac catheterization for hemodynamics recording with
simultaneous expired gas analysis was performed at rest and
during supine exercise at a 20-W constant workload for 6 min
on an electromagnetic braked cycle ergometer (Ergometrics
ER800; Ergoline GmbH, Bitz, Germany), as previously described
(Borlaug et al., 2015). Arterial and venous blood samples were
obtained, and hemodynamic and expired gas data were acquired
at rest and during exercise. Right heart catheterization through
the right internal jugular vein was performed. The pressure
kit transducers were zeroed at mid-axilla. Right atrial pressure,
pulmonary artery (PA) pressure, and PCWP were recorded
at end-expiration phase by using a 7-Fr Swan-Ganz catheter
and high-fidelity micromanometer-tipped catheters (Biosensors
International, Singapore) advanced through the lumen of a
7-Fr sheath (Terumo, Tokyo, Japan) in the right internal
jugular vein. The mean right atrial pressure and PCWP were
measured at mid A-wave. Arterial blood pressure (BP) was
continuously measured using a 6-Fr catheter (Terumo) through
the radial artery.
Oxygen uptake (VO2) data were obtained from expired
gas analysis with a computerized breath-by-breath metabolic
system (MetaMax 3B; Cortex Biophysik GmbH, Germany)
and averaged from the 60 s preceding arterial and mixed
venous blood sampling (Talreja et al., 2007). Ventilatory
efficiency was checked using the ventilatory equivalent for carbon
dioxide (VE/VCO2).
CO and stroke volume were calculated using the direct
Fick method and heart rate data. Pulmonary vascular
resistance (PVR), PA compliance (stroke volume/PA pulse
pressure), and systemic vascular resistance were also obtained
using standard formulas. LV systolic performance was
assessed according to LV stroke work calculated using the
standard formula.
Two-Dimensional and Tissue Doppler
Echocardiography
An echocardiographic ultrasound system (IE33; Philips,
Andover, MA, United States) was used for echocardiographic
examinations at rest and during exercise. Transthoracic
echocardiographic images were acquired in the fundamental
imaging mode. Each patient also underwent two-dimensional
imaging, Doppler echocardiography, and tissue Doppler
ultrasonography. LV dimensions and LVEF (M-mode)
were measured in the parasternal long-axis view at rest
according to the American Society of Echocardiography
guidelines (Lang et al., 2005). Left atrial volume index
was measured using the biplane area-length method (Lang
et al., 2015). Early (E) and late (A) diastolic transmitral
velocities and deceleration time were obtained using Doppler
echocardiography at rest and during exercise. Peak early
diastolic annular velocity was also measured at the septal
(e′septal) and lateral (e′lateral) mitral annulus on tissue Doppler
echocardiography at rest and during exercise. With respect
to right heart function, the tricuspid regurgitation peak
gradient, tricuspid annular plane systolic excursion (M-
mode), and tricuspid annular systolic velocity were measured
using echocardiography.
Speckle Tracking
Echocardiographic images were analyzed offline with
commercially available software (QLAB Software version
10, Cardiac Motion/Mechanics Quantification; Philips) for
speckle tracking. The endocardium border was automatically
detected after manually defining the points of the LV basal
myocardium and LV apex. Manual adjustment was done
if needed. Systolic global longitudinal strain (GLS) was
calculated from the magnitude of peak longitudinal strain of
17 ventricular segments (acquired from apical four-chamber,
three-chamber, and two-chamber views) according to the
American Society of Echocardiography/European Association of
Echocardiography consensus statement (Mor-Avi et al., 2011).
During offline strain analysis, 10 patients were excluded due
to inadequate image acquisition, especially during exercise. All
strain analysis was conducted by two experienced cardiologists
(Z-WC and C-YH) who were familiar with strain analysis.
Intraobserver and interobserver reproducibility was evaluated
in 15 randomly selected subjects. The coefficients of variation
for GLS were 3.1 and 5.5% for intraobserver and interobserver
reproducibility, respectively.
Statistical Analysis
The results are expressed as mean ± standard deviation or n
(%). Within-group differences of echocardiographic parameters
and hemodynamics data between rest and exercise were assessed
using paired Student’s t-test. Pearson’s correlation tests were
performed to determine correlations between PCWP and
echocardiographic parameters at rest and during exercise. The
correlation between PCWP and NT-proBNP level was non-
parametrically analyzed by Spearman’s correlation test. The
change of PCWP from the rest to exercise state was recorded
as 1PCWP. The correlation between 1PCWP and stress
echocardiographic parameters was also checked. Significant
determinants found in the Pearson’s correlation test (p ≤ 0.05)
were then examined using multivariate linear regression with
adjustment for age and sex. All statistical analyses were
performed using SPSS for Windows version 25.0 (SPSS Inc.,
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Chicago, IL, United States). A value of p ≤ 0.05 was considered
statistically significant.
RESULTS
Thirty-four patients were enrolled in ILO-HOPE trial between
January and August 2018. The baseline characteristics, including
age, sex, body mass index, comorbidities, medications, and
laboratory values, are summarized in Table 1. The average
age was 70 ± 12 years, and 74% were women. Concerning
comorbidities, 24 (71%) patients had hypertension, six (18%) had
coronary artery disease, and 13 (38%) had diabetes. The median
NT-proBNP level was 242 pg/mL.
Echocardiographic Parameters at Rest
and During Exercise
Echocardiographic parameters measured at rest and during
exercise are listed in Table 2A. The subjects had significantly
higher mitral E velocity, higher mitral A velocity, shorter
deceleration time, higher peak early diastolic annular velocity
(septal or lateral mitral annulus), and higher E/e′ ratio
during exercise than at rest. The mitral E/A ratio showed no
significant difference between rest and exercise. From the strain
echocardiography analysis, higher GLS magnitude and higher
early diastolic strain rate (SRe) were noted in the exercise stage.
In right-heart-related parameters, higher tricuspid regurgitation
peak gradient and tricuspid annular systolic velocity were
detected during exercise. The tricuspid annular plane systolic
excursion was similar between the exercise and rest stages.
TABLE 1 | Baseline characteristics of HFpEF patients.
HFpEF (N = 34)
Age, years 70 ± 12
Women (%) 25 (74)
Body mass index, kg/m2 26.1 ± 4.5
Comorbidities
Coronary disease (%) 6 (18)
Hypertension (%) 24 (71)
Diabetes (%) 13 (38)
Medications
ACEI or ARB (%) 19 (56)
Beta-blocker (%) 22 (65)
CCB (%) 11 (32)
Statin (%) 10 (29)
Diuretic (%) 15 (44)
Nitrate (%) 4 (12)
Laboratory values
Hemoglobin, g/dL 12.4 ± 1.5
Creatinine, mg/dL 1.0 ± 0.7
NT-proBNP, pg/mL 242 (195)
Values are mean ± standard deviation, median (interquartile range), or n (%).
ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor
blocker; CCB = calcium channel blocker; NT-proBNP = N-terminal pro-B-type
natriuretic peptide.
TABLE 2A | Rest and stress echocardiographic parameters in HFpEF patients
(N = 34).
Rest Stress p-value
LVEDD, mm 47.00 ± 4.47
LV ejection fraction, % 68.29 ± 7.83
Left atrial volume index, mL/m2 34.15 ± 8.65
Mitral E velocity, cm/s 85.64 ± 22.97 108.99 ± 31.35 < 0.001
Mitral A velocity, cm/s 89.96 ± 24.45 100.29 ± 28.51 < 0.001
Mitral E/A ratio 1.04 ± 0.57 1.18 ± 0.59 0.143
Deceleration time, ms 190.00 ± 49.48 140.29 ± 33.62 0.006
Tissue Doppler echocardiography
e′septal, cm/s 6.68 ± 2.03 7.90 ± 2.57 < 0.001
e′ lateral, cm/s 8.73 ± 2.55 9.80 ± 2.66 < 0.001
e′mean, cm/s 7.70 ± 2.18 8.85 ± 2.39 < 0.001
E/e′septal 13.40 ± 3.79 14.85 ± 6.31 < 0.001
E/e′ lateral 10.09 ± 2.41 12.52 ± 7.97 0.011
E/e′mean 11.44 ± 2.77 13.37 ± 6.88 0.001
Strain echocardiography
GLS,% −17.33 ± 1.97 −18.39 ± 2.39 0.009
AP2 L. strain,% −17.70 ± 1.98 −18.77 ± 2.88 0.038
AP3 L. strain,% −17.23 ± 2.75 −17.88 ± 2.73 0.248
AP4 L. strain,% −17.53 ± 2.25 −18.50 ± 2.16 0.002
SRIVR, 1/s 0.28 ± 0.11 0.30 ± 0.10 0.396
E/SRIVR, cm 335.76 ± 127.33 384.91 ± 158.59 0.194
SRe, 1/s 0.77 ± 0.18 0.98 ± 0.22 < 0.001
E/SRe, cm 111.68 ± 30.45 113.47 ± 42.54 0.779
Right heart function parameters
TRPG, mmHg 27.17 ± 9.18 41.83 ± 10.84 < 0.001
TAPSE, cm 2.29 ± 0.45 2.76 ± 1.99 0.281
TAS′, cm/s 13.18 ± 2.92 14.80 ± 4.46 < 0.001
Values are mean ± standard deviation. LVEDD = left ventricular end diastolic
dimension; mitral E/A ratio = ratio of peak early (E) to peak late (A)
diastolic transmitral velocities; e′septal/lateral/mean = peak early diastolic
annular velocity measured at the septal/lateral mitral annulus and their mean;
E/e′septal/lateral/mean = ratio of E to e′septal/lateral/mean; GLS = global
longitudinal strain; AP2/AP3/AP4 L. strain = longitudinal strain in apical
two-chamber/three-chamber/four-chamber view; SRIVR = strain rate during
isovolumetric relaxation; E/SRIVR = ratio of E to SRIVR; SRe = early diastolic strain
rate; E/SRe = ratio of E to SRe; TRPG = tricuspid regurgitation peak gradient;
TAPSE = tricuspid annular plane systolic excursion; TAS′ = tricuspid annular systolic
velocity. The bold font character means statistically significance (p < 0.05).
Hemodynamics Data at Rest and During
Exercise
Resting and exercise hemodynamic changes were recorded
(Table 2B). At rest, the subjects had elevated BP (systolic
BP = 170 ± 23 mmHg, mean BP = 108 ± 13 mmHg),
elevated PCWP (18 ± 7 mmHg), mildly increased
PVR (1.02 ± 0.94 mmHg/L/min), and normal CO
(5.3 ± 2.2 L/min). During exercise, all subjects had
significantly increased heart rate, BP, PA pressure, PCWP,
LV stroke work, and cardiac output. Concerning metabolic
factors, both VO2 and CaO2–CvO2 significantly increased
during exercise. However, PVR and PA compliance
presented a downtrend after exercise but without
statistical significance.
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TABLE 2B | Baseline and exercise hemodynamics in HFpEF patients (N = 34).
Rest 20-W exercise
Vital signs
Heart rate, beats/min 69 ± 10 102 ± 23†
Systolic BP, mmHg 170 ± 23 185 ± 45‡
Diastolic BP, mmHg 77 ± 12 81 ± 13‡
Mean BP, mmHg 108 ± 13 118 ± 16†
Central pressures
RA, mmHg 9 ± 4 15 ± 6†
PA systolic, mmHg 34 ± 11 55 ± 15†
PA mean, mmHg 22 ± 7 37 ± 11†
PCWP, mmHg 18 ± 7 29 ± 9†
Vascular and ventricular function
PVR, mmHg/L/min 1.02 ± 0.94 0.96 ± 1.00
PA compliance, mL/mmHg 5.1 ± 2.8 4.2 ± 2.8
SVR, DSC 1699 ± 614 969 ± 372†
LVSW, g/beat 95 ± 43 113 ± 40‡
Integrated function and metabolism
VO2, mL/min 218 ± 79 572 ± 131†
CaO2–CvO2, mL/dL 4.3 ± 0.8 6.5 ± 1.8†
CO, L/min 5.3 ± 2.2 9.5 ± 4.0†
Stroke volume, mL 78 ± 36 96 ± 37‡
Values are mean ± standard deviation. ∗Columns show rest and exercise
hemodynamics. All between-group comparisons at rest and during exercise
are p = not significant. †p < 0.0001 versus baseline, within-subject change.
‡p 5 0.05 versus baseline, within-subject change. BP = blood pressure;
CaO2–CvO2 = arteriovenous O2 content difference; CO = cardiac output;
DSC = dyne/s · cm5; LVSW = left ventricular stroke work; PA = pulmonary
artery; PCWP = pulmonary capillary wedge pressure; PVR = pulmonary vascular
resistance; RA = right atrial; SVR = systemic vascular resistance; VO2 = oxygen
consumption; W = watts.
Correlation Between PCWP and
Echocardiographic Parameters
At rest, no echocardiographic parameters, including tissue
Doppler and strain echocardiography, correlated well with
PCWP (Table 3A). Among the clinical parameters, only NT-
proBNP showed a significant correlation with resting PCWP
(p = 0.028) (Table 3B). During exercise, mitral E velocity,
mitral E/A ratio, deceleration time, and E/e′septal/lateral/mean
revealed significant correlations with exercising PCWP
(Table 3A). Moreover, stress echocardiographic parameters,
including mitral E velocity, mitral E/A ratio, deceleration time,
and E/e′septal/lateral/mean, showed an even better correlation
with post-exercise 1PCWP (Table 3A). GLS also showed a
significant correlation (p = 0.03) with 1PCWP. These significant
parameters remained independent factors after multivariate
linear regression analysis with adjustment for age and sex
(Table 4). The correlation between exercise E/e′septal and
post-exercise PCWP/1PCWP is plotted in Figures 1A,B.
DISCUSSION
To our knowledge, this is the first study to examine and
compare the correlation between LV diastolic echocardiographic
parameters, including traditional tissue Doppler and novel
strain analysis, and PCWP in HFpEF patients. No resting
echocardiographic correlated significantly with resting PCWP,
while some stress echocardiographic transmitral E wave-derived
parameters (mitral E velocity, mitral E/A ratio, deceleration
time, and E/e′septal/lateral/mean) correlated well with PCWP
during exercise. We also found that exercise E/e′ correlated
better with PCWP increase than post-exercise PCWP, which
emphasizes the importance of diastolic stress echocardiography.
Diastolic stress echocardiography was applied to detect impaired
LV diastolic function reserve during exercise (Lancellotti
et al., 2016). It is of value in the diagnosis of HFpEF in
patients with symptoms of breathlessness and poor exercise
capacity. Recent guidelines suggested that HFpEF can be
diagnosed on the basis of symptoms, preserved ejection
fraction, and objective evidence of echocardiographic diastolic
dysfunction (Ponikowski et al., 2016). However, HFpEF
symptoms often occur during exercise because LVFP can be
normal at rest and only increase during exercise, which, in
turn, leads to dyspnea and effort intolerance (Holland et al.,
2010). Further, even with the newest recommendations
for LV diastolic function evaluation, some patients are
still classified as indeterminate (Nagueh et al., 2016). The
recommended modality is supine bicycle, which allows Doppler
recordings and diastolic function assessment throughout
the test. Normal hemodynamic changes in HFpEF patients
included elevations in LV end-diastolic pressure (LVEDP),
PCWP, and PA systolic pressure, which occur in parallel
to each other. To non-invasively estimate hemodynamic
changes, it is important to validate the correlation between
echocardiographic parameters and hemodynamics data,
especially PCWP and LVEDP.
Among the diastolic echocardiographic parameters, E/e′ was
the most established parameter that is correlated with LVFP.
However, the correlation was validated and more reliable in
HFrEF (Ommen et al., 2000; Ritzema et al., 2011). Moreover, the
existing studies are relatively few and showed only a moderate
correlation. A systematic review published in 2016 disclosed that
there is insufficient evidence supporting the estimation of LVFP
with E/e′, and that the diagnostic accuracy of E/e′ is limited
(Sharifov et al., 2016). The pooled correlation coefficient between
E/e′ and invasively measured LVFP was 0.56 (Nauta et al., 2018).
Moreover, previous studies had small sample sizes and included
a wide variety of cardiac diseases, which are not specific for
HFpEF patients. Echocardiography and invasive hemodynamics
measurements were not always performed simultaneously.
Otherwise, very few studies reported the correlations between
invasive hemodynamics parameters and other echocardiographic
parameters. From the multicentre EACVI Euro-filling study in
2017 (Lancellotti et al., 2017), only mitral E velocity (p = 0.003),
mitral E/A ratio (p = 0.01), deceleration time (p = 0.0005),
and E/e′lateral (p = 0.03) significantly correlated with invasive
LVEDP (estimated using PCWP) in the subgroup analysis of
patients with LVEF > 50%. Both E/e′septal and E/e′mean did not
correlate well with invasive LVEDP. Further analysis showed no
significant difference with regard to percentage in different cut-
off of diastolic parameters (e′septal < 7 cm/s, e′lateral < 10 cm/s,
E/e′septal ≥ 15, E/e′lateral ≥ 13, E/e′mean ≥ 14, left atrial volume
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TABLE 3A | Correlation between rest/post-exercise PCWP/1PCWP and echocardiographic parameters.
Rest PCWP Post-exercise PCWP 1PCWP
Rest echocardiographic Pearson correlation p-value Pearson correlation p-value Pearson correlation p-value
parameters coefficient coefficient coefficient
LVEDD 0.086 0.634
LV ejection fraction −0.302 0.087
Left atrial volume index −0.093 0.608
Mitral E velocity 0.221 0.209 0.032 0.859
Mitral E/A ratio 0.224 0.211 −0.135 0.454
Deceleration time −0.257 0.143 −0.175 0.322
e′septal 0.313 0.071 −0.235 0.181
e′ lateral 0.096 0.590 −0.148 0.404
e′mean 0.202 0.252 −0.196 0.266
E/e′septal −0.061 0.732 0.351 0.042
E/e′ lateral 0.078 0.662 0.180 0.309
E/e′mean −0.004 0.981 0.274 0.117
GLS 0.186 0.384 0.189 0.378
SRIVR 0.025 0.907 −0.108 0.615
E/SRIVR 0.099 0.645 0.262 0.217
SRe 0.226 0.287 −0.058 0.788
E/SRe 0.086 0.689 0.215 0.312
TRPG 0.195 0.268 −0.061 0.732
TAPSE −0.092 0.603 −0.075 0.674
TAS′ −0.161 0.363 −0.089 0.617
Stress echocardiographic parameters
Mitral E velocity 0.469 0.005 0.532 0.001
Mitral E/A ratio 0.559 0.001 0.673 <0.001
Deceleration time −0.380 0.026 −0.525 0.001
e′septal −0.031 0.860 −0.216 0.219
e′ lateral −0.010 0.953 −0.252 0.151
e′mean −0.023 0.898 −0.257 0.142
E/e′septal 0.493 0.003 0.684 <0.001
E/e′ lateral 0.371 0.031 0.546 0.001
E/e′mean 0.425 0.012 0.620 <0.001
GLS 0.377 0.069 0.443 0.030
SRIVR 0.097 0.654 0.278 0.188
E/SRIVR 0.273 0.197 0.207 0.333
SRe 0.194 0.364 0.151 0.482
E/SRe 0.337 0.107 0.369 0.076
TRPG 0.236 0.179 0.130 0.465
TAPSE −0.065 0.716 0.136 0.444
TAS′ −0.295 0.101 −0.267 0.139
LVEDD = left ventricular end diastolic dimension; mitral E/A ratio = ratio of the peak early (E) to peak late (A) diastolic transmitral velocities; e′septal/lateral/mean = peak early
diastolic annular velocity measured at the septal/lateral mitral annulus and their mean; E/e′septal/lateral/mean = ratio of E to e′septal/lateral/mean; GLS = global longitudinal
strain; SRIVR = strain rate during isovolumetric relaxation; E/SRIVR = ratio of E to SRIVR; SRe = early diastolic strain rate; E/SRe = ratio of E to SRe; TRPG = tricuspid
regurgitation peak gradient; TAPSE = tricuspid annular plane systolic excursion; TAS′ = tricuspid annular systolic velocity. The bold font character means statistically
significance (p < 0.05).
index ≥ 34 mL/m2, tricuspid regurgitation velocity ≥ 2.8 m/s)
between LVEDP ≥ 15 and < 15 mmHg. The current
study population was entirely composed of HFpEF patients.
The correlation between main diastolic echocardiographic
parameters and PCWP at rest was even poorer in our analysis.
Although novel strain echocardiography parameters were also
analyzed, the GLS, strain rate (either in isovolumetric relaxation
or early diastolic phase), and ratio of mitral E velocity to strain
rate all showed no significant correlation to PCWP at rest.
Although diastolic stress echocardiography may help in the
diagnosis of HFpEF, the correlation between exercise E/e′ and
invasively measured LVFP remains inconclusive. Some studies
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TABLE 3B | Correlation between rest/post-exercise PCWP and clinical
parameters.








Age −0.088 0.622 −0.042 0.812
Sex 0.300 0.085 0.151 0.395
Body mass index 0.192 0.277 0.059 0.740
Comorbidities
Coronary disease 0.155 0.383 0.241 0.169
Hypertension −0.052 0.772 −0.056 0.754
Diabetes 0.263 0.133 0.180 0.307
Medications
ACEI or ARB 0.190 0.282 0.218 0.216
Beta-blocker 0.149 0.401 0.118 0.505
CCB −0.163 0.356 −0.006 0.975
Statin 0.216 0.221 0.284 0.103
Diuretic 0.022 0.900 −0.041 0.818
Nitrate 0.122 0.492 0.036 0.842
Laboratory values
Hemoglobin −0.124 0.486 −0.122 0.492
Creatinine 0.272 0.120 0.231 0.188
NT-proBNP∗ 0.483 0.004 0.333 0.054
∗The correlation between PCWP and NT-proBNP level was non-parametrically
analyzed by Spearman’s correlation test. ACEI = angiotensin-converting enzyme
inhibitor; ARB = angiotensin receptor blocker; CCB = calcium channel blocker; NT-
proBNP = N-terminal pro-B-type natriuretic peptide. The bold font character means
statistically significance (p < 0.05).
found a good correlation between exercise E/e′ and LVFP
(Burgess et al., 2006; Talreja et al., 2007; Obokata et al., 2017)
and even that exercise E/e′ was an independent predictor of
outcomes (Holland et al., 2010; Shim et al., 2011; Takagi et al.,
2014; Kosmala et al., 2018a,b), but some did not (Maeder et al.,
2010; Choi et al., 2016). In their 2017 systematic review, Oleg
et al. concluded that the evidence for the usefulness of E/e′ in
estimating LVFP during exercise remains limited (Sharifov and
Gupta, 2017). Our study provided comprehensive measurements
of resting and exercising echocardiographic parameters, as well
as simultaneous invasive hemodynamics studies at rest and
exercise in our cohort of purely HFpEF patients. From our
analysis, mitral E velocity, mitral E/A ratio, deceleration time,
and E/e′septal/lateral/mean showed a good correlation with PCWP
during exercise.
It had been known that transmitral Doppler E wave is
proportionate to the difference between left atrium (LA) pressure
and LV diastolic pressure, which was influenced by the rate of
myocardial relaxation. Otherwise, tissue Doppler e’ velocity is
a measure of LV myocardial relaxation in early diastole and
relatively load independent (Agmon et al., 2000). As a result,
it can be inferred that transmitral E wave-derived parameters
show some correlation with PCWP, and combination of E
and e’ (E/e’) may be a better predictor. However, from our
result, we found these transmitral E wave-derived parameters
(mitral E velocity, mitral E/A ratio, deceleration time, and
E/e′septal/lateral/mean) only correlated with PCWP significantly
when exercising but not at rest. It may be speculated that the
correlation between these transmitral E wave-derived parameters
and PCWP only exists significantly in condition of elevated LVFP
and impaired myocardial relaxation (such as HFrEF or HFpEF
when exercising).
Moreover, we found that only resting E/e′septal correlated
with increased PCWP during exercise (Table 3A). However,
in the exercise stage, echocardiographic parameters including
mitral E velocity, mitral E/A ratio, deceleration time, and
E/e′septal/lateral/mean showed a much better correlation with
1PCWP (Table 3A). These result indicated that the severity of
diastolic dysfunction or impaired myocardial relaxation during
exercise may influence the change of PCWP more rather than
PCWP during exercise. Further, the significant correlations
remained after multivariate regression analysis with adjustment
for possible confounding factors including age and sex. Dorfs
et al. (2014) demonstrated that PCWP increase was associated
with increased mortality despite a normal resting PCWP. Reddy
et al. (2018) also reported that increased PCWP was associated
with reduced exercise capacity. Otherwise, 1E/e′septal/lateral/mean
also correlated well with 1PCWP (Supplementary Table S1).
All these findings emphasize the importance of diastolic
TABLE 4 | Multivariate regression analysis with post-exercise PCWP and 1PCWP as the dependent variable (adjusted for age and sex) (N = 34).
Post-exercise PCWP Post-exercise 1PCWP
Variable β (95% CI) Adjusted R2 p-value β (95% CI) Adjusted R2 p-Value
Mitral E velocity, cm/s 0.137 (0.044–0.231) 0.195 0.005 0.094 (0.040–0.148) 0.261 0.001
Mitral E/A ratio 8.857 (3.956–13.757) 0.289 0.001 6.482 (3.824-9.140) 0.434 <0.001
Deceleration time, ms −0.104 (−0.195 to −0.013) 0.118 0.026 −0.087 (−0.138 to −0.036) 0.253 0.001
E/e′septal 0.718 (0.262–1.174) 0.220 0.003 0.603 (0.372–0.834) 0.451 <0.001
E/e′ lateral 0.427 (0.042–0.813) 0.110 0.031 0.381 (0.170–0.591) 0.276 0.001
E/e′mean 0.568 (0.133–1.002) 0.155 0.012 0.501 (0.273–0.729) 0.365 <0.001
GLS, % – – – 1.147 (0.122–2.171) 0.160 0.030
Mitral E/A ratio = ratio of the peak early (E) to peak late (A) diastolic transmitral velocities; e′septal/lateral/mean = peak early diastolic annular velocity measured at the
septal/lateral mitral annulus and their mean; E/e′septal/lateral/mean = ratio of E to e′septal/lateral/mean; GLS = global longitudinal strain. The bold font character means
statistically significance (p < 0.05).
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FIGURE 1 | (A) Unadjusted correlation between E/e′septal and post-exercise PCWP. (B) Unadjusted correlation between E/e′septal and post-exercise 1PCWP.
PCWP, pulmonary capillary wedge pressure; 1, change; E/e′septal, ratio of peak early diastolic transmitral velocity to peak early diastolic annular velocity measured at
the septal mitral annulus.
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stress echocardiography. On the basis of current evidence, we
recommend diastolic stress echocardiography as a diagnostic tool
for patients suspected of having HFpEF, especially those with a
normal or indeterminate resting diastology.
We also performed strain analysis through two-dimensional
echocardiographic speckle tracking. Strain is the measurement of
myocardium deformation, whereas the strain rate is the speed
of myocardial deformity. In previous studies, HFpEF patients
had a lower magnitude of GLS and decreased strain rate despite
preserved LVEF compared with normal controls (Kraigher-
Krainer et al., 2014; Tabassian et al., 2018). Moreover, GLS is
associated with reduced exercise capacity in HFpEF patients
(Hasselberg et al., 2015). Wang et al. (2007) showed that E/SRIVR
best correlated with PCWP, especially when E/e′ ranged from 8
to 15. Magoon et al. (2018) also found that E/SRe had a better
correlation with PCWP than E/e′septal in patients undergoing
coronary artery bypass grafting with preserved ejection fraction.
Meanwhile, Ebrahimi et al. (2019) reported that SRIVR was a
better index for predicting PCWP intra-operatively in patients
undergoing coronary artery bypass grafting. However, their study
population all had coronary artery disease, and the authors
performed the measurements after general anesthesia induction.
In our study, although the novel parameter GLS significantly
correlated with 1PCWP during exercise (p = 0.03), other
diastolic strain-based indices showed a poor correlation with
PCWP, either at rest or during exercise. In summary, strain
echocardiography has better sensitivity to detect subclinical
impairment of systolic function or subtle diastolic dysfunction
(Chen et al., 2018), E/e’ has better correlation with 1PCWP
during exercise.
At last, the BP response to exercise is an important
diagnostic parameter. In healthy subjects, systolic BP rise
according to the increasing workload. However, diastolic BP
usually remained unchanged or decrease slightly (O’Brien
et al., 2002). In baseline characteristics of HFpEF patients,
we found that the diastolic pressure increased significantly
after 20-W exercise (Table 2B). These suggested the HFpEF
patient in our study have stiff arteries. Chantler et al. (2008a)
investigated the influence of arterial system on left ventricle
performance. This interaction is called arterial–ventricular
coupling, which could be indexed by the ratio of effective
arterial elastance to LV end-systolic elastance (EA/ELV). During
exercise, ELV increased disproportionately to make sure the
sufficient cardiac performance to meet the needs of the
body. Borlaug et al. (2006) found that HFpEF patient had a
threefold smaller increase in ELV during upright bicycle exercise,
compared with hypertensive patients with LV hypertrophy.
As a result, the change of EA/ELV during exercise may
also be blunted. Otherwise, it can be inferred that these
effects have contributed to the exercise intolerance in HFpEF
patients (Chantler et al., 2008b), which could be reflected by
increased LVFP during exercise and subsequent abnormal stress
echocardiographic parameters.
Clinical Implication
Invasive hemodynamic measurements can help solve the
confusion in diagnosing HFpEF. The mean PCWP confirms the
diagnosis of HFpEF (Paulus et al., 2007), and hemodynamic
stress testing could be considered in “gray cases” of patients
with early HFpEF with normal filling pressure at rest. In
such cases, a steep increase in PCWP during exercise is a
typical hemodynamic response in HFpEF, indicating that the
dyspnea on exertion is of cardiac origin (Kitzman et al., 1991).
Moreover, HFpEF patients usually experience hemodynamic
derangement especially during exercise, presenting as a higher
LVFP (PCWP). HFpEF is an increasingly recognized cause
of pulmonary hypertension due to its emerging epidemic.
Some recent studies have shown that the exercise PCWP
level is highly associated with the symptoms and life quality
of HFpEF patients (Obokata et al., 2018), and more clinical
trials have investigated exercise PCWP as a primary outcome
(Borlaug et al., 2015). Theoretically, it is not possible to
perform invasive exercise hemodynamic testing in every patient.
Despite the increasing number of emerging diastolic function
echocardiographic parameters, our study suggested exercise E/e’
to non-invasively estimate the possible hemodynamic response.
By performing echocardiography during standardized exercise
tests, the risk and outcomes may be predicted, consequently
allowing treatment plan adjustments for HFpEF patients.
Study Limitations
The main limitation of our study is the relatively small sample
size. For this reason, some echocardiographic parameters,
including strain echocardiography-derived parameters,
might not correlate well with PCWP. Moreover, though
some parameters correlated significantly, statistical type
II error might exist. Second, this study is a subgroup
analysis from ILO-HOPE trial. All patient recruitment
and exclusion criteria were designed for ILO-HOPE trial.
For example, the patients with chronic atrial fibrillation
were excluded, and they are not uncommon in HFpEF
populations. However, we believe that these selection criteria
can also be applied appropriately in our subgroup analysis
to evaluate the correlation between echocardiographic
parameters and hemodynamics data for most HFpEF
patients. Third, some medication may influence the strain
analysis (especially beta-blockers), reduce preload, and
alleviate LVFP (ACEI or ARB, diuretics, and nitrate).
However, the improvement of hemodynamics change is
parallel to echocardiographic parameter. Our main finding
may not be affected. Fourth, our current study measured
echocardiographic data and cardiac performance at rest
and under limited levels of exercise but not maximal-effort
exercises. As a result, the correlation between hemodynamics
data and echocardiographic parameters was unknown at
peak exercise. However, it would be difficult for patients
to do peak exercises repeatedly in one single test and
usually HFpEF patients perform low level of exercises
in their daily life, especially the elderly. Fifth, our cross-
sectional study cannot infer causality. Also, the coefficient
of determination (adjusted R2) in correlation between
E/e’(septal) and post-exercise 1PCWP is only 0.468. The
strength of correlation might be from few patients in the
population. Further large-scale studies are required to evaluate
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the capacity of exercise E/e’ to predict 1PCWP during exercise
in HFpEF patients.
CONCLUSION
E/e′ showed a significant correlation with both exercise PCWP
and 1PCWP even after adjustment for age and sex. Nevertheless,
novel strain rate indices showed no association with PCWP and
1PCWP, whereas GLS correlated with 1PCWP. As exercise
PCWP and 1PCWP reflect the symptoms of HFpEF patients,
exercise E/e′ may further refine the diagnosis of HFpEF.
Our study results emphasize the clinical value of diastolic
stress echocardiography.
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Background: The force-velocity-power (FVP) profile is used to describe dynamic force
production capacities, which is of great interest in training high performance athletes.
However, FVP may serve a new additional tool for cardiac rehabilitation (CR) of coronary
artery disease (CAD) patients. The aim of this study was to compare the FVP profile
between two populations: CAD patients vs. healthy participants (HP).
Methods: Twenty-four CAD patients (55.8 ± 7.1 y) and 24 HP (52.4 ± 14.8
y) performed two sprints of 8 s on a Monark cycle ergometer with a resistance
corresponding to 0.4 N/kg× body mass for men and 0.3 N/kg× body mass for women.
The theoretical maximal force (F0) and velocity (V0), the slope of the force-velocity
relationship (Sfv) and the maximal mechanical power output (Pmax) were determined.
Results: The Pmax (CAD: 6.86 ± 2.26 W.kg−1 vs. HP: 9.78 ± 4.08 W.kg−1,
p = 0.003), V0 (CAD: 5.10 ± 0.82 m.s−1 vs. HP: 5.79 ± 0.97 m.s−1, p = 0.010),
and F0 (CAD: 1.35 ± 0.38 N.kg−1 vs. HP: 1.65 ± 0.51 N.kg−1, p = 0.039) were
significantly higher in HP than in CAD. No significant difference appeared in Sfv (CAD:
−0.27 ± 0.07 N.kg−1.m.s−1 vs. HS: −0.28 ± 0.07 N.kg−1.m.s−1, p = 0.541).
Conclusion: The lower maximal power in CAD patients was related to both a lower
V0 and F0. Physical inactivity, sedentary time and high cardiovascular disease (CVD)
risk may explain this difference of force production at both high and low velocities
between the two groups.
Keywords: force-velocity-power relationship, cardiac rehabilitation, physical activity, acute coronary syndrome,
cycle sprint, exercise physiology, health
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INTRODUCTION
After an acute coronary syndrome, a cardiac rehabilitation (CR)
program is essential to restore or increase physical capacities and
reduces cardiovascular disease (CVD) risk (Pavy et al., 2012; Iliou
et al., 2015; Price et al., 2016). The objective for active subjects
is to regain their place in society and for older persons is to
maintain their independence (Pavy et al., 2012; Iliou et al., 2015).
It is necessary to adapt the content of CR sessions to optimize
aerobic and anaerobic performance along with quality of life
(Price et al., 2016).
Specifically, the improvement of maximum power output of
the neuromuscular system is one of the objectives sought in CR.
Muscle power (P), which is the product of force (F), and velocity
(V), is essential to enhance anaerobic performance (Cronin and
Sleivert, 2005; Morin and Samozino, 2016). Maximal power
capacities depend on force production abilities over the entire
spectrum of contraction velocities, which can be well described
by the force-velocity (FV) relationship (Morin and Samozino,
2016). The orientation of this FV relationship toward rather
maximal force at low velocities (i.e., force capacity) or force at
high velocities (i.e., velocity capacity) is well characterized by its
slope, which refers to the FV profile (Giroux et al., 2016).
Several studies have been carried out on the force-velocity-
power (FVP) relationship and sport performance in top athletes
(Samozino et al., 2014a,b; Giroux et al., 2016; Morin and
Samozino, 2016). This FVP profile can be evaluated on
ballistic push-offs and sprint movements (on treadmill or cycle
ergometer) (Seck et al., 1995; Morin et al., 2010). Different profiles
may be determined according to the type of physical activity and
sometimes even the athlete’s position (e.g., toward force capacity
for forward players and toward velocity for back players in rugby)
(Morin and Samozino, 2016). The analysis of the FVP profile
highlights the weaknesses in force production capacity of each
athlete. A specific training oriented in force or in velocity should
be adapted according to whether the athlete wants to maintain
his/her specificity or tip the balance of the FV profile that presents
a deleterious imbalance for his/her future performances (i.e.,
change the slope of the right of the FV profile toward an optimal
slope) (Jiménez-Reyes et al., 2016; Morin and Samozino, 2016).
Optimizing the exercise training program is constantly sought
in rehabilitation among patients always younger with coronary
artery disease (CAD) (Price et al., 2016). Indeed, the CAD
prevalence rose from an estimated 290 cases per 100,000 for those
40–44 years of age to 11,203 cases per 100,000 at 1990–2015
(Roth et al., 2017). Therefore, it might be interesting to talk about
performance even in patients and to use the FVP relationship
to more precisely identify this loss of muscle force production
capacity in patients suffering from cardiovascular impairment
as well a loss of functional capacities of their neuromuscular
system. Usual rehabilitation sessions are based on the results of
functional explorations performed in aerobic (cardiorespiratory
exercise test) and resistance (static and dynamic quadriceps test)
at the beginning of the rehabilitation cycle. Instead of using the
results of a muscle test, we could rely on the results of the initial
FVP. So far, the measurement of muscle strength production
capacities has been determined by isometric and dynamic leg
extension test. The FVP profile would allow, through a simple
and rapid assessment, to target the weakest qualities in patients
in order to individualize the training for each person.
The aim of the present study was to analyze and compare
the force production capacities through the mechanical variables
of the FVP relationship obtained during pedaling between CAD
patients and healthy participants (HP). We hypothesized that
CAD patients present lower maximal power than HP, with
notably a lower maximal force production at low velocity; but
without previous studies, we had no evidence to suggest the




Coronary artery disease patients volunteered to participate in
this study at the beginning of the CR. The inclusion criteria
were the following: (a) over 18 years of age; (b) received medical
treatment and percutaneous coronary intervention (angioplasty
with stent implantation) or surgical revascularisation (coronary
artery bypass grafting); and (c) maximal aerobic power superior
to 60 W for women and 80 W for men (Borjesson et al., 2011).
They received a measurement of their maximal oxygen uptake
(V̇O2max) during an ergocycle stress test before and after a CR
program. The study protocol conformed to the ethical guidelines
of the 1975 Declaration of Helsinki and was approved by the
institution’s human research committee. The study was registered
in the National Institutes of Health ClinicalTrials.gov database.
HP were 18 years old as patients, they were free from
any kind of CVD, performing regular physical exercise
and were volunteers to participate. The ethics committee
(IRBN372016/CHUSTE) and the national commission for
informatics and liberties (CNIL165853) approved the cohort
study for pedaling testing.
History of sport was assessed by only two questions: (1) did
you do sports (CAD patients) or (2) do you practice sports (HP)?
If yes, which sport? Sport was quantified in weekly metabolic
equivalent of task (MET) and expressed in h/week (i.e., intensity
in MET × duration × frequency), using the compendium of
sports, and ranged from 6 (vigorous intensity = sport) to 18 MET
(running at 17 km/h) (Ainsworth et al., 2000).
Experimental Protocol
At the beginning of each experiment, saddle height was adjusted
and toe clips were well fastened to avoid losing the pedals.
After a 5-min warm-up, participants performed two maximal 8-s
duration sprints, separated by a 2-min rest period, against friction
loads of 0.4 and 0.3 N.kg−1 body mass for men and women,
respectively (Figure 1). We performed pre-tests to determine
these appropriate loads. They had to remain seated during the
test. For each trial, the participants had to pedal as fast as
possible during all the sprint. For this, the experimenter (MF)
encouraged vigorously each participant throughout the sprint.
We retained the data of the best sprint (i.e., the one with the
highest maximal power).
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FIGURE 1 | Protocol diagram.
FIGURE 2 | Friction loaded Monark cycle ergometer. A, Strain gauge; B, Belt;
C, Optical encoder; D, flywheel.
Material
A friction-loaded cycle ergometer (Monark, Vansbro, Sweden)
was used (Figure 2). All features of the ergometer were detailed
in previous studies (Arsac et al., 1996; Morin and Belli, 2004).
The apparatus was instrumented with a strain gauge (FGP
Instrumentation, FN 3030 type, Les Cloyes Sous Bois, France)
to measure the friction force applied by the tension of the belt
and an optical encoder (Hengstler type RI 32.0, 100 pts/turn,
Aldingen, Germany) to measure the flywheel displacement. The
inertia was determined from the linear relationship obtained by
free deceleration of the flywheel. Data were sampled at 200 Hz
and recorded in LabVIEW software. Data were filtered with a 4th
order low pass Butterworth filter at 30 Hz. Angular velocity and
pedaling frequency were calculated from filtered displacement.
F-V Relationship
The power output (P in watts) produced at each instant during
the sprint was computed as follows (Morin and Belli, 2004):
P = (Ffrict + Finert) × V, (1)
where Ffrict was the friction force, Finert the inertial force
(computed from the flywheel inertia and acceleration) and
V the flywheel linear velocity. Instantaneous flywheel linear
velocity was calculated from the flywheel displacement. The
force (F = Ffrict + Finert), power (P) and velocity (V)
variables corresponded to mechanical outputs at the flywheel
(Jiménez-Reyes et al., 2016).
The F, V, and P values were averaged for each pedal
downstroke, which were defined between two successive minimal
FIGURE 3 | Graphical representation of power-force-velocity relationship.
values of instantaneous power (Samozino et al., 2007). The
lower limb force production capacities can be described by
the negative linear relationship (F-V) and the second order
polynomial relationship (P-V). From these two relationships,
a few parameters, which reflected the mechanical limits of the
neuromuscular system, can be determined (Figure 3; Driss et al.,
2002; Morin and Samozino, 2016): the theoretical maximum
force (F0) which could be developed at zero velocity (intercept
value on the y-axis); the theoretical maximum velocity (V0)
until which force could be produced (intercept value on the
x-axis); and the maximum power output (Pmax), corresponding
to the maximum power that an individual is able to develop
and the slope of F-V relationship (Sfv) which can be computed
as follows:
Pmax = (F0 × V0)/4, (2)
Sfv = − F0/V0, (3)
Statistical Analysis
All data were expressed as mean ± standard deviation (SD).
After checking distribution of normality with the Shapiro–Wilk
test, Student’s t-tests for independent groups were used to detect
differences in F0, V0, Sfv, and Pmax between the two populations.
For all analyses, statistical significance was defined as p < 0.05.
Cohen’s d was also computed to indicate the effect size, which
corresponded to the difference between two means divided by the
pooled SD. We interpreted the data obtained in this way: <0.2
was trivial, 0.2–0.5 a weak effect, 0.5–0.8 a medium effect, and
>0.8 a strong effect (Parker and Hagan-Burke, 2007).
RESULTS
Twenty-four CAD patients and 24 HP aged 55.8 (± 7.1) y and
52.4 (± 14.8) y, respectively, participated in this investigation.
Overweight (mean BMI > 25 kg/m2) concerned 54% of the
CAD patients and they had significantly higher BMI than HP
(27.5 ± 5.4 vs. 24.4 ± 3.4 kg/m2, p < 0.05). In addition, these
patients were physically inactive (5.3 ± 6.8 vs. 39.7 ± 42.0 MET-
h/week, p < 0.001). Descriptive characteristics of participants are
presented in Table 1.
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TABLE 1 | Morphological characteristics of participants.
Variable CAD Patients n = 24 (7 Females/17 Males) Healthy Participants n = 24 (8 Females/16 Males) p-value
Age (y) 55.8 ± 7.1 52.4 ± 14.8 0.319
Body mass (kg) 81.5 ± 17.1* 71.9 ± 13.6 0.036
Height (cm) 172 ± 9 171 ± 10 0.864
BMI (kg/m2) 27.5 ± 5.4* 24.4 ± 3.4 0.020
PA (MET-h/week) 5.3 ± 6.8*** 39.7 ± 42.0 0.000
BMI, body mass index; PA, physical activity; CAD, coronary artery disease; MET, metabolic equivalent of task. Values presented as means ± SD. Statistical difference
between two groups *(p < 0.05), ***(p < 0.001).
TABLE 2 | Mechanical performance sprint variables.
Variable CAD Patients (n = 24) Healthy Participants (n = 24) p-value Cohen’s d
F0 (N) 106.84 ± 27.78 117.14 ± 43.43 0.333 0.283
F0 (N.kg−1) 1.35 ± 0.38* 1.63 ± 0.51 0.039 0.642
V0 (m.s−1) 5.10 ± 0.82* 5.79 ± 0.97 0.010 0.722
V0 (rad.s−1) 19.6 ± 3.16* 22.3 ± 3.73 0.010 0.726
Sfv (N.kg−1.m.s−1) −0.27 ± 0.07 −0.28 ± 0.07 0.541 0.142
Pmax (W) 543.47 ± 170.36* 709.88 ± 328.14 0.032 0.612
Pmax (W.kg−1) 6.86 ± 2.26** 9.78 ± 4.08 0.003 0.816
F0, theoretical maximum force; V0, theoretical maximum velocity; Sfv, Slope of linear force-velocity relationship; Pmax, maximal power output; CAD, coronary artery
disease. Values presented as means ± SD. Statistical difference between two groups *(p < 0.05), **(p < 0.01).
The average of mechanical parameters of the FVP for each
group are reported in Table 2. We noted a significant difference
for Pmax, V0, and F0. A smaller in Pmax (−29.8%, p = 0.003), V0
(−11.9%, p = 0.010), and F0 (−18.2%, p = 0.039) were observed in
CAD patients compared to HP. However, no statistical difference
was observed between the two populations for Sfv (p = 0.557) of
FVP (Figure 4).
DISCUSSION
This study was the first to examine the mechanical parameters of
FVP in CAD patients. The main findings of this research were
that (i) Pmax, V0, and F0 were significantly lower in CAD patients
than in HP, while (ii) Sfv was similar for these two populations.
Decrease in Pmax, F0 and V0 on CAD
Patients
Considering power output as the product of force and velocity
(eq.1), the decline of maximum power was induced by a
reduction of both force production capacities at high (V0) and
low (F0) velocities. The values presented in the literature are
mostly based on high performance athletes, which leads to higher
results than those reported in our study (Vandewalle et al.,
1987; Dorel et al., 2005). Dorel et al. (2005) and Vandewalle
et al. (1987) measured peak power (Pmax) of elite cyclists who
performed short maximal sprints (about 5–6 s) on a Monark cycle
ergometer. The findings of these two studies were, respectively
19.3 ± 1.3 and 16.8 ± 1.23 W.kg−1, i.e., it was almost two and
three times the maximum power developed, respectively, by HP
and CAD patients.
FIGURE 4 | Mean force-velocity profile of healthy subjects and coronary
patients.
This difference in force and velocity between the two groups
can be explained by different factors. First, CAD patients were
significantly fatter than HP and therefore had a higher BMI. In
addition, we have no significant difference between the BMI in
CAD patients before and after CR (Before CR: 27.6 ± 5.5 kg/m2
and after CR: 26.6 ± 5.0 kg/m2, p = 0.44). Secondly, prior to
their acute coronary syndrome, patients were physically inactive.
They spent on average 5 MET-h/week, which was very low
knowing that 1 MET represented the metabolism at rest (3.5 ml
O2/kg/min) (Jetté et al., 1990). Besides, it was recommended
to walk on average 10,000 steps/d and to practice at least
150 min of physical activity weekly (Le Masurier et al., 2003)
which represents an average dose of 7.5 MET-h/week (Hupin
et al., 2015). We noted a significant difference on V̇O2max
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in CAD patients before and at the end of CR (before CR:
22.70 ± 5.20 ml/min/kg and after CR: 25.82 ± 5.78 ml/min/kg,
p = 0.0018). Thanks to CR, CAD patients improved their
V̇O2max by 15%. Compared to the reference values for people
of the same age [i.e., 38.4 ml/min/kg (Wilmore et al., 2008)]
this confirms that CAD patients are deconditioned before
the CR program. Thirdly, patients often had more sedentary
behavior before cardiovascular event. These risk behavioral
factors, combined with CVD risk factors such as smoking and
poor diet, significantly increase cardiovascular morbidity and
mortality (Gbd 2013 Risk Factors Collaborators, 2015). We can
suppose that high CVD risk and an excess fat mass prevented
them from contracting at high velocities.
This difference of V0 might be due to a remodeling of the
motor units toward a slower typology (Power et al., 2014). Other
physiological factors could be involved, such as an increase
internal resistance produced by connective tissue (Valour et al.,
2003) an increase in percentage of type I fibres (Thom et al., 2007)
and selective atrophy of type II fibers (Häkkinen et al., 1996). This
last assumption was in accordance with (Hautier et al., 1998), who
showed an important relationship between maximal power and
the relative area of fast twitch fibers. Indeed, most HP practiced
explosive sports such as football and tennis, which requested fast
twitch fibers and anaerobic metabolism.
The variation in F0 might be caused by sarcopenia, the
loss of muscle mass in patients (Häkkinen et al., 1996). In
addition, most of the patients had sedentary behavior (i.e.,
overweight and physically inactive), which led to higher a
percentage of fat tissue compared to HP. Thirdly, they might
also have a neuromuscular activation deficit or the decrease
in the effectiveness of the transmission of the voluntary
command to the muscle could explain the decrease in force
(Morse et al., 2004).
In addition, all CAD patients (except one) were receiving
beta-blocker medical treatment (none among HP). These
medications have the effect of decreasing heart rate and blood
pressure (Goldberger et al., 2015). Beta-blockers would change
neuromuscular recruitment strategy, which would explain the
impaired maximal sprint performance (Hunter et al., 2002; Fisher
et al., 2010). Moreover, statin therapy demonstrated a benefit
in CAD patients to reduce CVD risk (Shepherd et al., 1995);
however, they had deleterious effects on skeletal muscle, ranging
from muscle complaints (which explained the withdrawal of
statin in 2 CAD patients) to myositis (Mikus et al., 2013).
Finally, the treatment of CAD patients (statin, beta-blockers),
the disease and low physical activity had negative effects on
muscle function.
Similar Values of Slope
No significant difference was observed for the Sfv variable
between the two groups. The Pmax impacted both force
production at high and low velocities. The current results differed
with previous studies which indicate higher F0 values (Driss et al.,
1998; Giroux et al., 2016). Indeed, Driss et al. (1998) assessed
mechanical properties of FVP in male volleyball players during
short maximal sprint (about 6 s) on a Monark cycle ergometer
and they reported a F0 value almost two times higher than ours.
Limitation
As physical activity was evaluated solely through a few questions,
which is an approximate measure of the quantity of physical
exercise, the main limitation of this study regards the objectivity
of physical activity assessment. For future studies, more precise
tools such as actimeters should be used.
Perspectives
This study could be continued by a randomized study with a
larger number of participants to assess the impact of training
in force or velocity production force capacities according to the
initial FVP of the patients. Indeed, evidence may be emerging
that high-intensity strength training is more effective to increase
acutely myofibrillar protein synthesis, cause neural adaptations
and, in the long term, increase muscle strength, when compared
to low-intensity strength training (Hansen et al., 2019). Also,
studies report that cardiovascular demand is lower in high-
intensity than low-intensity resistance exercises, thus potentially
pointing toward sufficient medical safety of a simple sprint
on cycle ergometer for the cardiovascular system (Bjarnason-
Wehrens, 2019). The F-V (deficit in force or velocity) imbalance
initially observed from an evaluation of the FVP (sprint on
cycle ergometer) would be optimized thanks to an adapted
training program. We hypothesize that F-V profile could be
used in CR in CAD patients, as an additional and novel tool,
to induce a F-V balance adapted through personalized sessions
(Supplementary Material).
CONCLUSION
The lower maximal power in CAD patients was related to both
a lower V0 and F0. Physical inactivity, sedentary time and high
CVD risk may explain this difference of force production at both
high and low velocities between the two groups.
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Exercise training has been reported to ameliorate heart dysfunction in both humans
and animals after myocardial infarction (MI). Exercise-induced cardioprotective factors
have been implicated in mediating cardiac repair under pathological conditions.
These protective factors secreted by or enriched in the heart could exert
cardioprotective functions in an autocrine or paracrine manner. Extracellular vesicles,
especially exosomes, contain key molecules and play an essential role in cell-to-cell
communication via delivery of various factors, which may be a novel target to study the
mechanism of exercise-induced benefits, besides traditional signaling pathways. This
review is designed to demonstrate the function and underlying protective mechanism
of exercise-induced cardioprotective factors in MI, with an aim to offer more potential
therapeutic targets for MI.
Keywords: exercise, cardioprotective factors, exosomes, extracellular vesicles, myocardial infarction
INTRODUCTION
Myocardial infarction (MI) is a serious result of cardiovascular disease and the leading cause of
mortality and morbidity (Andersson et al., 2018). Approaches to inhibit the pathological process of
MI are essential for its treatment and prognosis. To date, well-documented evidences have proved
that appropriate exercise training can alleviate MI, which reduces mortality and improves the net
clinical benefit in patients with MI (Anderson et al., 2016; Lear et al., 2017; Moholdt et al., 2018).
Therefore, exercise training has been widely recommended as a therapeutic strategy for MI.
Various factors, including multiple polypeptides, nucleic acids, and similar substances are
induced during exercise, which, in part, exert protective biological effects against several diseases
(Whitham et al., 2018). Parts of cardioprotective factors are largely secreted by or enriched in
the heart, which facilitate direct communication between the myocardium and other organs, and
induce repair of cardiac injury under pathologic conditions (Shimano et al., 2012). Recently, it
has been reported that the level of some cardioprotective factors is significantly increased during
exercise training (Sanchis-Gomar et al., 2016; Whitham et al., 2018). Discovery and characterization
of exercise-induced cardioprotective factors are of great interest because they may lead to a
better understanding of the alterations in cell-to-cell communication in MI and help identify new
therapeutic targets.
However, the secretory mechanisms of exercise-induced cardioprotective factors and their
network regulation in MI are complex. Extracellular vesicles (EVs) released by cells are composed
of a lipid bilayer enclosing soluble cytosolic material and nuclear components, which could act
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in an autocrine or paracrine manner to play a role in intercellular
communication (Kowal et al., 2014). EVs divide into apoptotic
bodies, microvesicles, and exosomes (EXs) depending on their
size (Kowal et al., 2014). EVs, especially the most widely studied
EXs, can be induced by exercise to facilitate the exchange
of peptides, non-coding RNAs (ncRNAs), mRNA, DNA, and
metabolites between cells and tissues, and are considered to play
a key role in intercellular communication under physiological
and pathological conditions, such as MI (Kowal et al., 2014;
Davidson et al., 2017).
Intriguingly, circulatory EVs/EXs content varies in an
intensity-dependent manner in response to exercise training (Bei
et al., 2017). The heart is the main endocrine organ affected
during exercise, and some cardiac-derived protective factors can
be induced by exercise and carried by EVs/EXs to ameliorate the
pathological processes of MI (Ogawa and de Bold, 2014; Sanchis-
Gomar et al., 2016). Thus, this review summarizes the protective
role and underlying mechanism of cardiac-derived protective
factors that can be induced by exercise in MI, with an aim to
demonstrate their potential as therapeutic targets (Figure 1).
EXERCISE-INDUCED PEPTIDES AND MI
Certain cardiac-derived peptides exert multiple biological
functions under pathophysiological states. It has been reported
that exercise can induce the secretion of various cardioprotective
factors, which exert protective effects in MI (Safdar et al.,
2016) (Table 1).
Growth Differentiation Factor 15 (GDF15)
and Follistatin-Like1 (FSTL1)
Growth differentiation factor 15 (GDF15), also known as
macrophage inhibitory cytokine 1, is a polypeptide molecule that
could be synthesized and secreted by cardiomyocytes (Shimano
et al., 2012; Emmerson et al., 2017). GDF15 expression is
induced under various pathophysiological states and significantly
increased during MI onset (Khan et al., 2009). It has also
been found that higher levels of GDF-15 in patients with
acute coronary syndrome are associated with raised risks of
spontaneous MI, as well as cardiovascular and total mortality
(Hagström et al., 2016). Thus, GDF15 could serve as both a
biomarker and predictor for the prognosis of MI.
Moreover, GDF15 expression can be induced by exercise.
A recent study reported that plasma GDF15 levels in healthy
male individuals significantly increased from 215 pg/mL at rest to
295 pg/mL at the end of the exercise bout, and further increased
to about 350 pg/mL at the end of recovery (Kleinert et al., 2018).
More interestingly, GDF15 from femoral artery and femoral vein
has been, respectively, tested before, during, and after exercise
and found no difference. This finding suggests that exercise-
induced GDF15 may not be secreted by the skeletal muscle
(Kleinert et al., 2018), but possibly be derived from other organs,
especially the cardiac muscle.
Growth differentiation factor 15 has been found to play
important roles in regulating the pathophysiological process
of MI via its vital anti-inflammatory function (Kempf et al.,
2011). Excessive inflammatory cell recruitment to the infarcted
area after MI aggravates myocardial remodeling and leads to
fatal complications. Kempf et al. (2011) reported that GDF15-
deficient mice showed a significant increase in the recruitment
of polymorphonuclear leukocytes (PMNs) to the infarcted
myocardium and an increase in the incidence of cardiac
rupture. Conversely, infusion of recombinant GDF15 in MI mice
repressed PMN recruitment by directly inhibiting chemokine
signaling and integrin activation, indicating that GDF15 protects
against fatal cardiac rupture after MI though controlling
inflammatory cell recruitment. Rainer et al. (2014) further
showed that suppression of cardiomyocyte-specific transforming
growth factor (TGF)-β promoted GDF15 expression, which
inhibited neutrophil integrin activation and heart remodeling
after infarction (Rainer et al., 2014). Although GDF15 is
increasing after MI and its higher level can predict a
worse prognosis, it may be a promising exercise-induced
therapeutic target for MI.
FSTL1, a member of the follistatin family, is abundantly
expressed in the skeletal and cardiac muscle, and has been
shown to mediate multiple aspects of MI (Wei et al., 2015;
Shen et al., 2019). Maruyama et al. (2016) found that FSTL1
expression significantly increased after MI, and inhibiting
its expression increased mortality due to cardiac rupture in
the acute phase of MI. Moreover, FSTL1 deficiency-induced
cardiac rupture was mainly associated with attenuation of the
migratory and proliferative capabilities of cardiac fibroblasts
and reduction of extracellular matrix proteins mediated via
the extracellular signal-regulated kinase (ERK)1/2 pathway
(Maruyama et al., 2016). Shen et al. (2019) showed that
FSTL1 expression declined dramatically in hypoxia-induced
mesenchymal stem cells (MSCs), while overexpression of FSTL1
significantly prolonged MSC retention after implantation
in the ischemic myocardium, thereby preserving heart
function after MI by limiting scar formation, reducing
inflammatory response, and enhancing neovascularization.
These findings suggest that FSTL1 might serve as a key
therapeutic target for MI.
Exercise training has been shown to induce FSTL1 expression
(Xi et al., 2016; Kon et al., 2019a). In healthy individuals, 60 min
of cycling dramatically increased the serum FSTL1 level by 22%,
with a concentration increase from 16.9 ng/mL (pre-exercise) to
20.1 ng/mL (immediately after exercise), which further increased
to 21.9 ng/mL at 30 min after completing the exercise [23].
More interestingly, exercise training further increases ischemia-
induced FSTL1 expression. A previous study showed that FSTL1
expression in MI mice was 1.96-fold higher than that in control
mice, and it further increased by 4.04-fold after intermittent
aerobic exercise (Xi et al., 2016). In addition, exercise-induced
FSTL1 has been shown to improve cardiac remodeling and
prognosis after MI via promoting angiogenesis and reducing
cardiac fibrosis (Xi et al., 2016).
Interestingly, it was previously detected by a luciferase-based
reporter gene assay that FSTL1 as an upstream regulator of GDF-
15. It has been found that treatment with FSTL1 activated GDF15
production in cultured cardiomyocytes. More importantly,
transgenic production of FSTL1 stimulated GDF15 production
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FIGURE 1 | Exercise-induced cardioprotective factors on cardiac repair after MI. The heart is an endocrine organ that produces and releases cardioprotective
factors during exercise training. Cardioprotective factors mainly derived from cardiomyocytes, endothelial cells, and cardiac fibroblasts, which not only secreted by
traditional signaling pathways but also delivered via EVs/EXs that changed components during exercise. Subsequently, these factors exert important regulatory
functions for cardiac repair after MI in autocrine or paracrine manners, which may partially explain exercise-induced beneficial mechanism of MI. BDNF, brain-derived
neurotrophic factor; CTRP9, C1q/TNF-related protein 9; EVs, extracellular vesicles; EXs, exosomes; FSTL1, follistatin-like 1; FGF21, fibroblast growth factor 21;
GDF15, growth differentiation factor 15; ILs, interleukins; lncRNA, long non-coding RNA; MI, myocardial infarction; MIF, migration inhibitory factor; miR, microRNA;
MALAT1, metastasis associated lung adenocarcinoma transcript 1; NRG, neuregulin; ncRNAs, non-coding RNAs. ↑ means upregulate, ↓ means downregulate, N
means not clarified or controversial.
in the murine heart, whereas cardiomyocyte selective deletion
of FSTL1 decreased production of GDF15 in cardiomyocytes,
suggests that these proteins function as components of an
interactive network (Widera et al., 2012). Moreover, the
circulating concentration of FSTL1 has been shown to be
dependently related to GDF15 and act as a biomarker to
predict cardiovascular mortality in patients with acute coronary
syndrome (Widera et al., 2012). Overall, the co-expression of
FSTL1 and GDF15 provides an explanation for the mechanism
of exercise-induced cardioprotection in MI, at least in part.
Irisin and Fibroblast Growth Factor 21
(FGF21)
Irisin, a new type of muscle factor highly expressed in the
myocardium, has been considered as a novel exercise-induced
cardioprotective factors (Tsuchiya et al., 2015; Wang H. et al.,
2017). Irisin levels have been shown to be significantly induced
by various exercise types. Plasma irisin levels were increased by
65% in mice after 3 weeks of free wheel running exercise, while
circulating irisin levels were increased by twofold in healthy adult
humans after 10 weeks of supervised endurance exercise training
compared to the non-exercising group (Bostrom et al., 2012).
More interestingly, the effects of different exercise duration and
models on irisin levels are distinct. Irisin levels were shown to
increase significantly after acute strenuous exercise and a 30 min
bout of intensive exercise in children and young adults, but
remained unchanged after 6 weeks of chronic exercise training
(Loffler et al., 2015). Endurance exercise significantly increased
irisin levels, which began to decrease after 2 h of exercise
(Nygaard et al., 2015).
Recently, irisin has been found to protect against the
pathologic process of MI via its anti-apoptotic, pro-angiogenetic,
and cardiac regenerative functions (Wang H. et al., 2017; Liao
et al., 2019; Zhao et al., 2019). Wang H. et al., 2017 showed
that irisin treatment induced remarkable improvements in
ventricular functional recovery and reduction of infarct size in the
Langendorff perfused ischemia/reperfusion (I/R) injury heart of
mice via suppressing the opening of mitochondrial permeability
transition pore, which results in mitochondrial swelling, and
protecting mitochondrial function to reduce cardiomyocyte
apoptosis. Liao et al. (2019) reported that treatment with irisin
for 2 weeks significantly reduced infarct size and fibrosis in
MI mice, significantly increased angiogenesis in the ischemic
area, and decreased cardiomyocyte apoptosis via activating the
ERK signaling pathway. Besides, it has been recently reported
that irisin can induce cardiac regeneration and functional
improvement of MI mice via promoting the function of cardiac
progenitor cells (CPCs) (Zhao et al., 2019). Thus, irisin is a
key exercise-induced cardioprotective factor exerting multiple
functions in MI.
FGF21 has been found to ameliorate the pathological
progression of MI (Joki et al., 2015; Hu S. et al., 2018;
Tang et al., 2018). It has been shown that injection of
MI mice with recombinant interleukin (IL)-22 in the 1st
week after acute MI effectively prevents left ventricular
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TABLE 1 | Exercise-induced peptides mediate MI.
Names Secreted cells Functions Main modulation mechanisms References
GDF15 Cardiomyocytes Inhibit inflammation Repress PMN recruitment by
directly inhibiting chemokine
signaling and integrin activation
Kempf et al., 2011
FSTL1 Fibroblasts,
cardiomyocytes
Inhibit inflammation and cardiac
fibrosis, promote angiogenesis
Attenuate the migratory and
proliferative capabilities of cardiac
fibroblasts and expression of
extracellular matrix proteins
Maruyama et al., 2016
Irisin Cardiomyocytes Reduce apoptosis; induce
cardiac regeneration
Suppress the opening of
mitochondrial permeability
transition and protect mitochondria
function; promote the function of
cardiac progenitor cells













Joki et al., 2015; Hu S. et al.,
2018




and production of inflammatory
cytokines, inhibit NF-κB and p38
MAPK pathways, induce M2
macrophage polarization
Yin et al., 2014; Li et al., 2019
NRG Cardiac endothelial
cells
Attenuate apoptosis Attenuate endoplasmic reticulum
stress by activating PI3K/AKT
pathway

















Targeting its functional receptor,
tyrosine receptor kinase B
Wang et al., 2018
CTRP9 Cardiac endothelial
cells
Attenuate cardiomyocyte death Activation of ERK/MMP-9 and
ERK/Nrf2 signaling, upregulation of
anti-oxidative proteins
Yan et al., 2017
BDNF, brain-derived neurotrophic factor; CTRP9, C1q/tumor necrosis factor-related protein-9; CSCs, cardiac stem cells; ERK, extracellular signal-regulated kinase;
FSTL1, follistatin-like 1; FGF21, fibroblast growth factor 21; GDF15, growth differentiation factor 15; IL, interleukin; MI, myocardial infarction; MIF, migration inhibitory
factor; miR, microRNA; MAPK, mitogen-activated protein kinase; mTOR, mammalian target of rapamycin; MMP, matrix metalloproteinases; NRG, neuregulin; NF-κB,
nuclear factor-κB; PMN, polymorphonuclear leukocytes; PI3K/AKT, phosphatidylinositol-3-kinase/protein kinase B.
(LV) dysfunction and attenuates ventricular remodeling via
markedly increasing FGF21 expression in a signal transducer
and activator of transcription (STAT)3-dependent manner,
indicating that FGF21 might be a promising therapeutic target
for MI treatment (Tang et al., 2018). Another recent study
showed that increased FGF21 expression can ameliorate
cardiac remodeling in MI mice via increasing capillary
density around the infarct area and reducing cardiomyocyte
apoptosis together with decreasing pro-inflammatory cytokine
level in an adiponectin-dependent manner (Joki et al.,
2015). Besides, FGF21 has been reported to protect against
I/R-injury via decreasing miR-145-mediated autophagy
(Hu S. et al., 2018).
Circulating FGF21 levels have been shown to significantly
increase with exercise training (Geng et al., 2019). In healthy
subjects, the level of FGF21 increases from 276.8 to 460.8 ng/L
after 2 weeks of physical activity (Cuevas-Ramos et al., 2012).
Another random cross-sectional study showed that 5 weeks
of endurance exercise significantly increased circulating FGF21
levels in the elderly, and decreased their liver fat content
(Taniguchi et al., 2016). It has also been speculated that
exercise may induce cardiac-specific FGF21 expression via
the sirtuin1 (Sirt1)/peroxisome proliferator-activated receptor
gamma coactivator-1α (PGC-1α) signaling pathway (Guo et al.,
2016). Thus, FGF21 is considered as an important exercise-
induced cardioprotective factor for MI treatment.
It has been widely considered that irisin is widely expressed
in cardiac and skeletal muscle, while FGF21 is also abundantly
exist in the liver, adipose tissue, skeletal and cardiac muscle
to mediate lipid metabolism. A previous study identified that
exercise-induced irisin secretion could interact with FGF21 to
exert biological functions, suggesting that they may regulate
muscle–adipose crosstalk during exercise (Lee et al., 2014).
Thus, their regulatory network may be a way to explain
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muscle–adipose or organ-organ crosstalk during exercise
training, and thereby indicating further mechanisms of
exercise-induced benefits in MI.
IL Family
Several members of the IL family have been identified as
cardioprotective factors, some of which are induced by exercise.
IL-33, a cytokine belonging to the IL-1 family, is abundantly
expressed in the heart, and attenuates inflammatory response
and acts as the specific ligand for soluble ST2 (Shimano et al.,
2012; Chen et al., 2018). IL-33 is mainly secreted by cardiac
fibroblasts, exerting its function in a paracrine manner to
exchange information with cardiomyocytes, and thereby playing
an important role in the pathophysiological process of MI
(Chen et al., 2018).
It has been reported that IL-33/ST2 pathway activation
results in inhibition of apoptosis and inflammation, reduction
of cardiac fibrosis, and improvement of cardiac function
(Chen et al., 2018). Yin et al. (2014) found that IL-33
effectively suppressed macrophage infiltration and production
of inflammatory cytokines in the myocardium after MI, and
injection of recombinant IL-33 in MI mice reduced infarct size,
attenuated cardiac remodeling, and improved cardiac function by
inhibiting nuclear factor-κB (NF-κB) and p38 mitogen-activated
protein kinase (MAPK) signaling pathways. Besides, Li et al.
(2019) showed that IL-33 reduced infarct area and prevented the
progression of fibrosis by inducing M2 macrophage polarization
in MI mice model via activating the Janus kinase (JAK)/STAT
pathway. Thus, IL-33 exerts anti-inflammatory effects in MI.
Various factors, including exercise training, have be shown
to stimulate IL-33 expression. Further, it has been demonstrated
that long-term medium-intensity exercise not only decreases the
expression of pro-inflammatory factors, like Toll-like receptor
4 (TLR4), NF-κB, and IL-18, but also significantly increases
the level of the anti-inflammatory factor IL-33 in patients with
diabetes mellitus (Liu et al., 2015). Hence, IL-33 is considered as
an exercise-induced cardioprotective factor that exerts important
protective functions in MI.
Besides, IL-6 and IL-1β have also been identified as
cardioprotective factors, as they aggravate MI. Distinctly, exercise
training has been shown to reduce their expression, which may
be a potential approach to ameliorate MI (Pedersen, 2017).
Although not all IL family members are widely expressed in
the heart and induced by exercise, they exert vital functions to
regulate the course of MI. Several members of this family have
been identified as exercise-induced cardioprotective factors, and
may serve as promising therapeutic targets for MI.
Other Exercise-Induced Polypeptides
Neuregulin (NRG) is expressed in human cardiac endothelial
cells and acts as an endothelial cell-derived molecule that exerts
cardioprotective effects (Hedhli et al., 2011). NRG has been found
to protect against cardiomyocyte apoptosis induced by hypoxia-
reoxygenation, and in an in vivo study it was shown to reduce
infarct size and cardiomyocyte apoptosis after myocardial I/R-
injury (Hedhli et al., 2011). Furthermore, the cardioprotective
effect of NRG was shown to be mediated via attenuation of
endoplasmic reticulum stress and cardiomyocyte apoptosis by
activating the phosphatidylinositol-3-kinase/protein kinase B
(PI3K/AKT) signaling pathway under I/R states (Fang et al.,
2017). More interestingly, exercise can upregulate NGR and its
ligand expression to promote cardiac repair, indicating that NRG
is an exercise-induced cardioprotective factor and serves as a
promising therapeutic target for MI (Cai et al., 2016).
Migration inhibitory factor (MIF) is a macrophage factor
that regulates inflammation and immunity, and is secreted
by cardiomyocytes and cardiac fibroblasts to promote
cardiomyocyte survival and regulate inflammation after
MI (Voss et al., 2019). Besides, it has been reported that
MIF promotes cardiac stem cell survival, proliferation, and
endothelial differentiation by targeting its receptor CD74 via
activation of the PI3K/AKT/mammalian target of rapamycin
(mTOR) and adenosine monophosphate-activated protein kinase
(AMPK) signaling pathways. This finding suggests a potential
therapeutic role of MIF in the treatment of MI (Cui et al., 2016).
Additionally, MIF expression can also be induced by exercise,
and it has been identified as an exercise-induced cardioprotective
factor that protects against MI (Chang et al., 2019).
Brain-derived neurotrophic factor (BDNF), widely expressed
in various non-neural tissues, such as vascular endothelial cells
and myocardial cells, plays a protective role in MI via targeting
its functional receptor, tyrosine receptor kinase B (Zhang et al.,
2019). Recent studies have found that BDNF can promote
angiogenesis, inhibit inflammatory response, and attenuate
cardiac remodeling, thereby improving cardiac function and
prognosis after MI (Wang et al., 2018). Well-documented
evidences have shown that BDNF expression is significantly
induced by exercise training, and thereby it can be considered as
a beneficial exercise-induced cardioprotective factor (Wang et al.,
2018; Zhang et al., 2019).
C1q/TNF-related protein-9 (CTRP9) is a novel
cardioprotective factor primarily secreted by the adipose
tissue and cardiac endothelial cells (Zhao et al., 2018). CTRP9
has been shown to enhance adipose-derived mesenchymal
stem cell (ADSC) proliferation and survival after implantation
to MI mice. Further, CTRP9 stimulates ADSC migration and
attenuates cardiomyocyte cell death after MI via binding with
N-cadherin, activation of ERK/MMP-9 and ERK/Nrf2 signaling,
and upregulation/secretion of anti-oxidative proteins (Yan
et al., 2017). Besides, CTRP9 expression is also induced by
exercise, and a single bout of high intensity interval training is
sufficient to stimulate CTRP9 secretion in healthy men (Kon
et al., 2019b). Thus, CTRP9 has been identified as a novel
exercise-induced cardioprotective factor exerting potential
therapeutic effects in MI.
EXERCISE-REGULATED NCRNAS
AND MI
Non-coding RNAs, which do not code for proteins but
functionally regulate protein expression, have been identified as
critical regulators of cell function and important candidates that
protect against MI (Guo et al., 2017). MicroRNAs (miRNAs,
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miRs) are a class of short-chain ncRNAs that have been reported
to regulate MI via negatively modulating their target genes
(Chistiakov et al., 2016). Cardiac-derived miRNAs induced by
exercise may explain the exercise-induced beneficial effects on MI
(Gomes et al., 2014) (Table 2).
miR-1 and miR-133
miR-1 and miR-133 are highly expressed in cardiomyocytes
and play an important role in regulating myocardial autonomy,
conduction, contraction, and myocyte differentiation and
proliferation (Chistiakov et al., 2016). Previous studies have
reported that miR-1 and miR-133 expression is regulated by
exercise. It was shown that miR-1 and miR-133 expression
significantly increased in marathon athletes after exercise (Gomes
et al., 2014). However, another study demonstrated that miR-
1 and miR-133 expression was significantly downregulated after
exercise (Pietrangelo et al., 2015). These paradoxical results may
be attributed to individual variations and differences in exercise
duration. More interestingly, both miR-1 and miR-133 have been
shown to exert important regulatory functions in MI (Duan et al.,
2018; Yu et al., 2019).
While the regulatory role of miR-1 in MI remains
controversial, studies suggest that transplantation of stem cells
with miR-1 overexpression exerts important protective effects
after MI. It has been reported that transplantation of embryonic
stem cells with miR-1 overexpression can significantly reduce
apoptosis and improve cardiac function via phosphatase and
tensin homolog deleted on chromosome 10 (PTEN)/AKT
pathway activation (Glass and Singla, 2011). Additionally,
transplantation of MSCs overexpressing miR-1 into the infarcted
myocardium of mice was shown to improve cell survival rate,
promote cardiomyogenic differentiation, and improve cardiac
function, indicating that miR-1 has a protective effect on MI
(Huang et al., 2013). However, the direct function of miR-1 in
MI requires further investigation.
miR-133 plays a cardioprotective function in MI. Li et al.
(2015) found that overexpression of exogenous miR-133
significantly attenuated cardiomyocyte apoptosis, both in vitro
and in vivo, in a hypoxia-reoxygenation injury model via
inhibition of death associated protein kinase 2 (DAPK2).
Izarra et al. (2014) further reported that miR-133 can attenuate
myocardiocyte apoptosis through inhibiting the expression of
pro-apoptotic genes, including caspase-9, apoptotic protease
activating factor, DAPK2, Bcl2-like 11, and Bcl-2-modifying
factor. In an MI rat model, it was reported that overexpression of
miR-133 significantly promotes angiogenesis and cardiomyocyte
proliferation, and inhibits cardiac hypertrophy and fibrosis,
thereby improving cardiac function (Izarra et al., 2014).
Another study showed that transplantation of miR-133-
overexpressing MSCs in ischemic area in MI rat model markedly
improved cardiac function (Chen et al., 2017). Therefore,
overexpression of miR-133 may be an important therapeutic
strategy for MI treatment.
miR-208 and miR-499
The cardiac-enriched miRNAs, miR-208 and miR-499, are mainly
involved in modulation of differentiation and development of
cardiac fibroblasts and cardiomyocytes, and play a vital role in
maintaining normal cardiac function (Chistiakov et al., 2016). It
has been shown that the expression of miR-208 is significantly
downregulated, while that of miR-499 is markedly upregulated
after exercise training, which may partly explain the benefits of
exercise (Baggish et al., 2014; Soci et al., 2016).
miR-208 promotes cardiomyocyte apoptosis and cardiac
remodeling after MI. Yan et al. (2016) found that inhibition of
miR-208 expression in neonatal rat cardiomyocytes under
hypoxia condition could relieve cardiomyocyte injury.
Bian et al. (2015) showed that overexpression of miR-
208 markedly aggravated I/R-induced myocardial injury
in rats and promoted hypoxia-induced cardiomyocyte
apoptosis in vitro, while knockdown of miR-208 suppressed
cardiomyocyte apoptosis. Further, they found that miR-
208 induced apoptosis via its target gene Ets1. The
expression of miR-208 is directly correlated with β-MHC
levels and cardiac collagen capacity. Therefore, inhibiting
miR-208 expression may be a potential therapeutic
approach for MI.
miR-499 has important regulatory effects on the pathological
process of MI. Wang et al. (2014) found that miR-499
protected cardiomyocytes against H2O2-induced apoptosis
and overexpression of miR-499 in rat cardiomyocytes increased
cell survival rate by inhibiting the mitochondrial apoptosis
pathway and pro-apoptotic gene expression. The pro-apoptotic
gene Dyrk2 promoted apoptosis by increasing the level of
p53 phosphorylation, whereas miR-499 significantly inhibited
Dyrk2 expression, preventing the transfer of activated p53 to the
mitochondria and inhibiting apoptosis. miR-499 has also been
shown to suppress calcineurin-mediated dephosphorylation of
dynamin-related protein-1 (Drp1) to inhibit cardiomyocyte
apoptosis, thereby reducing Drp1 accumulation in the
mitochondria and mitochondrial fission (Wang et al., 2011).
Furthermore, Shi et al. (2019) found that miR-499 reduced
H9C2 cell injury by inhibiting the expression of Sox6, and
suppressed apoptosis by increasing Bcl-2 and decreasing Bax and
caspase-3 expression under hypoxia-reoxygenation condition.
Therefore, miR-499 can target multiple genes to protect against
apoptosis after MI.
Other Cardiac-Derived miRNAs
miR-126, mainly expressed in endothelial cells, significantly
promotes angiogenesis around the infarct area after MI
(Jiang et al., 2014). The expression of cardiac-enriched
miR-126 is significantly changed after MI, exerting pro-
angiogenetic effects to maintain vascular wall integrity by
negatively regulating its target gene Spred1 (Guo et al.,
2018). Exercise can increase miR-126 expression. It has
been reported that miR-126 expression was upregulated
by 2.1- and 4.6-fold in healthy subjects after a maximal
symptom-limited exercise test and 4 h of cycling, respectively
(Uhlemann et al., 2014). Thus, miR-126 is an important
exercise-induced factor that protects against MI mainly by
promoting angiogenesis.
miR-21, a miRNA transcribed by RNA polymerase II, is widely
expressed in endothelial cells and exerts protective functions after
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TABLE 2 | Cardiac-enriched ncRNAs regulate MI.
ncRNAs Regulated by
exercise
Functions Main modulation mechanisms References
miR-1 Controversial Inhibit apoptosis, promote
cardiomyogenic differentiation
Activate PTEN/AKT pathway and
improve transplanted MSC survival
rate
Glass and Singla, 2011; Huang
et al., 2013
miR-133 Controversial Attenuate cardiomyocyte
apoptosis and cardiac fibrosis,
promote angiogenesis and
cardiomyocytes proliferation
Inhibit pro-apoptotic genes DAPK2
expression, improve transplanted
MSC survival rate
Izarra et al., 2014; Li et al.,
2015; Chen et al., 2017
miR-208 Downregulate Aggravate cardiac fibrosis,
promote apoptosis
Induce apoptosis through
regulation of target gene Ets1,
directly proportional to β-MHC and
cardiac collagen capacity
Bian et al., 2015
miR-499 Upregulate Inhibit cell apoptosis Inhibit mitochondrial apoptosis
pathway, inhibit pro-apoptotic gene
Dyrk2, reduce the
dephosphorylation of Drp1 and the
accumulation of Drp1 in
mitochondria
Wang et al., 2011, 2014
miR-126 Upregulate Promote angiogenesis,
maintain vascular wall integrity
Inhibit its target gene Spred1 Guo et al., 2018
miR-21 Upregulate Inhibit fibrosis, inflammation,
and apoptosis
Inhibit its target gene Jagged1,
inhibit KBTBD7, p38 and NF-κB
pathway and TNF-α induced
apoptosis
Wang Z.H. et al., 2017; Yang
et al., 2018; Zhou X.L. et al.,
2018
lncRNA H19 Normalized H19 gene
methylation




Target to miR-103/107, miR-139,
and miR-675-5p, respectively
Wang et al., 2015; Gong et al.,
2017; Huang P. et al., 2019
lncRNA
MALAT1




Sponge miR-558, miR-145, and
miR-200a-3p, respectively
Guo et al., 2019; Huang S.
et al., 2019; Sun and Zhang,
2019
DAPK2, death associated protein kinase 2; Drp1, dynamin-related protein-1; KBTBD7, kelch repeat and BTB (POZ) domain containing 7; lncRNA, long non-coding RNA;
MI, myocardial infarction; miR, microRNA; MALAT1, metastasis associated lung adenocarcinoma transcript 1; MSC, mesenchymal stem cell; NF-κB, nuclear factor-κB;
PTEN, phosphatase and tensin homolog deleted on chromosome 10; TNF-α, tumor necrosis factor-α.
MI. A previous study demonstrated that miR-21 exerts anti-
fibrotic effects via promoting cardiac fibroblast-to-myofibroblast
transformation by regulating its target gene Jagged1 (Zhou X.L.
et al., 2018). Another study showed that miR-21 attenuated
inflammation, cardiac dysfunction, and maladaptive remodeling
post-MI through targeting kelch repeat and BTB (POZ) domain
containing 7 and inhibiting p38 and NF-κB pathway activation
(Yang et al., 2018). Intriguingly, a recent study showed that the
serum level of miR-21 was upregulated in elderly patients with
acute MI, and that miR-21 suppressed TNF-α-induced apoptosis
in human cardiomyocytes via stimulating the activation of
JNK/p38/caspase-3 signaling pathway (Wang Z.H. et al., 2017).
Additionally, miR-21 expression has been shown to be regulated
by exercise, indicating a novel mechanism underlying exercise-
induced benefits in MI (Wahl et al., 2016).
Long ncRNAs (lncRNAs)
lncRNAs are transcripts longer than 200 nucleotides that
regulate various biological processes by interacting with multiple
transcription factors (Wang et al., 2015). Recently, it has been
identified that lncRNAs play a crucial regulatory function
in MI. The lncRNAs H19 and metastasis associated lung
adenocarcinoma transcript 1 (MALAT1) have been widely
studied, and their levels are shown to be regulated by exercise.
Exercise-induced lncRNA H19 expression has been shown to
involve in epigenetic modifications (Xu et al., 2017). lncRNA
MALAT1 expression can be induced by swimming via inhibition
of apoptotic functions, thereby protecting hippocampal neurons
against ischemic diseases (Shang et al., 2018).
The lncRNA H19 has been reported to play multiple roles
after MI. Wang et al. (2015) reported that lncRNA H19
directly binds to miR-103/107 and reduces its expression, which
promotes Fas-associated protein with death domain expression,
and participates in H2O2-induced necrosis in H9C2 cells. This
finding revealed that lncRNA H19 prevents cardiomyocyte
necrosis in MI. Furthermore, lncRNA H19 was shown to
alleviate myocardial cell injury through reduction of miR-139
expression and further upregulation of its target gene Sox8
via PI3K/AKT/mTOR and MAPK pathway activation (Gong
et al., 2017). Additionally, lncRNA H19 has been shown to
enhance angiogenesis, prevent cardiomyocyte apoptosis, and
improve cardiac function after MI via targeting miR-675-5p
(Huang P. et al., 2019). Besides, overexpression of lncRNA H19
in mice was shown to reduce infarct size and improve cardiac
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function via activating autophagy (Zhou M. et al., 2018). These
findings demonstrate that lncRNA H19 exerts essential protective
functions in MI.
lncRNA MALAT1 is highly expressed in vascular endothelial
cells and has a complex function in MI (Li L. et al., 2018). It
was initially reported that genetic deletion or pharmacological
inhibition of MALAT1 reduced vascular growth in vivo,
suggesting that MALAT1 promoted angiogenesis in ischemic
diseases (Michalik et al., 2014). Besides, it has been shown that
MALAT1 protects against cardiomyocyte apoptosis after MI by
sponging miR-558, thereby inducing Unc-51-like autophagy-
activating kinase 1-dependent protective autophagy (Guo et al.,
2019). However, a recent study reported that MALAT1 promoted
cardiac fibrosis and deteriorated cardiac function post-MI by
increasing TGF-β1 activity and inhibiting miR-145 expression
(Huang S. et al., 2019). Additionally, MALAT1 has been shown
to increase cell apoptosis in MI via acting as a competing
endogenous RNA to sponge miR-200a-3p (Sun and Zhang, 2019).
Thus, lncRNA MALAT1 exerts critical regulatory functions in
various biological processes during MI, including angiogenesis,
cell proliferation, apoptosis, and cardiac fibrosis. Nevertheless,
whether it plays a protective or detrimental role in MI requires
further investigation.
NOVEL SECRETORY MECHANISMS OF
EXERCISE-INDUCED
CARDIOPROTECTIVE FACTORS IN MI
Recent researchers have identified EVs as an important cell-
to-cell communication way (Doroudgar and Glembotski, 2011).
EVs, secreted by cells in the form of vesicles containing various
signaling molecules, play a role in cell-to-cell communication
under pathophysiological conditions (Safdar et al., 2016). As
previously described, EXs are one of the most widely studied
EVs. Generally, EXs act in an endocrine, autocrine, or paracrine
manner to exert their biological functions (Safdar et al., 2016).
The biogenesis and release of EXs is related to complex
regulatory factors. As previously described, EXs biogenesis begins
within the endosome system and is matured in an endosomal
sorting complex required for transport (ESCRT)-dependent
or independent manner (Colombo et al., 2014). Molecular
regulators implicated in exosome release include multiple factors,
especially Soluble NSF Attachment Protein Receptor (SNARE)
and Rabs GTPases (Colombo et al., 2014). Thus, EXs carries not
only secreted factors but also a cluster of scaffold proteins, which
may be used to derive their source cells. It has been found that
EXs originated from cardiomyocytes mainly express caveolin-
3 and Troponin T, from cardiac fibroblast express CD90.2, and
from endothelial cells express CD31 (Loyer et al., 2018).
At present, many kinds of cells have been shown to
secrete EXs, including various stem cells, endothelial cells,
cardiofibroblasts, and cardiomyocytes (Barile et al., 2017). EXs
derived from different cells exhibit different functions. A recent
study reported that cardiomyocytes release EVs under ischemic
stress; and cardiomyocytes as the main source of bioactive EXs
in coronary serum (Li H. et al., 2018). Interestingly, certain cells
exert various biological functions by releasing EXs with different
components, which varies under different culture conditions
and stimuli (Gallet et al., 2017; Ribeiro-Rodrigues et al., 2017;
Huang P. et al., 2019).
Previous studies have shown that EVs/EXs stimulated by
ischemia exert important cardioprotective functions after MI via
changing their contents (Gallet et al., 2017; Ribeiro-Rodrigues
et al., 2017; Gao et al., 2018). Ribeiro-Rodrigues et al. (2017)
found that EXs secreted by cardiomyocytes under ischemic
conditions contained high levels of matrix metalloproteinases
(MMP), miR-222, and miR-143, and stimulated the formation of
new functional vessels following MI. Barile et al. (2014) reported
that infarcted hearts injected with EVs from CPCs showed
reduced cardiomyocyte apoptosis, enhanced angiogenesis, and
improved LV ejection fraction compared with those injected with
control medium, and this effect was induced by the changed levels
of miR-210, miR-132, and miR-146a-3p in EVs. Li H. et al., 2018
also found that, compared to EXs from healthy controls, EXs
from patients with myocardial ischemia enhanced endothelial cell
proliferation, migration, and tube formation via downregulation
of miR-939-5p, and thereby increased endothelial nitric oxide
production, eventually promoting angiogenesis.
More interestingly, exercise can induce various organs to
release EVs/EXs that are enriched in various peptides, ncRNAs,
and other substances. The release of EXs was shown to
significantly increase immediately after cycling exercise and then
decline again within 90 min at rest, while release of EXs was
moderate but appeared more sustained after treadmill running.
Moreover, release of EXs into the circulation has been shown to
be initiated in the aerobic phase, suggesting that it is independent
of the metabolic changes during exercise (Fruhbeis et al., 2015).
Further, in another study, after a 1 h bout of cycling exercise
in healthy humans, an increase in the circulation of over 300
proteins was observed, and most of them were secreted by
EXs, suggesting that exercise exerts systemic biological effects
(Whitham et al., 2018). Thus, EXs may provide a new approach
to explain the multiple protective mechanisms of exercise in MI.
Additionally, it has been found that exercise can
induce cardiomyocytes to release EVs/EXs, which exert a
cardioprotective function in MI. A recent study showed that
the serum level of EVs was increased by about 1.85-fold in
mice after 3 weeks of swimming (Bei et al., 2017). Furthermore,
intramyocardial injection of EVs induced by exercise exerted
additional anti-apoptotic effects on H2O2-treated H9C2
cardiomyocytes compared to exercise alone. The protective
effects on acute ischemia in mice were mediated by the activation
of the ERK1/2 and HSP27 pathways (Bei et al., 2017). Thus,
exercise-induced EVs/EXs released by cardiomyocytes exert
important protective functions in MI.
Cardioprotective factors carried by EXs have been found to
regulate MI pathology (Hu M. et al., 2018). In an MI mice model,
it was reported that the level of cardiac-enriched miRNAs, such as
miR-1 and miR-499 was predominantly increased in circulating
EXs, subsequently mediating functional crosstalk between the
ischemic heart and bone marrow for repair of cardiac injury
(Cheng et al., 2019). Recently, the exosomal lncRNA H19 derived
from MSCs has been reported to mediate the cardioprotective
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effects in infarcted hearts via promoting endothelial cell function
and angiogenesis (Huang P. et al., 2019). Besides, polypeptide
molecules, like MIF and BNDF can also be delivered by EXs to
exert biological functions (Suire et al., 2017; Amosse et al., 2018).
Thus, EXs may serve as important vehicles to deliver exercise-
induced cardioprotective factors and as mediators of intercellular
communication in MI, which may be a possible mechanism
underlying exercise-induced benefits.
In summary, exercise has beneficial effects on MI, but its
mechanisms are complex and need to be fully elucidated. It has
been found that exercise can induce the secretion of a variety
of polypeptide molecules, ncRNAs, and other substances derived
from the myocardium and other organs. Several recent studies
have reported that EVs/EXs are enriched in a large number
of cardioprotective factors, and their secretion is regulated by
exercise. This review summarizes the effects of newly discovered
exercise-induced cardiogenic peptides and ncRNAs on MI and
their potential mechanisms, thus aiming to provide a new
theoretical basis for the application of exercise training in the
clinical treatment of MI.
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